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SUMMARY
SUMMARY
The work presented herein represents an exam ination o f the a -  
adrenoceptors mediating contractions in isolated vascular preparations from the 
rabbit and the factors involved in modulating these responses.
1) The a-adrenoceptor population in the rabbit isolated lateral saphenous vein, 
based upon agonist and antagonist potency profiles, could not be ascribed to be 
either a homogeneous population of either postjunctional a j -  or a 2 -adrenoceptors, 
but had characteristics of both.
2) A homogeneous population of postjunctional a 2 -adrenoceptors could be 
isolated in the lateral saphenous vein using receptor protection experiments with the 
combination of rauwolscine and phenoxybenzamine.
3) Only limited success was achieved in attempting to isolate a homogeneous 
population of postjunctional a  ^ -adrenoceptors in the lateral saphenous vein using 
receptor protection experim ents with the com bination o f YM 12617 and 
phenoxybenzamine. The residual response to NA remaining after this procedure 
had characteristics of a mixed population of both postjunctional a ^ -  and a 2 - 
adrenoceptors.
4) A comparison of the effects of angiotensin II and Bay K 8644 revealed 
marked differences in their ability to modulate responses to NA mediated via 
postjunctional a^ - and a 2 -adrenoceptors. A II  produced a selective enhancement of 
responses mediated via postjunctional a 2 -adrenoceptors, while the action of Bay K 
8644 was not dependent upon receptor subtype.
20
5) In the lateral saphenous vein after isolation o f postjunctional <*2 - 
adrenoceptors, both Bay K 8644 enhanced responses to NA. The mechanism of 
this potentiation also appears to differ for these agents. Bay K 8644 enhanced 
responses mediated via voltage-dependent Ca^+ channels, while A II  inhibited the 
influx of Cd?+ mediated via these channels.
6) The effects of A II on responses m ediated via postjunctional a.2~ 
adrenoceptors, was mimicked by its physiological precursor angiotensin I, 
suggesting that local vascular production of A II may be im portant for the 
facilitatory action of this peptide.
7) Nifedipine, like Bay K 8644, had a non-differential effect on responses to 
NA mediated via postjunctional a^ - and (^-adrenoceptors in a number of isolated 
vascular preparations.
8) Under normal experimental conditions, based upon agonist and antagonist 
potencies, the rabbit isolated distal saphenous artery contains a homogeneous 
population of postjunctional ap-adrenoceptors.
9) In the presence of A II, there was a marked increase in the responsiveness 
of the distal saphenous artery to U K -14304, which was prazosin-resistant, 
rauwolscine-sensitive, and so mediated via postjunctional a 2 -adrenoceptors.
10) After attempted isolation of postjunctional oc2 -adrenoceptors in the distal 
saphenous artery using receptor protection experiments, with the combination of 
rauwolscine and phenoxybenzamine, no responses were observed.
21
11) A D  uncovered responses to a-adrenoceptor agonists after the combination 
of rauwolscine and phenoxybenzamine. The agonist and antagonist potencies after 
this protocol were consistent with a homogeneous population of postjunctional ot2 - 
adrenoceptors.
12) Some of the results in the present study indicate an interaction between 
postjunctional a j -  and ot2 -adrenoceptors in vascular smooth muscle. The 
implications for such an interaction is discussed in detail. Furthermore, evidence is 
presented demonstrating an interaction between postjunctional c^-adrenoceptors 
and a number of vasoactive agents.
13) Sympathetic neurotransmission in the rabbit isolated distal saphenous artery 
is the resultant of an interaction between three receptor systems, postjunctional ocj- 
and ot2 -adrenoceptors and purinoceptors. a  j-adrenoceptors are of principal 
importance, although a role for the two other receptor systems can be demonstrated 
under the appropriate experimental conditions.
22
INTRODUCTION
INTRODUCTION
Section 1 : Alpha-adrenoceptors on vascular smooth muscle 
Historical subdivision o f adrenoceptors
Some of the earliest experimental evidence suggesting that adrenoceptors 
could be differentiated into two distinct classes was provided by Dale (1906). He 
dem onstrated in the pithed cat, that pressor responses to adrenaline could be 
blocked by ergot alkaloids, unmasking a depressor response to the agonist. The 
prevailing view at this time was that adrenaline was the most likely mediator of 
sympathetic neurotransmission (Elliot, 1905). In a more comprehensive study, 
Barger & Dale (1910) demonstrated that noradrenaline mimicked the effects of 
sympathetic nerve stimulation more closely than adrenaline, but this observation 
was overlooked for many years. However in this study, these authors, comparing 
the potency ratios for a large series of catechols, again emphasised that motor and 
inhibitory sympathomimetic activity varied to some extent independently. Therefore 
even at the begining of the century, when the concept of receptors was very much 
in its infancy, the use of relatively selective antagonists and comparing agonist 
potency ratios, provided retrospective evidence for receptor subdivision.
It appears however, that workers at this time were rather sidetracked by 
believing that the polarity of the response was crucial. One explanation forwarded 
to explain the fact that adrenaline could excite some smooth muscles but inhibit 
others was that of Cannon & Rosenbleuth (1933), who called the sympathetic 
transmitter sympathin, to emphasise that its actions were not identical to adrenaline. 
These authors suggested that sympathin, released upon nerve stimulation, could 
combine with one of two hypothetical substances. These substances made the
23
sympathin excitatory or inhibitory so that two sympathins could be produced: 
sympathin E (excitatory) or sympathin I (inhibitory). This hypothesis persisted for 
some tim e, before d ifferent adrenoceptor subtypes were defined on a 
pharmacological basis in 1948.
It was in this year that Ahlquist noticed that there were two distinct orders of 
potency for a series of catecholamines, adrenaline (AD), noradrenaline (NA), a -  
methylnoradrenaline (a-M eNA), a-m ethyladrenaline (a-M eAD) and isoprenaline 
(ISO), when tested on a wide variety of preparations. For excitatory events, but 
excepting stimulation of the heart, the order of potency was:
(-) AD > (±) AD > (±) NA > a-M eNA > a-M eAD > (±) ISO 
while for inhibitory events, but excluding inhibition of the gut, the order of potency 
was:
(±) ISO > (-) AD > a-MeAD > (±) AD > a-M eNA > (±) NA 
He concluded that the differences in potency orders could only be explained by 
assuming differences in the receptors. Therefore he classified the receptors that 
mediated mainly excitatory effects, but that included inhibition in the gut, "a" and 
the other which was mainly inhibitory, but included stimulation of the heart, "P". 
This dual receptor theory was generally ignored at the time until the selective p- 
blocking drug dichloroisoproteronol was introduced (Powell & Slater, 1958). This 
compound, followed by pronethalol (Black & Stephenson, 1962) and propranolol 
(Black et al., 1964) then allowed the rigorous examination and confirmation of 
Ahlquist's classification.
Subdivision o f a-adrenoceptors
The pharmacological subdivision of a-adrenoceptors awaited the realisation 
that NA was able to inhibit its own release from sympathetic nerves via pre­
junctional a-adrenoceptors in a negative feedback system (see: Starke, 1977,
24
W estfall, 1977). The first evidence to indicate this mechanism, was from the 
experim ents o f Brown and G illespie (1956, 1957), who observed that 
phenoxybenzamine was able to increase the amount of NA appearing in venous 
blood from the cat spleen following nerve stimulation. This observation was 
com plicated by the fact that the end organ response was reduced by the a -  
adrenoceptor antagonist. Several explanations were forwarded to explain the 
paradox that phenoxybenzamine increased NA bioavailability, but reduced tissue 
response, generally concentrating on factors relating to the metabolism and/or 
uptake of the transmitter (Brown & Gillespie, 1957, Gillespie, 1966).
A prejunctional mechanism of action however became a more likely 
explanation from studies by Langer et al. (1971) and Starke (1972). These authors 
demonstrated, in guinea-pig atria and perfused rabbit heart respectively, that a -  
adrenoceptor antagonists increased transm itter overflow  following nerve 
stim ulation, w ithout altering NA m etabolism  or uptake. The paradoxical 
postjunctional action on a-adrenoceptors was not a complication since the end 
organ response in these preparations is mediated via (3-adrenoceptors. Further 
evidence favouring prejunctional a-adrenoceptor modulation of transmitter release 
was the demonstration that a-adrenoceptor antagonists increased stimulation 
induced overflow of NA and dopamine (3-hydroxylase, a marker for exocytotic 
release o f NA, in the dog spleen, while cocaine only increased NA levels (De Potter 
et al., 1971). It is now a wideheld belief that NA can inhibit its own release by 
interacting with a-adrenoceptors located on nerve endings.
Differences between pre- and postjunctional a-adrenoceptors were soon 
implicated by examining agonist and antagonist potencies. Phenoxybenzamine was 
shown to be more potent at blocking contractions induced by nerve stimulation, 
than it was at increasing transmitter release in cat spleen (Dubovich & Langer,
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1974), while clonidine was shown to be equipotent with NA at inhibiting 
transmitter release, but less potent than NA in eliciting contractions in the rabbit 
pulmonary artery (Starke et al., 1974). These pharmacological differences, and the 
different locations of a-adrenoceptors, led Langer (1974) to propose the 
subdivision into " a  j "-postjunctional sites and " a 2 "-prejunctional sites. This 
subclassification of a-adrenoceptors has subsequently been consolidated with 
numerous reports of differences between agonist and antagonist selectivity profiles 
(see: Starke, 1977, Westfall, 1977, Vizi, 1979).
Postjunctional a-adrenoceptors on vascular smooth muscle 
In Vivo
Prior to the subdivision of a-adrenoceptors on the basis of anatomical 
location, it was believed that postjunctional a-adrenoceptors were a homogeneous 
population ie. solely a \ -adrenoceptors. The potency order for agonists at these 
receptors was as follows :- adrenaline > noradrenaline > phenylephrine »  
isoprenaline, while the pA 2  value for phentolamine was generally close to 8 . 0  
(Furchgott, 1972). With the discovery that subtypes of a-adrenoceptors existed, 
and with the availability of newer drugs with greater selectivity between subtypes, 
in particular the selective a\-adrenoceptor antagonist prazosin, Starke and Langer 
(1979) suggested that each a-adrenoceptor could be defined as follows. At a \-  
adrenoceptors, phenylephrine was a more potent agonist than clonidine, while 
prazosin was a more potent antagonist than yohimbine. In contrast at a 2 - 
adrenoceptors clonidine was a more potent agonist than phenylephrine, while 
yohimbine was a more potent antagonist than prazosin. W ith these "rules of 
thumb", particularly the relative antagonist potencies, any given response mediated 
via a-adrenoceptors could then be defined as being a j -  or a 2 -adrenoceptor
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mediated.
The first report in favour o f receptor heterogeneity o f vascular 
postjunctional a-adrenoceptors, based on the potency of an antagonist, came from 
studies with prazosin in whole animals. In the pithed rat and perfused organs of the 
anaesthetised cat, it was observed that the pressor effects of phenylephrine were 
more susceptible to blockade by prazosin than were the equivalent responses to NA 
(Drew & W hiting, 1979). These authors did not attempt to define the prazosin 
resistant response to NA. However other experimental evidence supported the 
possibility that this component may have been a 2 -adrenoceptor mediated. For 
example, pressor responses in pithed rats to the relatively selective a 2 -adrenoceptor 
agonists, guanabenz and xylazine, were shown to be relatively resistant to prazosin, 
but susceptible to yohimbine, while the converse was true for phenylephrine 
(Docherty et al., 1979, Docherty & McGrath, 1980). NA stimulation of both 
postjunctional a^ - and a 2 -adrenoceptors was subsequently demonstrated in pithed 
rabbits, with the sequential adm inistration of the antagonists prazosin and 
rauwolscine, the combination of which produced a greater effect than either 
antagonist alone (McGrath et al., 1982). The presence of postjunctional vascular 
a 2 -adrenoceptors, m ediating pressor responses, has subsequently been 
demonstrated in a wide number of species, including man (see: McGrath, 1982).
Postjunctional a-adrenoceptors In Vitro
The demonstration of postjunctional a 2 -adrenoceptors in vivo precipitated 
an extensive search for equivalent responses in vitro , in order to allow rigorous 
pharmacodynamic analysis of these receptors. In contrast to the relative ease of 
dem onstrating postjunctional a 2 -adrenoceptors in whole animals however, 
incontrovertible evidence showing responses mediated via these receptors in 
isolated vascular preparations, with the criteria outlined below, has proven much
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more difficult. McGrath (1982) proposed that ot2 -adrenoceptor agonism could be 
assumed if responses were susceptible to rauwolscine (or some other suitable 
antagonist) but resistant to prazosin (or equivalent) and other aminergic receptor 
blockers. Responses to a-adrenoceptor agonists in the vast majority of isolated 
vascular preparations, particularly arterial vessels, have been shown to be sensitive 
to prazosin (McGrath, 1982). A number of factors may be responsible for the 
elusive nature o f postjunctional a 2 -adrenoceptors in vitro. These are discussed 
below.
The first report of the existence o f postjunctional a 2 -adrenoceptors in 
isolated preparations were those in the canine saphenous and femoral veins (De 
Mey & Vanhoutte, 1981). In comparison to the corresponding arterial preparations, 
the "selective" a\-adrenoceptor agonists methoxamine and phenylephrine were 
much less potent than NA in the veins. In addition, responses to NA in the veins 
were antagonised com petitively by yohimbine, but only weakly and non- 
com petitively by prazosin. The presence of a 2 -adrenoceptors in the canine 
saphenous vein was corroborated by the demonstration that, after exposure to 
phenoxybenzamine, the contractile response to clonidine could be blocked by 
yohimbine but not by prazosin (Constantine et al., 1982).
These results led others to examine the a-adrenoceptor characteristics in a 
number of venous preparations from different species. In an extensive study of 15 
venous preparations, Shoji et al., (1983) concluded that the canine saphenous, 
cephalic, femoral and external jugular veins contained mixed populations of a -  
adrenoceptors. The existence of both postjunctional a^ - and a 2 -adrenoceptors, in 
the same preparation, mediating the same functional response, has complicated the 
unequivocal demonstration of postjunctional a 2 -adrenoceptors. Their presence 
however, has subsequently been reported in the saphenous veins of the rat
28
(Cheung, 1985), human (Docherty & Hyland, 1985) and of the rabbit (Alabaster et 
al., 1985, Schumman & Lues, 1983). It should be noted that even in some of 
these preparations, eg. the rabbit saphenous vein, despite the fact that the 
postjunctional a-adrenoceptor population had many characteristics of an <X2~ 
adrenoceptor, in terms of agonist potencies and sensitivity to rauwolscine, prazosin 
was also a very potent, though non-competitive antagonist (Schumman & Lues, 
1983, Daly et al., 1988a). In the latter study, the authors suggested that 
postjunctional a 2 -adrenoceptor mediated responses were susceptible to prazosin 
due to an interaction between the a-adrenoceptor subtypes. Such an interaction 
would obviously interfere with the demonstration of a 2 -adrenoceptors in vitro. 
The existence of venous preparations, which have a homogeneous population of 
postjunctional a 2 -adrenoceptors is not precluded however, as evidenced from the 
recently characterised adrenoceptor population in the rabbit ear vein (Daly et al., 
1988b).
It has been even more difficult to dem onstrate postjunctional a 2 - 
adrenoceptors in isolated arterial preparations, the likely source of a 2 - 
adrenoceptor-mediated pressor responses in whole animals. However, some 
success has been achieved in studies utilising human arterial vessels. Indeed, one of 
the main stimuli toward recent research into heterogeneity of postjunctional a -  
adrenoceptors were the observations of Jauering et al. (1978), who demonstrated 
that responses of human digital arteries were antagonised very weakly by prazosin. 
Recent comparisons of human arteries and veins (femoral and digital) indicate the 
presence of both a^ - and a 2 -adrenoceptors mediating contractions in both tissues 
but with a dominance of a  j-adrenoceptors in the arterial preparations and a 2 - 
adrenoceptors in the veins (Glusa & Markwardt, 1983, Stevens & Moulds, 1985). 
The greater success in identifying postjunctional a 2 -adrenoceptors in human 
isolated blood vessels may be due to the peripheral location of the vessels studied in
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contrast to the large conduit arteries used from rats and rabbits. This is supported 
by the recent finding of an inverse correlation between human arterial vessel 
diameter and the magnitude of the a 2 *adrenoceptor mediated response observed 
(Neilsen et al., 1989). In addition, when small arterioles were examined from the 
rat cremaster region, (X2 -adrenoceptor mediated responses could be demonstrated 
(Faber, 1988).
One additional explanation for the difficulty in demonstrating postjunctional 
0 C2 -adrenoceptors in vitro may be the lack of humoral agents normally present in 
the whole animal. In 1983, Schumman & Lues demonstrated that responses to 
BHT-920 were potently antagonised by prazosin in the rabbit saphenous vein. 
However in the presence of angiotensin II (A II) responses to BHT-920 became 
resistant to prazosin and therefore more classically (^-adrenoceptor mediated. This 
led to the conclusion that (X2 -adrenoceptors depended on the presence of A II for 
their complete expression. The requirement for the presence of tissue stimulants for 
the expression of (X2 -adrenoceptors has also been reported in the canine saphenous 
artery with Bay K 8644 (Sulpizio & Hieble, 1987), the canine portal vein with a 
number of pharmacological and physiological stimulants (Furuta, 1988) and in the 
perfused rat tail after raising tone with vasopressin (Templeton et al., 1989).
Difficulties in demonstrating postjunctional (X2 -adrenoceptors on isolated 
vascular smooth muscle are therefore complicated by a number of factors, including 
the co-existence of both oij- and a 2 -adrenoceptors in the same preparation, the size 
of the vessel used in isolated studies and the absence of factors normally found in 
the whole animal. The difficulties have also been compounded by observations in 
recent years suggesting further subdivision of both otj- and oc2 -adrenoceptors in 
both vascular and non-vascular tissues. As yet no consensus is apparent for 
proposed heterogeneity of either receptor subtype. The relative merits of each 
proposed subdivision are considered in a critical review by McGrath et al. (1989).
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Function and Location o f  a-adrenoceptors in the Vasculature
As described above, 0 4 - and o^-adrenoceptors are present on both arterial 
and venous smooth muscle. Therefore activation of either receptor subtype can 
influence blood pressure by increasing peripheral resistance and/or by reducing 
venous capacitance, thereby increasing cardiac output. The relative importance of 
these mechanisms in mediating pressor responses to a-adrenoceptor agonists have 
been studied in recent years.
In pithed rats, stimulation of either receptor subtype has been shown to 
result in an increase in total peripheral resistance (Gerold & Haeusler, 1983, Richer 
et al., 1987, Hiley & Thomas, 1987, MacLean & Hiley, 1988). For equivalent 
sized pressor responses, this effect was greater for a  j-adrenoceptor agonists, 
suggesting a more important role for a  ^ -adrenoceptors in small arterioles. Using 
radioactive microspheres it has been demonstrated that a^-adrenoceptor stimulation 
induced vasoconstriction in the splenic, mesenteric, caudal, and most markedly in 
the kidney vascular beds resulting in a redistribution of cardiac output to the heart, 
lungs and liver (Waldron & Hicks, 1985, Hiley & Thomas, 1987). By comparison, 
a 2 -adrenoceptor activation produced an increase in mesenteric and caudal vascular 
resistances.
In addition to increasing peripheral resistance, both a j -  and a 2 - 
adrenoceptors can mediate an increase in cardiac output (Gerold & Haeusler, 1983, 
Kalkman, et al., 1984, Hiley & Thomas, 1987, MacLean & Hiley, 1987). For 
a 2 -adrenoceptors, this effect is due largely to an increase in venous return, while 
aj-adrenoceptor-mediated increases in cardiac output, may additionally involve an
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increase in cardiac rate (McGrath et al., 1982, Hiley & Thomas, 1987) or 
contractility (Scholz, 1980). A lack of effect for a  j-adrenoceptors on venous 
smooth muscle is suggested from observations in conscious rats, where only ay-  
adrenoceptor agonists increased mean circulatory filling pressure, an indicator of 
total body venous tone (Pang & Tabrizchi, 1986). However, such generalisations 
are difficult to sustain between species, for example in the dog, a  ^ -adrenoceptors 
appear to be the more important in controlling venous capacitance (Appleton et al.,
1986).
In addition to their presence on vascular smooth muscle, a-adrenoceptors 
can influence cardiovascular haemodynamics at other sites in the vasculature, 
although in general the physiological relevance of these mechanisms is not clear. 
For example, in the heart a j-ad renocep to rs mediate a positive chronotropic 
(McGrath etal., 1982) and inotropic action (see: Scholz, 1980). These actions may 
become important in abnormal conditions, such as ischaemia (see: McGrath, 1987). 
In addition to the presence of prejunctional a 2 -adrenoceptors m odulating 
transmitter release from sympathetic nerve terminals, they have also been shown to 
modulate transmitter release from parasympathetic nerve terminals (see Gillespie,
1980). A similar negative feedback mechanism for a  j-adrenoceptors has also been 
proposed (Story et al., 1985). The stimulation of a 2 ~adrenoceptors has also been 
demonstrated to mediate the release of EDRF from endothelial cells of canine 
coronary and femoral vascular smooth muscle (Cocks & Angus, 1983, Angus et 
al., 1986), a feature which may be important for flow regulation in individual 
vascular beds.
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Mechanism o f  action o f  a-adrenoceptors in vascular smooth muscle
Ca 2 + sources for contraction
In parallel with the subdivision of postjunctional a-adrenoceptors was an 
examination of the Ca^+ sources utilised upon stimulation of each subtype. De Mey 
& Vanhoutte (1981) initially suggested that a  j-adrenoceptor mediated responses 
were more sensitive to the action of calcium channel blockers (CCB's) than were 
those to a 2 -adrenoceptor stimulation. The susceptibility o f a^-adrenoceptors to 
CCB's was consistent with observations made earlier in the rabbit aorta (a 
preparation containing a  ^ -adrenoceptors), which were shown to consist of two 
phases, a transient response via release of intracellular C a^+ , sustained by a 
secondary component, dependent upon the influx of extracellular Ca^+ (Bohr, 
1963, Deth & VanBreemen, 1977). However, Van Meel et al., (1981) provided 
contrary evidence in pithed rats and reached the conclusion that aj-adrenoceptor 
mediated responses were independent of the entry of extracellular Ca^+, while a 2 - 
adrenoceptors were highly dependent on such a component to maintain contraction. 
This conclusion has been hotly contested in the literature, with suggestions that 
differential attenuation is a consequence of receptor reserve and agonist efficacy 
rather than on receptor subtype (see: Nichols & Ruffolo, 1988) or on the time 
course of response to a given agonist (O'Brien et al., 1985). This prolonged 
disagreement demonstrates one of the limitations of analysing pharmacological 
phenomena quantitatively from whole animal studies, principally because the use of 
bolus injections of agonists in vivo do not reflect "equilibrium" responses. This 
further highlights the necessity to find suitable in vitro preparations containing 
homogeneous populations of either subtype, to permit rigorous pharmacodynamic 
analysis of responses. Greater clarification for the effects of CCB's on a^ - and a 2 - 
adrenoceptor mediated responses in pithed rats were obtained by using infusions of 
agonists, in order to give a more equilibrium response. Under these conditions
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responses mediated via either a-adrenoceptor subtype were attenuated (McGrath & 
O 'Brien, 1987). Regardless of the source, the net effect o f a ^ -  and a 2 " 
adrenoceptor stimulation is to increase the free cytosolic levels of Ca^+ within the 
cell, with the subsequent activation of contractile proteins resulting in the 
contraction of vascular smooth muscle. A number of transduction processes linking 
receptor occupation with end organ response have been proposed for both 
subtypes. These are briefly discussed below.
Membrane Potential
a-adrenoceptor activation can result in changes in membrane potential. 
Depolarisation can occur simultaneously with contractions produced by either a j -  
adrenoceptors (eg. Suzuki 1983) or a 2 -adrenoceptors (Cheung, 1985). However, 
there is not always a direct correlation between the two events (see: McGrath et al., 
1989), such that the primary action of most a-adrenoceptors appears, not to be a 
direct change in membrane potential, but rather a modulation of biochemical or 
electrophysiological properties pre-existing in the cell.
Second Messengers
Most of the available evidence suggests that a  j-adrenoceptors in vascular 
smooth muscle stimulate the breakdown of phosphatidylinositol-4,5-bisphosphate 
(PIP2 ). This results in the generation of inositol 1,4,5-triphosphate (IP3 ), which in 
turn releases Ca^+ from non-mitochondrial intracellular stores (Michell & Kirk,
1981). Two other putative second messengers are also produced, namely, 1,2- 
diacylglycerol (DAG) and 1,3,4,5-tetrakisphosphate (IP4 ), which may be involved 
in permitting the entry of extracellular Ca^+ into the cell (Putney, 1987, Campbell 
et al., 1985, Spedding, 1987).
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Few studies have exam ined the biochem ical consequences o f ot2 - 
adrenoceptor stimulation in vascular smooth muscle because of the lack of suitable 
preparations. There is evidence however, in other tissues, that a 2 -adrenoceptor 
occupation results in an inhibition of cyclic AMP production by adenylate cyclase 
(Exton, 1985, Fain & Garcia-Sainz, 1980). In agreement with such a mechanism 
Fredholm, et al., (1985) demonstrated that clonidine dose-dependently reduced 
forskolin induced stimulation of adenylate cyclase activity, in cat isolated middle 
cerebral artery. However, oc2 -adrenoceptor stimulation is not limited to changes in 
cyclic AMP levels, since in NG108-15 cells a 2 -adrenoceptor agonists have been 
shown to accelerate Na+/H+ exchange (Isom, et al., 1987).
Sympathetic Neurovascular Transmission
As mentioned previously Barger & Dale (1910) were the first authors to 
dem onstrate that noradrenaline mimicked responses to sym pathetic nerve 
stimulation more closely than did adrenaline. It was not until 1946 however, that 
noradrenaline was shown to be the main sympathetic transmitter, when Von Euler 
demonstrated that noradrenaline concentrations in sympathetically innervated tissue 
were very high in comparison to adrenaline. Furthermore, noradrenaline levels 
were reduced after sympathectomy, indicating a close association with nerves rather 
than muscle. Noradrenaline was subsequently accepted to be the mediator of 
sympathetic nerve stimulation. More recently however this concept has had to be 
modified, since many examples have been found where vascular responses to nerve 
stimulation remain partly resistant to a-adrenoceptor antagonists.
This has led to two alternative proposals to a-adrenoceptor mediated 
sympathetic transmission. Firstly, Hirst & Neild (1980) have suggested that 
noradrenaline is the neurotransmitter in arteriolar smooth muscle, but that it acts
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upon a distinct class of adrenoceptors, namely "gamma"-adrenoceptors. Another 
explanation which has gained more credence, is the "co-transmission" hypothesis, 
which puts forward the idea that another transm itter is released along with 
noradrenaline. The most likely candidate for "co-transmitter" involved in 
sympathetic vascular transmission is ATP (see: Bumstock & Sneddon, 1985). A 
number of experimental observations suggest this; one example being that in pithed 
rats, the pressor response to sympathetic nerve stimulation can be blocked by the 
sequential administration of a-adrenoceptor antagonists and the purinergic receptor 
antagonist a-,p-methylene ATP (Flavahan et al., 1985).
The fact that a  ^ -adrenoceptor antagonists were found to be more effective at 
blocking responses to sympathetic nerve stimulation than they were at blocking 
equivalent sized responses to exogenous NA, led to the suggestion that 
postjunctional a  ^-adrenoceptors were neurogenic receptors, while 
adrenoceptors were located extrajunctionally , responding to circulating 
catecholam ines (M cGrath, 1982). It is now apparent however, that this 
generalisation is not always the case. Postjunctional a 2 -adrenoceptors have been 
implicated in mediating the end organ response to sympathetic nerve stimulation in 
canine, human and rat saphenous veins (Flavahan et al., 1984, Docherty & 
Hyland, 1985, Cheung, 1985). Figure 1 illustrates the two major transmitters and 
the receptors through which they act at the sympathetic neurovascular junction.
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This diagram represents the current, accepted view  of 
sympathetic neurovascular transmission and demonstrates the 
location of the a-adrenoceptors and purinoceptors involved.
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Section 2 : The Renin-Angiotensin System
Historical overview
The first direct demonstration that the kidney could influence blood pressure 
was made in 1898 when Tigerstedt & Bergman observed that injection of saline 
extracts from renal homogenates into anaesthetised rabbits produced pressor 
responses. These authors termed the responsible pressor agent renin. However it 
was not until 1934, when Goldblatt et al. dem onstrated that a persistent 
hypertension could be induced in dogs, by producing renal ischemia, that greater 
interest in a pressor substance of renal origin was rekindled.
The focus of attention was subsequently directed back to renin and its 
presence in kidney extracts was reconfirmed in 1938 (Kohlstaedt et al., Pickering 
& Printzmetal). It was observed however, that renin itself was not the active 
pressor substance. Partially purified renal renin extract, which increased blood 
pressure when injected into whole animals, had little effect on the isolated dog tail 
or perfused rabbit ear artery preparations, unless plasma was added to the perfusate 
(Kohlstaedt et al., 1940, Helmer & Page, 1939). These authors suggested that 
renin was an enzyme-like substance activated by a renin activator found in blood. In 
1940 Page & Helmer named the responsible pressor substance formed from the 
above interaction "angiotonin". Independently, Braun-M enendez et al. (1940) 
found that a pressor substance could be obtained from venous blood from 
ischaemic kidneys and that this substance had similar pharmacological properties to 
the product of the interaction between renin and blood globulins. They termed this 
substance "hypertensin" and postulated that renin was an enzyme whose substrate 
was a blood protein. Page et al., (1943) subsequently agreed that renin activator 
was in fact a substrate, and should be designated "renin substrate" accordingly.
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Renin substrate has subsequently been shown to be an alpha-globulin of 
approximately 57,000 MW (Skeggs et al., 1963) largely synthesized in the liver 
(Nasjletti & Masson, 1971). The dual nomenclature for the pressor substance, 
angiotonin or hypertensin, continued for almost two decades until a compromised 
name of angiotensin was adopted (Braun-Menendez & Page 1958).
After its discovery, attempts were made to purify and elucidate the structure 
of angiotensin. In the course of such studies Skeggs et al. (1954) were able to 
separate two hypertensins, designated I and II respectively and demonstrated that 
hypertensin I was rapidly converted to hypertensin II by an enzyme in plasma. 
These compounds were shown to be peptides and the amino acid composition of 
each was determined (Skeggs et al., 1955, Lentz et a l,  1956). Horse hypertensin 
II was shown to be an octapeptide with the amino acid sequence:
Asp-Arg-Val-Tyr-Ileu-His-Pro-Phe-His-Leu 
being produced by the action of a converting enzyme upon a non-pressor 
decapeptide (hypertensin I) by cleavage of a histidylleucine dipeptide (Skeggs et 
al., 1956). The sequence of ox hypertensin I was also determined in the same year 
by Elliot & Peart (1956) and found to be almost identical to that of horse 
hypertensin I:
Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu 
varying only at the fifth amino acid residue. Human angiotensin has subsequently 
been shown to be identical to that of horse angiotensin (Arakawa et al., 1967). 
Angiotensin was produced synthetically in 1958 (Schwarz et al., 1957) and this 
led to the discovery that this compound had many physiological roles relating to the 
maintenance of blood pressure.
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Circulating and Local Angiotensin II production
As described above angiotensin II (A II) is produced from a biochemical 
cascade process involving two substrates, angiotensinogen and angiotensin I (A I), 
and two enzymes, namely, renin and a plasma angiotensin converting enzyme. The 
traditional concept of the renin-angiotensin system has been of a circulation-bome 
endocrine system, whose components are secreted by different organs, with the 
biological end product of this cascade, A n, being conveyed by arterial blood to act 
on specific target organs (for review see: Peach, 1977). More recently evidence in 
favour of an additional, local tissue A II generating system has accumulated ( see: 
Dzau, 1987, 1988, Campbell, 1987, Unger et al., 1989).
Renin
Under normal circumstances the kidney appears to be the most important 
source o f renin. In 1976, Thurston dem onstrated that plasm a renin fell to 
undetectable levels after bilateral nephrectomy, and despite the fact that renin has 
also been shown to be present in and to be synthesized by vascular smooth muscle 
cells (Gould et al., 1964, Re et al., 1982), vascular renin levels are also reduced 
after bilateral nephrectomy (Thurston et al., 1979), albeit at a slower rate. In 
addition, Loudon et al., (1983) have shown that arterial smooth muscle renin 
levels are related to the exogenous administration, ie. the plasma levels, of renin. 
These results suggest that the majority of tissue renin is also of renal origin. Locally 
produced renin may be important in some vascular beds; for example, in the saline 
perfused rat hindlimb, tetradecapepdde renin substrate, in the absence of exogenous 
renin, produced pressor responses which could be blocked by renin-inhibitory 
peptide (Oliver & Sciacca, 1984). However, it is known that a large number of 
enzymes found in peripheral tissues have renin-like activity and could be 
responsible for the ultimate production of A II (for references see: Peach, 1977).
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A lternatively, the im portance of the local production of renin may be 
pathophysiological. Assad & Antonaccio (1982) have demonstrated that vascular 
renin levels in spontaneously hypertensive rats remain elevated even after bilateral 
nephrectomy, when plasma levels of renin are undetectable.
Angiotensinogen
The liver has been suggested to be the major source of the substrate for 
renin, angiotensinogen (Nasjletti & Mason, 1971). This site of production however 
is not exclusive, since it has also been shown to be synthesized in other tissues 
w ithin the blood brain barrier (Ganten et al., 1972), and in addition, 
angiotensinogen messenger RNA has been detected in a number of extrahepatic 
tissues including vascular smooth muscle (Campbell & Habener, 1986).
Angiotensin Converting Enzyme
It was initially suggested that A I was converted to A II by angiotensin- 
converting enzyme (ACE) solely in the blood, from observations demonstrating the 
lack of effect of A I in, for example, saline perfused kidneys (Skeggs et al., 1956) 
or rabbit aortic strips (Helmer, 1957), where A II was active. Carlini et al., (1958) 
however, were able to demonstrate activity for A I in a number of preparations. 
Then in 1968, Ng & Vane demonstrated that conversion of A I into A II in plasma, 
was very slow in comparison to the rate of generation of A II when passing through 
the pulmonary circulation. This led to the wideheld belief that the lung was the most 
important site for ACE and the subsequent generation of circulating A II. ACE itself 
is a fairly non-specific peptidyl dipeptide hydrolase which cleaves peptide bonds of 
a variety of amino acids (Yang et al., 1971) and is identical to kininase II which 
inactivates bradykinin.
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It is now apparent that production of A II  locally in vascular smooth muscle 
is also very important. ACE has been demonstrated to be present in a wide variety 
o f tissues, and is very prominent on vascular endothelial cells (Wilson et al.,
1987), with some evidence suggesting that it may be present on vascular smooth 
muscle (Velletri & Bean, 1982).There are now numerous reports to suggest that A 
II can be produced locally, by conversion of A I, in isolated vascular smooth 
muscle (eg. Malik & Najletti, 1976, Oliver & Sciacca, 1984, Juul et al., 1987), an 
effect which can be blocked by ACE inhibitors. Indeed the use of ACE inhibitors 
has provided perhaps the most compelling evidence for an important physiological 
role for local vascular A II production. These agents have been found to be very 
effective antihypertensive agents in various models of experimental hypertension 
(Rubin et a i,  1981), even when circulating A II levels are normal or low. In some 
of these models, eg. the spontaneously hypertensive rat (SHR), the magnitude and 
duration of blood pressure reduction correlates better with the inhibition of tissue 
ACE, than with inhibition of serum enzyme activity (Cohen & Kurtz, 1982, Unger 
et al., 1984). This is perhaps demonstrated most strikingly in the latter study 
whereby, several hours after a single dose of an ACE inhibitor was administered, 
when serum ACE activity as well as the pressor response to exogenous A I had 
returned to normal, blood pressure remained reduced. The duration of the 
antihypertensive response was paralleled by the suppression of aortic and kidney 
ACE activity.
Direct evidence for the existence of the vascular renin-angiotensin system, 
acting independently from the circulating system, is provided by the observations 
that basal A II production occurs in cultured bovine aortic endothelial cells (Kifor & 
Dzau, 1987), although the true physiological importance of this remains to be 
determined. However it is very much apparent that in addition to the traditional
42
concept of the circulating renin-angiotensin system, there also exists a functionally 
important local A II generating system in vascular smooth muscle cells, which is 
independent to some degree from the circulating system. The components of the 
renin-angiotensin system are outlined in figure 2.
Metabolism o f Angiotensin II
It has been known since the discovery of A II, that enzymes found in the 
blood and tissues function to metabolise and inactivate the pressor substance 
(Braun-Menendez et al., 1940). These enzymes have been termed angiotensinases 
and are generally non-specific in their actions. They include aminopeptidases 
(angiotensinase 'A') (Khairallah et al., 1963) which hydrolyse A II at the N- 
terminal bond, endopeptidases (angiotensinase ’B') (Regoli et al., 1963) which 
hydrolyse the middle portion of the peptide and carboxypeptidases (angiotensinase 
'C') (Johnson & Ryan, 1968) which hydrolyse the carboxy terminal of A II.
Release o f Renin
In most instances the rate limiting step in the renin-angiotensin biochemical 
cascade is the amount of renin produced. Since plasma renin and most vascular 
renin, under normal conditions, is o f renal origin (Thurston et al., 1979, Loudon 
et al., 1983), the amount of renin released from the kidney will determine the 
levels of production of the biologically active angiotensins. To this extent, a number 
of mechanisms exist which control renal renin secretion.
These mechanisms which control renin secretion include:- i). An intrarenal 
baroreceptor, which is dependent on the balance between renal perfusion pressure 
and ureteral pressure (Kaloyanides et al., 1973) and appears to utilise cyclo-
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oxygenase products (Blackshear et al., 1979). ii). Decreased Na+ levels in the 
distal tubule of the kidney reduce renin release from the closely associated 
juxtaglomerular cells (Churchill et a l ,  1978). iii). Sympathetic nerve stimulation to 
the juxtaglomerular cells evokes renin release into the circulation, an effect mediated 
via (3-adrenoceptors (Weber et al., 1983) which can also be activated by circulating 
catecholamines (Pettinger et a l,  1972). and v). A II can itself inhibit renin release 
in a 'short loop' mechanism (Keeton et al., 1976).
Physiological and Pharmacological Effects o f  Angiotensin II 
Actions o f Angiotensin II on Vascular Smooth Muscle
A II is a potent vasoconstrictor agent in all species studied. On a molar basis 
it is about 40 times more potent than noradrenaline (DeBono et. a l ,  1963). The 
regional haemodynamics of A II suggest that its vasoconstrictor activity, mediated 
via arteriolar constriction, is greatest in the splanchnic beds and the kidney, by an 
action at both pre- and postglomerular arterioles (Wilson, 1986), moderate in skin 
and least in skeletal muscle (Douglas, 1980). A II has been reported to cause 
constriction of coronary blood vessels (Frank et al., 1970), although paradoxical 
coronary vasodilatation may occur due to the stimulation of prostaglandin synthesis 
by the peptide (Needleman et al., 1975). A II also contracts large conduit arteries, 
a function which may be important in the pathophysiology of hypertension (see: 
Dzau & Safar, 1988). It was initially suggested to show selectivity for the arterial 
rather than the venous vasculature (Folkow et al., 1961), although some venous 
preparations, such as rat portal and mesenteric veins, clearly respond to A II 
(Somlyo & Somlyo 1966). More recently, Pang & Tabrizchi (1986) demonstrated 
that A II infusion in conscious rats increased mean circulatory filling pressure, an 
indicator of venous tone, while, Kaufman & Vollmer (1985) and Maclean & Hiley 
(1988) have shown, using ACE inhibitors in pithed rats, that A II contributed to the
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m aintenance of blood pressure by decreasing venous capacitance, thereby 
maintaining cardiac output. Furthermore, Stokland et al., (1982) concluded that 
half the rise in systemic pressure produced by A II infusion, was caused by 
venoconstriction with the resultant increase in preload and cardiac output.
In addition to the acute contractile effects of A II on vascular smooth 
muscle, this peptide raises blood pressure gradually when administered in low or 
subpressor rates of infusion. This "slow pressor" effect was first demonstrated in 
the rabbit (Dickinson & Lawrence, 1963) and appears to be particularly marked in 
the rat (Brown et al., 1981). The mechanism of action for the "slow" pressor effect 
o f A II is unknown, although it has been proposed that inducing vascular 
hypertrophy may be important (Lever, 1986).
Relaxatory responses to A II can be dem onstrated, under certain 
conditions, in blood vessels such as rabbit renal vein (Webb, 1982), or the rabbit 
mesenteric vasculature (Pure & Needleman, 1979). These A H-induced relaxations 
can be blocked with cyclo-oxygenase inhibitors, and may be due to the production 
of prostaglandin E 2  or I2  (Pure & Needleman, 1979). The physiological 
significance of A H-induced relaxation remains unclear.
The contractile effects of A II on vascular smooth muscle are mediated by 
specific receptors. As early as 1976 it was suggested that angiotensin receptors 
were heterogeneous (Moore et al., 1976). Subdivision of these receptors has 
subsequently been suggested in vascular smooth muscle (Tabrizchi & Pang, 1987), 
in the kidney cortex (Douglas, 1987). However, the lack of suitable competitive 
antagonists of A II  has meant that no general consensus on subtypes of angiotensin 
receptors is apparent.
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Mechanism o f action o f Angiotensin II in vascular smooth muscle
Deth and van Breemen (1977) observed in the rabbit aorta that responses to 
A II were largely dependent on the release of Ca^+ from an intracellular store. In 
general responses to A II are poorly attenuated by omitting extracellular Ca^+ from 
the bathing medium or by Ca^+-entry blockers (see: Peach, 1977, Hof et al., 
1982). It is now apparent that A n, in common with many other vasoactive agents, 
stimulates the breakdown of phosphatidylinositol-4,5-bisphosphate (PIP2 ) and the 
generation of inositol triphosphate (IP3 ), which subsequently mobilises Ca^+ from 
intracellular stores (Alexander et al., 1985). A II stimulated breakdown of 
polyphosphoinositides concomitantly releases another putative 2 nd messenger, 1 - 
,2-diacylglycerol (DAG) (Griendling, et al., 1986), which may be involved in 
regulating the entry of extracellular Ca^+ into the cell (Campbell et al., 1985). A II 
also stimulates Na+/H + exchange, with subsequent intracellular alkalinization, in 
vascular smooth muscle cells (Greindling et al., 1988, Bingham, 1986). The 
physiological response of any vascular tissue represents the integration of these 
intracellular signals.
A feature of responses to A II in vascular smooth muscle, particularly with 
higher concentrations, is the inability to maintain the contraction either in vivo or 
in vitro (Bock & Gross, 1961, St. Louis et al., 1977). The desensitisation to A II 
has been attributed to a number o f factors including, the production of 
prostaglandins (Aiken, 1974), or the formation of a stable drug-receptor complex 
(St. Louis et al., 1977). In favour of the latter, Danthuluri & Deth (1986) have 
recently demonstrated the inability of A II to maintain production of DAG, an agent 
which may regulate the entry of extracellular Ca^+ into the cell (Campbell et al., 
1985). This suggests that the inability of A II to maintain the response is due to a 
loss of effectiveness of the hormone-receptor complex in signal transduction.
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Aldosterone secretion
Another action of the renin-angiotensin system, pertinent to blood pressure 
control, is its influence on aldosterone secretion. Aldosterone is a mineralocorticoid 
secreted from cells in the zona glomerulosa in the adrenal cortex, whose function is 
to enhance sodium reabsorption in the distal tubules and collecting duct of the 
kidney. The overall effect of enhanced aldosterone secretion is to increase 
circulating blood volume, with a subsequent tendency for increased arterial pressure 
(Horton, 1973). It is now evident that the renin-angiotensin system is a potent 
stimulant of aldosterone secretion (Brown et al., 1979), although there is some 
doubt as to whether A II or the des-Asp metabolite (A III) is physiologically the 
more important (Semple & Morton, 1976).
Central actions of Angiotensin II
In addition to the actions of A II in the periphery, this peptide also produces 
a number of effects, pertaining to blood pressure control, which are mediated via 
the central nervous system. It was initially difficult to comprehend how a circulating 
peptide had access to the brain to produce such central effects. However, it is now 
believed that circulating A II mediates its central actions via the circumventricular 
organs, small areas of the brain that lack a blood brain barrier (see Reid, 1984). In 
addition an endogenous brain renin-angiotensin system has been demonstrated 
(Ganten, 1972).
A central action of A II on blood pressure was first demonstrated by 
Bickerton & Buckley (1961). These authors used cross-circulation techniques and 
observed that injections of A II into the central circulation of an animal’s head, 
isolated from its own trunk, produced a hypertensive effect in the vasculature of its
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own trunk, which was mediated by an increase in sympathetic efferent activity. 
This central pressor action of A II, by increasing sympathetic outflow, has been 
confirmed subsequently with infusions of A II via vertebral arteries (Dickinson & 
Yu, 1967, Yu & Dickinson, 1971) and with direct central injections of A II 
(Scholkens et al., 1982). In addition to enhancing sympathetic discharge, it has 
been suggested that part of the central pressor action o f A II may be due to a 
reduction of vagal tone with a subsequent increase in cardiac output (Reid et al.,
1982), or by stimulating vasopressin release, an effect which may be important in 
the rat (Severs, et al., 1973). A II has also been shown to have a dipsogenic effect, 
which can be induced by either peripheral or central administration of A II 
(Fitzsimons, 1972, 1975) and in addition it can stimulate ACTH secretion from the 
pituitary gland (Sobel, 1983). Overall the central actions of A II can potentially 
increase blood pressure directly by increasing sympathetic output or indirectly by 
increased fluid volumes. A more extensive account of the actions of angiotensin(s) 
in the central nervous system can be found in review papers by Reid (1984) and 
Phillips (1987).
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SECTION 3: Interactions between the Renin-Angiotensin System 
and the Peripheral Sympathetic Nervous System
It is perhaps not surprising that the sympathetic nervous system and the 
renin angiotensin system, both of which play an integral part in the control of 
cardiovascular haemodynamics, do not work independently from one another. As 
mentioned previously, activation of the renin angiotensin system can increase 
sympathetic outflow from the central nervous system. In addition both systems 
have been suggested to interact with each other at a number of sites in the 
periphery.
Prejunctional Action of Angiotensin II on Sympathetic Nerve 
Terminals
An interaction between A II and the peripheral sympathetic nervous system 
was first implicated by the observations that pressor responses to A II were reduced 
following sympathectomy or pretreatment with reserpine (Zimmerman, 1962, 
Baum, 1963). These results suggested that part of the pressor response to A II was 
mediated via the sympathetic nervous system. Confirmation of such an action was 
forthcoming in studies which detailed enhanced responses, in the presence of A n, 
to procedures which caused the release of NA from nerves (McCubbin & Page, 
1963), or to direct sympathetic nerve stimulation in the guinea-pig vas deferens and 
cat spleen (Bennelini et al., 1964). This facilitatory action for A II has 
subsequently been described in a number of vascular preparations from a range of 
species (eg. Panisset & Bourdois, 1968, Johnson et al., 1974, Nicholas, 1970, 
Majewski eta l., 1984) and can be mimicked with tetradecapeptide renin substrate 
and A I, suggesting a possible role for A II produced at a local tissue level (Malik &
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Najletti, 1976, Boke & Malik, 1983).
This enhancement of responses produced by A II was attributed principally 
to a prejunctional action, since equivalent sized responses to exogenous NA were 
either not affected (rarely), or potentiated to a smaller degree than nerve stimulation 
responses. Such a prejunctional mechanism was directly demonstrated when A II 
was observed to cause an increase in 3[H]-NA overflow in perfused canine 
hindlimb, rabbit portal vein and rabbit coeliac artery, in response to sympathetic 
nerve stimulation (Hughes & Roth, 1971, Zimmerman et al.y 1967). A number of 
suggestions were forwarded to explain this effect, including increased transmitter 
synthesis (Roth, 1972), blockade of neuronal uptake of NA (Panisset & Bourdois, 
1968, K hairallah 1972) or a facilitatory action on NA release during nerve 
stimulation. Of these mechanisms, the latter appears to be most important. This is 
demonstrated by the fact that A II potentiation of NA release, persisted in the 
presence o f cocaine (Hughes & Roth, 1971, Eikenberg, 1982) and perhaps more 
convincingly, A II increased the release of both NA and dopamine p-hydroxylase 
during sympathetic nerve stimulation (Ackerly et al., 1976), while cocaine has 
been shown to increase only the former (De Potter et al., 1971). In more recent 
years, Trachte and co-workers have re-examined the prejunctional facilitatory action 
of A II on sympathetic nerve stimulation, in light of the proposed existence of 'co- 
transmitters'. These authors have demonstrated that A II and in addition its des-Asp 
metabolite, A III, enhanced responses to sympathetic nerve stimulation in rabbit vas 
deferens. This effect was due to facilitation of the adrenergic component of the 
response, while in contrast, the non adrenergic (purinergic) component of the 
response was reduced. These observations are particularly interesting because they 
provide evidence suggesting that co-transmitters are not released concomitantly, and 
that their relative importance in mediating the end organ response, could vary 
depending upon the prevailing circumstance (Saye et al., 1986, Trachte et al.,
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1987, Trachte, 1988).
Postjunctional Interaction between Angiotensin II and Adrenoceptors
Part o f the facilitatory action of A II on responses to sympathetic nerve 
stimulation, may be due to an increase in the responsiveness of vascular smooth 
muscle to NA. This proposed action has been more controversial than the well 
documented prejunctionally mediated increase in transmitter release, because it is 
not evident in all vascular preparations. For example responses to injection or 
infusion o f NA in the canine renal and hindpaw vascular beds, rabbit portal vein 
and coeliac artery were unaffected by A II (Bell, 1972, Hughes & Roth, 1971, 
Zimmerman & Whitmore, 1967). In contrast, A II has been shown to enhance 
responses to NA in other preparations such as the perfused rat caudal artery 
(Nicholas, 1970), rabbit femoral artery (Purdy & Weber, 1988), rat, canine and 
feline mesenteric blood vessels (Malik & Najletti, 1976, Panisset & Bourdois, 
1968, Chiba & Tsukada, 1986), human digital arteries (Moulds & Worland, 1980) 
and in rabbit aorta (Day & Moore, 1976). Despite these contrasting observations in 
isolated preparations, the use of ACE inhibitors in whole animals has clearly 
demonstrated a role for endogenous A II in influencing pressor responses to a - 
adrenoceptor stimulation.
A number of ACE inhibitors, and the A II receptor antagonist saralasin, 
have been demonstrated to reduce responses to both sympathetic nerve stimulation 
and to exogenous NA, or a-adrenoceptor agonists in pithed animals, presumably 
by preventing endogenous A II formation (Hatton & Clough, 1982, Clough et al., 
1982, Antonaccio & Kerwin, 1981, De Jonge et al., 1983). This has not always 
been easy to demonstrate however, since re-infusion of A II does not consistently 
reverse the effects of ACE inhibition (Bull & Drew, 1984, Kaufman & Vollmer, 
1985, Grant & McGrath, 1988a). This inability of A II infusion to reverse the
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effects of endogenous A II removal, may reflect an important role for inhibition of 
local tissue A II  formation independent of the circulating renin-angiotensin system 
(Bull & Drew, 1984). Alternatively, it may reflect a complex interaction between A 
II and cyclo-oxygenase products (Grant & McGrath 1988a).
The mechanism whereby A II enhances vascular responsiveness to NA or 
a-adrenoceptor agonists is not clear. It has been suggested that ACE inhibition 
attenuates pressor responses to NA, by the reduction in blood pressure evoked by 
these agents per se, since restoring basal blood pressure with vasopressin also 
restored responses to NA (De Jonge et al., 1982). This suggests a non-angiotensin 
dependent mechanism with the degree of vascular tone being crucial. In contrast 
however, captopril attenuated pressor responses to NA without reducing basal 
blood pressure (Hatton & Clough, 1982) and in addition, teprotide had no effect on 
pressor responses to 5-HT and A II, but markedly decreased both blood pressure 
and responses to a-adrenoceptor agonists in pithed rats (Grant & McGrath, 
1988b). These latter observations provide strong evidence for a specific interaction 
between A II and a-adrenoceptor mediated responses. Two recent reports have 
implicated small resistance arterioles as the site for this interaction (Kaufman & 
Vollmer, 1986, MacLean & Hiley, 1988). In these studies, ACE inhibition 
antagonised a-adrenoceptor mediated increases in total peripheral resistance without 
influencing corresponding changes in cardiac output..
It has been suggested that ACE inhibitors selectively attenuate responses to 
a 2 -adrenoceptor stimulation (De Jonge et al., 1981, De Jonge et al., 1982, 
Timmermans et al., 1982, Docherty, 1988). T hese authors dem onstrated  that 
responses to NA in the presence o f prazosin, and to a 2 -adrenoceptor agonists, 
were reduced by captopril, while corresponding a  j-adrenoceptor mediated 
responses were unaffected. Such a selective interaction between A II and
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postjunctional oc2 -adrenoceptors is supported in the rabbit lateral saphenous vein, 
by the observation that responses to BHT-920 were resistant to prazosin only in the 
presence of A II (Schumman & Lues, 1983). However attractive such a proposal 
may seem, a number of observations suggest that this generalisation cannot be 
sustained. For example, it has been shown that A II  increased contractile responses 
to BHT-920 in rabbit isolated thoracic aorta, but that these responses remained 
susceptible to prazosin (Lues & Schumman, 1984). There is also evidence 
suggesting that the inhibitory effect of ACE inhibitors depends not upon receptor 
subtype, but rather on the time course of the response produced by a-adrenoceptor 
agonists (O'Brien et al., 1985). Indeed it has recently been reported that ACE 
inhibitors are more selective against the secondary component of responses to a - 
adrenoceptor agonists, irrespective of their selectivity for a-adrenoceptor subtype 
(Grant & McGrath, 1988b, MacLean & Hiley, 1988). Purdy & Weber (1988) have 
also demonstrated A II induced enhancement of responses to NA, mediated via a i -  
adrenoceptors, in rabbit isolated femoral artery. This facilitation produced by A II, 
was greater if the a  \ -adrenoceptor reserve was reduced with benextramine. 
Therefore no generalisation is apparent with regard to the interaction of A II and a 
particular a-adrenoceptor subtype. It is interesting to note, that the second phase of 
the pressor response to a-adrenoceptor agonists, and procedures which reduce 
receptor reserve, are associated with an increasing dependency of responses on 
extracellular Ca^+. Since A II facilitates responses best under these circumstances, 
this suggests a possible causal link.
The Release o f Catecholamines from the Adrenal Medulla
As early as 1940, A II, in a crude peptide preparation, was shown to cause 
the release of adrenal medullary catecholamines (Braun-Menendez et al., 1940). 
This has subsequently been confirmed in a number of studies (for review see:
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Peach, 1974), although recently Vollmer et al., (1988) have demonstrated that 
ACE inhibitors do not reduce the output of catecholamines upon electrical 
stimulation of the adrenal gland, even when the renin-angiotensin system is highly 
activated, in the pithed rat. The physiological relevance o f this action of A II is 
therefore questionable.
fi-Adrenoceptor Mediated Production o f Angiotensin II
In 1984 Kawasaki et al., dem onstrated that P-adrenoceptor mediated 
increases in responses to sympathetic nerve stimulation in the rat perfused 
mesenteric bed, could be blocked by captopril or saralasin. These results therefore 
suggested that p-adrenoceptor stimulation resulted in the production of A II, and 
that this agent subsequently increased stim ulation-induced responses. This 
mechanism was confirmed in 1986 by Nakamura et al., who observed an increase 
in immunoreactive A II in response to the p-adrenoceptor agonist isoprenaline and 
has also been shown to occur in the subendothelial layer of rat vena cava (Gothert 
& Kollecker, 1986). These results provide further evidence for an important role of 
local tissue production of A II, and the possibility that circulating catecholamines, 
particularly adrenaline, could potentiate their own contractile effects on vascular 
smooth muscle, by stimulating the production of A II with the subsequent pre- and 
postjunctional facilitatory action that this peptide produces.
It is therefore apparent that, in addition to producing direct vasoconstriction 
themselves, the sympathetic nervous and renin-angiotensin systems interact in a 
complex manner. This interaction involves A II increasing sympathetic function at 
the level o f the central nervous system, peripheral sympathetic nerves and at a -  
adrenoceptors on vascular smooth muscle.
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Aims of the study
One of the principal effects of angiotensin II (A II) in the cardiovascular 
system is to facilitate responses produced via the sympathetic branch of the 
autonomic nervous system. At the outset of the project, much of the available 
evidence indicated that A II produced such an effect by a dual action. There was a 
well documented enhancement of transmitter output via a prejunctional mechanism 
(Zimmerman, 1979) and secondly a postjunctional facilitation of responses also 
seemed to be involved, particularly on responses mediated via postjunctional <*2 - 
adrenoceptors.
Such a selective interaction between A II and postjunctional ot2 - 
adrenoceptors on vascular smooth muscle, was suggested from two seminal 
studies. Firstly, De Jonge et al., (1984) demonstrated that angiotensin-converting 
enzyme (ACE) inhibitors selectively attenuated pressor responses to selective a.2~ 
adrenoceptor agonists. Secondly in the rabbit isolated lateral saphenous vein 
contractions produced by B-HT 920 were sensitive to low concentrations of both 
prazosin and rauwolscine but, in the presence of A II, the response possessed 
characteristics consistent with an action at o^-adrenoceptors. The selective a^ - 
adrenoceptor agonist phenylephrine was unaffected by A II. These latter findings 
suggested that A II may play an obligatory role in the functional expression of 
postjunctional 0-2' adrenoceptors in vitro.
A number of other observations however, suggested that the above 
interpretation was too simplistic. Grant & McGrath (1988a,b) reported that ACE 
inhibitors modulated responses to a-adrenoceptor agonists independently of the 
subtype of a-adrenoceptor activated, but dependent upon the nature of the response 
to a bolus injection of a particular agonist. Similarly A II was observed to confer
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a  i-adrenoceptor agonism on B-HT- 920 in the rabbit isolated thoracic aorta, a 
compound which in the absence of A II had acted as a weak a j-ad ren o cep to r 
antagonist
All of these observations suggested that there were interesting interactions 
between A II and a-adrenoceptor agonists, which needed to be clarified if the 
physiological interaction between the renin-angiotensin and sympathetic nervous 
systems were to be understood. Initially I concentrated on seeking a greater 
haemodynamic characterisation of the interaction between ACE inhibitors and a - 
adrenoceptors in pithed rats, by measuring the additional parameter of cardiac 
ouput. It became apparent however, that this model was inappropriate to study 
these phenomena for a number of reasons. For example, bolus injections of a -  
adrenoceptor agonists produce biphasic pressor responses in the pithed rat, which 
could be differentially modulated. Responses to the bolus injection of an agonist do 
not represent an 'equilibrium response'. Furthermore, ACE inhibitors reduced basal 
blood pressure, an effect which complicated the interpretation of their interaction 
with postjunctional a-adrenoceptor-mediated responses. It was therefore more 
desirable to examine the effects of A II on responses to NA mediated via 
postjunctional a ^ -  and a 2 -adrenoceptors in isolated vascular preparations. Of 
particular importance to us, was to use the endogenous ligand, NA, the definitive 
a-adrenoceptor agonist (Furchgott, 1972).
This was rather difficult however, since, at the outset of this project, one of 
the most paradoxical observations in adrenergic pharmacology, was the difficulty in 
clearly demonstrating isolated vascular preparations which contained postjunctional 
a 2 *adrenoceptors, despite the relative ease of demonstrating a 2 -adrenoceptor- 
mediated responses in whole animals (McGrath, 1982). The only convincing 
examples were to be found in the canine or human saphenous veins, the cat cerebral
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artery or the human isolated digital artery, preparations which were very difficult to 
obtain on a regular basis. The starting point of this project therefore, was to find a 
suitable vascular preparation which contained a homogeneous population of 
postjunctional a 2 -adrenoceptors from the rabbit. Having achieved this we would 
then have a good basis to examine the effects of A II (and other modulatory 
influences) on responses to NA mediated via these receptors. Since there was some 
evidence in the rabbit isolated lateral saphenous vein that postjunctional v.2~ 
adrenoceptors were present (Alabaster et al., 1985, Schumman & Lues, 1983), 
this vessel was chosen for study.
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METHODS & M ATERIALS
METHODS & MATERIALS
1) Isolated vascular smooth muscle preparations
A wide variety of vascular preparations were employed in a number of 
different experiments. Tissues were obtained from white albino rabbits of either 
sex, weighing between 2.0-3.0 kg, which were killed by stunning followed by 
exsanguination. Segments of the lateral saphenous vein, left renal vein, ear vein, 
distal saphenous artery, central ear artery, renal artery, femoral artery or superior 
mesenteric artery were cleaned of fat and connective tissue in situ and placed in 
ice-cold modified Krebs-Henselite solution (Krebs). When necessary, preparations 
were cleaned further with the aid of a dissecting microscope. 3-5 mm length 
segments were taken from each preparation and suspended between two 0 . 2  mm 
thick wire supports. The upper support was connected by cotton to a Grass FT03 
isometric transducer while the lower support was connected to a glass tissue holder. 
The venous or arterial segments were mounted in 30 ml isolated organ baths, 
bathed in Krebs maintained at 37°C, and gassed with 95% O2  plus 5% CO2 . They 
were then placed under an initial tension as follows: lateral saphenous vein 2  g.wt., 
left renal vein 0.5 g. wt., ear vein 0.3 g. wt., distal saphenous artery 1.5 g. wt., 
central ear artery 2.0 g. wt., renal artery 2 g. wt., femoral artery 1.5 g. wt. or 
superior mesenteric artery 2 g. wt. Isometric contractions were measured by a 
Grass FT03 transducer connected to a Linseis 6052 pen recorder. A diagram of the 
experimental apparatus is shown in figure 3.
In all experiments, tissues were left to equilibrate for a 60 min period, 
during which time a steady resting tension was achieved. Each preparation was then 
exposed to 3|iM NA and allowed to contract for 10 min. Exposure to a "sighting"
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Figure No. 3
Diagrammatic representation of the experimental apparatus 
used in studying contractions of isolated vascular smooth 
muscle preparations.
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concentration of an agonist minimised changes in the sensitivity of the preparations 
to further addition of agonists and is similar to the method used by Ruffolo et al., 
(1979). Following complete washout, an additional one hour equilibration period 
was allowed before commencement of any other experimental procedure. Basal 
tension, following the sighting response, remained stable in all preparations for the 
rest of the experiment and was as follows: lateral saphenous vein 0.3 - 0.4 g.wt., 
left renal vein 0.15 - 0.2 g. wt., ear vein 0.05 - 0.1 g. wt., distal saphenous artery 
0.7 - 0.9 g. wt., central ear artery 0.9 - 1.2 g. wt., renal artery 0.5 - 0.7 g. wt., 
femoral artery 0.7 - 0.9 g. wt. or superior mesenteric artery 0.7 - 0.9 g. wt.
2 ) Effect o f agonists and antagonists
In order to examine the effects of various agonists and antagonists in rabbit 
blood vessels, the following standard protocol was adopted:
Cumulative concentration response curves (CCRC) to agonists were 
constructed by increasing the concentration of agonist in the bath by approximately 
3-fold increments. When responses to agonists were not well maintained, addition 
of the next concentration was made as close to the peak as possible. An initial 
control CCRC, to any given agonist, was obtained in each preparation. Following 
attainment of the maximal control contraction, preparations were washed until 
complete relaxation was effected. The preparations were then left for a further 
period of 45-60 min before re-exposure to the agonist.
In experiments using reversible antagonists, these drugs were added to the 
organ bath at least 45 min prior to the onset of a second CCRC. In general only two 
CCRC's were obtained from each segment of a preparation, with the exception of 
receptor isolation experiments (see below) and some experiments in the left renal 
vein using phenoxybenzamine. In the latter, after obtaining an initial control CCRC
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to NA, the receptor reserve was reduced by exposing the tissue to 
phenoxybenzamine (1 nM) for a period of 15 min. The tissues were subsequently 
washed at least four times and 30 min later a CCRC to NA was constructed. After 
complete washout, a 60 min period was allowed before a further CCRC was 
obtained. When examining the effects of angiotensin II, angiotensin I and Bay K 
8644 on agonist responses, these drugs were added approximately 15 min prior to 
the onset of a CCRC to an agonist. In some experiments saralasin was added 10 
min prior to A H
3) Receptor isolation experiments
In receptor isolation experiments a control CCRC to NA was obtained in 
each preparation. Following washout, to effect complete relaxation, one of the 
following protocols was adopted:
a) Isolation o f postjunctional a 2 -adrenoceptors
Segments of lateral saphenous vein were exposed to lpM  rauwolscine 5 
min prior to the addition of 0.3fiM phenoxybenzamine. This combination of 
antagonists was allowed to remain in contact with the tissue for a further period of 
30 min (total time: 35 min for rauwolscine; 30 min for phenoxybenzamine). The 
preparations were then washed a minimum of seven times over the period of one 
hour. During the first two washes ljiM  rauwolscine was present in an attempt to 
maximise protection of postjunctional (^-adrenoceptors. 2 0  min following the final 
washout, a CCRC to NA was obtained in each preparation. This CCRC to NA then 
served as an internal control in examining the effects of antagonists and of 
facilitatory agents such as A II on a third CCRC constructed 60 min later. The 
experimental and theoretical protocol for (^-adrenoceptor isolation is represented
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schematically in figure 4.
A very similar protocol was followed in an attempt to isolate postjunctional 
ot2 -adrenoceptors in the distal saphenous artery. It was found necessary, however, 
to leave the combination o f rauwolscine ljiM  and phenoxybenzamine 0.3jiM in 
contact with the tissue for a 60 min period (total times: rauwolscine 65 min; 
phenoxybenzamine 60 min) in order to effect complete removal of postjunctional 
a  i -adrenoceptors. In addition only one CCRC to an agonist was obtained in the 
distal saphenous artery after the isolation procedure.
b) Isolation o f postjunctional a  j-adrenoceptors
Essentially, experim ents attem pting to isolate postjunctional a ^ -  
adrenoceptors in the lateral saphenous vein followed the same protocol as those 
carried out in order to isolate postjunctional 0 C2 -adrenoceptors. The exception was 
that YM 12617 was used to mask a  j-adrenoceptors (as opposed to rauwolscine 
masking ot2 -adrenoceptors) thereby preventing phenoxybenzam ine from 
irreversibly binding to a  ^ -adrenoceptors. Therefore, after obtaining an initial 
CCRC to NA, preparations were exposed to 0.1 pM  YM 12617 5 min before the 
addition of 0.3pM phenoxybenzamine and both antagonists were then washed out 
after a period of 30 min (total time: YM 12617 35 min; phenoxybenzamine 30 min). 
The preparations were then washed a minimum of 7 times over the period of one 
hour. YM 12617 was present during the first two washes in an attempt to maximise 
protection of a  j-adrenoceptors. 20 min following the final washout, a CCRC to 
NA was obtained in each preparation. The effects of antagonists and of facilitatory 
agents such as A II on responses to NA were examined on a further CCRC 
constructed 60 min later. The protocol for attempted isolation of postjunctional ctj- 
adrenoceptors is outlined in Figure 5.
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NACRC agonist CRC agonist CRC
45 mins
Rauw lpM (35 or 65 mins) 
PBZ 0.3JJ.M (30 or 60 mins) 
subsequently 7 washes over 
1 hour.
Rauw lpM  present for first 
two washes.
45 mins
various antagonists
Receptor isolation theory
Hypothetical postulation for the 
co-existence of both alpha-1 and 
alpha-2 adrenoceptors in a vascular 
smooth muscle preparation
Rauwolscine binds to alpha-2 
adrenoceptors thereby masking them
Rauwolscine
1 1
Rauwolscine
PBZ
phenoxybenzamine irreversibly 
binds to and functionally removes 
alpha-1 adrenoceptors. Rauwolscine 
prevents phenoxybenzamine from 
interacting with alpha-2 
adrenoceptors
PBZ
Upon washout of the antagonists a 
homogeneous population of 
alpha-2 adrenoceptors remains
Figure No. 4
Experimental and theoretical protocol adopted in attempting to 
isolate postjunctional oc2-adrenoceptors.
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NA CRC 
^
agonist CRC 
 ►»
agonist CRC
45 mins
YM 12617 0.1jxM(35mins) 
PBZ 0.3|iM (30 mins) 
subsquently 7 washes over 
1 hour.
Ym 12617 O.lpM present for 
first two washes.
45 mins 
various antagonists
Receptor isolation theory
Hypothetical postulation for the 
co-existence of both alpha-1 and 
alpha-2 adrenoceptors in a vascular 
smooth muscle preparation
YM 12617 binds to alpha-1 
adrenoceptors thereby masking them
YM 12617
U1 mi
YM 12617 
PBZ
PBZ
phenoxybenzamine irreversibly 
binds to and functionally removes 
alpha-2 adrenoceptors. YM 12617 
prevents phenoxybenzamine from 
interacting with alpha-1 
adrenoceptors
PBZ
Upon washout of the antagonists a 
homogeneous population of 
alpha-2 adrenoceptors remains
Figure No. 5
Experimental and theoretical protocol adopted in attempting to 
isolate postjunctional oq-adrenoceptors.
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4) Ca2+ readdition experiments
Some experiments, in the lateral saphenous vein, were carried out to analyse 
the effects of A II  and Bay K 8644 on the influx of extracellular Ca^+ into the cell, 
stimulated by either depolarisation or by postjunctional (^-adrenoceptor activation. 
Segments of lateral saphenous vein were set up as previously described and an 
initial CCRC to NA was obtained.
To exam ine responses upon the addition of extracellular C a^+ in 
depolarised preparations, tissues were subsequently washed and bathed in 
nominally Ca^+-free Krebs solution containing 65mM KC1 (exchanged with NaCl 
on an equimolar basis). Subsequently a Ca CCRC was obtained by adding 
Ca^+ to the organ baths in approximately 2-fold increments. Following attainment 
of the control maximum response, tissues were washed in nominally Ca^+-free 
Krebs until complete relaxation was effected and allowed to bathe in this solution. 
A second Ca^+ CCRC was obtained 45-60 min later in the presence of A II or Bay 
K 8644.
In order to examine responses to the addition o f extracellular Ca^+ in 
response to stimulation of postjunctional o^-adrenoceptors, the following protocol 
was adopted:
After obtaining an initial CCRC to NA in the lateral saphenous vein, 
postjunctional ct2 -adrenoceptors were isolated by the method previously described. 
Tissues were subsequently washed and allowed to bathe in nominally Ca^+-free 
Krebs. A CCRC to Ca^+ was then constructed in the presence of NA 30|iM, added 
10 min prior to the onset of the Ca CCRC. Following attainment of the control 
maximum response, tissues were washed in nominally Ca^+-free Krebs until
66
complete relaxation was effected and allowed to bathe in this solution for 45 min. 
NA 30p.M was then added to the organ baths 10 min before a second Ca^+ CCRC, 
in the presence of A II or Bay K 8644, was obtained. In each experiment, one 
preparation received no ancillary drugs and served as a time control.
5) Electrical field  stimulation
Some experim ents were carried out in o rder to determ ine the 
neurotransm itter(s) responsible, and the receptors through which the(se) 
transmitter(s) acted, to producing contractions in the distal saphenous artery, in 
response to electrical field stimulation.
Segments of distal saphenous artery were suspended between two 0.2 mm 
thick wire supports as previously described. The upper support was connected by 
cotton to a Grass FT03 isometric transducer, while the lower support was 
connected to a modified glass tissue holder. These modified tissue holders 
encompassed Linton small tissue, platinum plate, electrodes which were connected 
to a Square One Instruments electrical stimulator.
Tissues were exposed to a "sighting" concentration (3p.M) of NA after 45 
min. 15 min after complete washout of the NA, tissues were subjected to electrical 
field stimulation with the following parameters: 16 Hz for 1 second, pulse width 
0.03 msec at a supramaximal voltage of 35V. Repetitive stimulation was applied, 
once every 5 min, until constant responses were achieved. Subsequently, a control 
frequency-response-curve (FRC), was obtained for each preparation. The FRC 
consisted of obtaining responses to the following frequencies of stimulation; 4, 8 , 
16, 32 and 64 Hz at a stimulation duration of 1 second and 4 and 8  Hz at a 
stimulation duration of 1 0  seconds.
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After obtaining a control FRC, tissues were exposed to either, prazosin 
(O.ljiM ), rauw olscine (ljiM ), or oc-,p-,m ethylene-ATP (3 |iM ). The a -  
adrenoceptor antagonists were applied 30-45 min prior to the onset of a second 
FRC, while a-,p-,methylene-ATP was given 25-30 min before. After application 
of the various antagonists, these compounds remained in contact with that particular 
preparation for the remainder of the experiment. Further to the second FRC, an 
alternative antagonist was added cumulatively to the organ bath (eg .a -,p -, 
methylene-ATP may have been given to the preparation which had already received 
prazosin, prazosin to that having received rauwolscine etc.) in a random order, to 
examine the effects of a combination of two of the three antagonists.
In a seperate series of experiments, after obtaining a control FRC, tissues 
were exposed to two of the three aforementioned antagonists and a second FRC 
was obtained. The effects of A II (0.05|iM) or of the third alternative antagonist 
were subsequently examined on the remaining residual response when a third FRC 
was obtained.
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6) Calculation o f  results
Unless otherw ise stated, responses to agonists are expressed as a 
percentage (mean ± s.e.mean) of the maximum response of the first control CCRC 
to any given agonist. In nerve stimulation experiments, results are expressed as a 
percentage of the response to 64 Hz obtained in the first FRC. Differences between 
means were considered statistically significant if p < 0.05 for either paired or 
unpaired observations - Student's r-test.
In examining the effects of antagonists, agonist concentration-ratio values 
were determined from the concentrations producing 50% of the maximum response 
in the absence and presence of each concentration of antagonist. In all experiments, 
one preparation was run in parallel with experimental tissues, but received no 
antagonist, and was used to determine time-dependent changes in agonist sensitivity 
(Furchgott, 1972). According to Arunlakshana & Schild (1959) if antagonism is 
competitive, a plot of the logarithm of dose ratio - 1 against the negative logarithm 
of the molar concentration of the antagonists, yields a straight line whose slope is 
one and the intercept along the abscissa scale is the pA 2 , which is equal to the 
antagonist dissociation constant (Kg) under equilibrium conditions. Antagonism 
was considered competitive if the 95% confidence limits for the slope of the Schild 
plot, drawn by linear regression, overlapped unity. Concentrations of antagonists 
which did not consistently produce greater than 3-fold rightward displacements of 
the agonist CCRC were excluded from quantitative Schild analysis. In some 
experiments, the agonist concentration-ratio values in the presence of antagonist 
were determined at the 25%, 50% and 75% level of the maximum response to NA 
as described by Flavahan & Vanhoutte (1986).
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7) Solutions & Drugs
The composition of the modified Krebs-Henselite solution was as follows 
(in mM): NaCl 118.4, N aH C 0 3  25, KC1 4.7, KH 2 P 0 4  1.2, M gS0 4  1.2, CaCl2  
2.5, glucose 11. Na2EDTA was also included to prevent degradative oxidation of 
NA and as standard, with the exception o f nerve stim ulation experiments, 
propranolol (ljiM ) and cocaine hydrochloride (10}iM) were also included to inhibit 
p-adrenoceptors and neuronal uptake of NA respectively. The nominally Ca^+-free 
Krebs was identical to that above without Ca^+ being added. The following 
compounds were used:
prazosin HC1 (Pfizer);
rauwolscine HC1 (Roth);
YM 12617 (Y amanouchi);
CH 38083 (Chinoin);
U K -14304 (Pfizer);
(-)-phenylephrine HC1 (Sigma);
(-)-noradrenaline bitrate (Sigma);
propranolol HC1 (Sigma);
cocaine HC1 (MacCarthys);
phenoxybenzamine HC1 (S,K&F);
angiotensin II amide (Ciba);
Bay K 8644 (Bayer);
saralasin ([Sar^,Ala^]-angiotensin II) (Sigma);
captopril (Squibb);
cilazaprilat (Roche);
5-Hydroxytryptamine creatinine sulphate (Sigma);
U46619 (Upjohn);
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nifedipine (Bayer).
With the following exceptions all drugs were dissolved in distilled water. 
NA was prepared in 23|iM Na2 EDTA to prevent oxidative degradation. YM 12617, 
Bay K 8644 and nifedipine, as stock solutions of ImM, were prepared in 20% 
absolute alcohol. Phenoxybenzamine (ImM ) was also prepared in 20% absolute 
alcohol in distilled water and a drop of IN  HC1 was added to remove turbidity. 
Further dilutions of YM 12617, Bay K 8644, nifedipine and phenoxybenzamine 
were made in distilled water.
YM 12617 (5-[2-[[2-(ethoxyphenoxy) ethyl] amino] propyl]-2-methoxy benzene- 
sulphonamide HC1);
CH 38083 (7,8-(methylenedioxi)-14-a-hydroalloberbane HC1);
UK-14304 (5-bromo-6-[2-imidazolin-2-ylamino]-quinoxaline bitartrate);
Bay K 8644 (methyl l,4-dihydro-2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)- 
pyridine-5-carboxylate);
U46619 (5Z,9a, 13E, 15S)-11,9-(Epoxymethano)prosta-5,13-dien-1 -oic acid.
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RESULTS
RESULTS
Alpha-adrenoceptors in the rabbit isolated lateral saphenous vein
M ost of the evidence in the literature suggests that postjunctional <*2 - 
adrenoceptors can be most easily demonstrated in isolated venous preparations. The 
rabbit isolated lateral saphenous vein has previously been reported to contain a 
homogeneous population of postjunctional oc2 -adrenoceptors (Alabaster et al., 
1985), although other authors have not been able to demonstrate this unequivocably 
(Purdy et al., 1980, Schumman & Lues, 1983, Daly et al., 1988a). The present 
study therefore, re-examined the a-adrenoceptor population in this preparation and 
attempted to isolate different components of the response to the endogenous ligand 
NA.
Agonist potencies
The a-adrenoceptor agonists NA (non-selective), phenylephrine (selective 
a^ ) and UK-14304 (selective a 2 ) produced concentration-dependent contractions 
in the rabbit lateral saphenous vein. The rank order of potencies for these agonists 
was as follows: U K -14304 > NA > phenylephrine. Based upon the maximum 
contractions, NA and phenylephrine can be classed as full agonists, while UK- 
14304 is a partial agonist compared to NA (Figure 6 ). The pD 2  and Emax values 
for each agonist are given in Table la.
Effects o f a-adrenoceptor antagonists on responses to NA
Unfortunately, consecutive CCRC's to NA were not reproducible, there 
being a small but significant increase in the maximum response with time (Figure
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7). Therefore, one preparation was run in parallel with experimental tissues, but 
received no ancillary drug, and was used to determine time-dependent changes in 
agonist responses.
As shown in Figure 8 , the a  j-adrenoceptor antagonists, prazosin and YM 
12617 produced concentration-dependent, rightward displacements of the NA 
CCRC. The pA 2  value for prazosin was 7.93, while that for YM 12617 was 8.36. 
For each antagonist the slope of the Schild plot was significantly different from 
unity, indicating non-competitive antagonism (Table lb). Prazosin appeared to have 
a greater effect on the lower portion of the NA CCRC. The mean log agonist- 
concentration ratio, in the presence of O.lfiM prazosin, calculated at the 25% level 
of the maximum response to NA, was greater than that calculated at the 75% level, 
although this tendency was not significant (Table 2). Conversely, the rightward 
shift of the NA CCRC, produced by YM 12617, was similar at all levels of the NA 
CCRC (Table 2).
Increasing concentrations of the selective a 2 -adrenoceptor antagonist 
rauwolscine, produced a non-parallel displacement of the NA CCRC (Figure 9a). A 
component of the response to NA, equivalent to approximately 20-35% of the 
maximum, was resistant to rauwolscine. Therefore, in contrast to prazosin, the log 
agonist-concentration ratio, in the presence of 0.5|J.M rauw olscine, was 
significantly greater at the 50 and 75% levels of the maximum response to NA, than 
it was at the 25% level (Table 2). Based upon a Schild plot of the agonist 
concentration-ratios at the 50% level of the maximum response, it was observed 
that the antagonism produced by rauwolscine was also non-competitive, with a pA 2  
value of 8.41 (Table lb). Interestingly, in approximately 30% of the preparations, 
the addition of rauwolscine to the bathing medium produced a small transient 
contraction (<15% of the maximum response to NA). This effect was never seen in
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the presence of prazosin (0.1 pM) or YM 12617 (0.1p.M) (n = 5). Based upon pA 2  
values, the potency order for the three antagonists in the saphenous vein was 
rauwolscine = YM 12617 > prazosin (Table lb).
Figure 9b demonstrates the effect of varying concentrations of rauwolscine 
on responses to NA in the presence of prazosin (0.1 fiM). Under these conditions 
the com ponent o f the response to NA, which was previously resistant to 
rauwolscine, was not seen and the log agonist concentration ratio value (50% level 
of NA maximum response) was increased from 2.16 ± 0.08 in the presence of 
2.5fiM rauwolscine alone, to 2.53 ± 0 .1 8  in the presence o f the combination of 
2.5|iM  rauwolscine and 0.1 (iM prazosin.
Attempted isolation of postjunctional (X2  -adrenoceptors
The previous results suggested the presence o f both cxj- and o ^ -  
adrenoceptors in the lateral saphenous vein. An attempt was therefore made to 
isolate a homogeneous population of postjunctional ot2 -adrenoceptors using the 
protocol described in figure 4. Phenoxybenzamine (0.3pM) virtually abolished all 
responses to NA in this preparation (Figure 10a). The rationale employed therefore, 
was to prevent phenoxybenzamine binding to oc2 -adrenoceptors by masking these 
receptors with l(iM  rauwolscine. This concentration of rauwolscine was considered 
to be without effect at a  ^ -adrenoceptors, since even in the presence of the higher 
concentration of 2.5jiM, a component of the response to NA which was susceptible 
to prazosin, remained resistant to rauwolscine (Figure 9).
Following the inclusion of rauwolscine (ljiM ) before, and during, the 
incubation period with phenoxybenzamine (0.3|iM), a large component of the 
response to NA was spared. The maximum response to NA was significantly 
increased after the protection protocol, being 67.3 ± 4.5 compared to 5.8 ± 2.7 of
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F ig u re  No. 6
Concentration-dependent responses to the a-adrenoceptor agonists NA 
(O). U K -14304 ( □ )  and phenylephrine ( # )  in rabbit isolated lateral 
saphenous vein. Results are expressed as a % of a) the maximum response 
to NA in each preparation or b) as a % of the maximum response to each 
individual agonist.
Each point represents the mean ± s.e.mean (n = 8  -11).
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F ig u re  No. 7
Reproducibility of two consecutive concentration-response curves to NA in 
rabbit isolated lateral saphenous vein expressed as: a) a % of the maximum 
response of the first CCRC to NA or b) a % of the maximum response of 
each individual CCRC. The 1st CCRC to NA is represented by (O) while 
( # )  represents the 2nd CCRC.
Each point represents mean ± s.e.mean (n =24). Statistically significant 
differences between the 1 st and 2nd CCRC's are represented by; *p<0.05, 
**0.01<p<0.001, Student's t- test.
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F ig u re  No. 8
Effects of the a r-adrenoceptor antagonists a) prazosin O.OljiM ( # ) ,  
0.1 |iM  (□ ) ,  ljiM  ( ■ )  and of b) YM 12617 O.Ol^iM ( # ) ,  0.1 ^ iM (□ ) ,  
ljiM  (■ )  on responses to NA (O) in rabbit isolated lateral saphenous vein. 
Each point represents the mean ± s.e.mean (n = 5-12).
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F ig u re  No. 9
Effect of the c^-adrenoceptor antagonist rauwolscine 0.05|iM  ( # ) ,  0.5|iM 
( □ )  and 2.5|iM  (M ) on responses to NA (O) in a) the absence and b) 
the presence of 0.1 p.M prazosin in rabbit isolated lateral saphenous vein. 
The effect of prazosin 0.1 (A) alone against responses to NA is also
shown.
Each point represents mean ± s.e.mean (n = 4-7)
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a ) Agonist bDi  Earn.
NA 7.53 ± 0.08 1
(n = 8 )
phenylephrine 5.83 ± 0.06 0.95 ±  0.02
(n = 7)
UK 14304 7.85 ± 0 .1 6  0.86 ± 0 .0 4
(n = 8 )
b) Antagonist pA2 Slope
prazosin 7.93 0.62
(0.1 - ljiM ) (8.37 -7 .57) (0.51 -0.72)*
YM 12617 8.36 0.47
(0.1 - ljiM ) (8.81 - 7.91) (0.34 - 0.60)*
rauwolscine 8.41 0.80
(0.05 - 2.5|iM) (8.60 - 8.22) (0.74 - 0.86)*
Tafrig 1
a) List o f pD 2  values (with 95% confidence limits) and Em ax values for a -  
adrenoceptor agonists; and of b) pA 2  values with the slopes of the Schild plots 
(with 95% confidence limits) for a-adrenoceptor antagonists against responses to 
NA in rabbit isolated lateral saphenous vein in the presence of propranolol (l|iM ) 
and cocaine (10|iM). pA2  values were determined from a regression analysis of the 
log agonist concentration ratio from 18-24 individual observations. * denotes slope 
of Schild plot significantly different from unity.
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Antagonist 25% 50% 75%
prazosin (O.lpM) 0.81 ±  0.07 0.69 ±  0.07 0.64 ± 0.10
(n = 1 2 )
YM 12617 (0.1 jiM) 0.69 ±  0.20 0.69 ±  0.12 0.71 ± 0.16
(n = 5)
rauwolscine (0.5pM) 1.47 ± 0 .1 4  1.70 ± 0 .1 2  1 .8 5 ± 0 .0 9 a
(n = 5)
Table X
log agonist concentration-ratio values for NA measured at the 25%, 50% and 75% 
level of the maximum response to NA, in the presence of prazosin (0.1 |iM), 
YM 12617 (O.ljiM) or rauwolscine (0.05pM) 
denotes a significant difference in the value for rauwolscine (0.5JJ.M) calculated at 
the 25% and 75% levels of the maximum response to NA. p<0.05
80
the control maximum response, with phenoxybenzamine alone (Figure 10). 
Consecutive CCRC's to NA were reproducible with time after the protection 
protocol (Figure 11).
Effects o f a-adrenoceptor antagonists after attempted isolation of 
postjunctional a2~adrenoceptors
The residual response to NA, rem aining after the com bination of 
rauwolscine and phenoxybenzamine, was relatively resistant to the selective a j -  
adrenoceptor antagonists YM 12617 and prazosin (Figure 12a). The log agonist 
concentration-ratio values for NA in the presence of YM 12617 (0.1p.M) or 
prazosin (O.ljiM) were reduced markedly, after the protection procedure, compared 
to control values (Table 3). Figure 13 shows representative trace recordings of the 
effects of O.lfiM prazosin on NA-induced contractions under normal experimental 
conditions and after attempted isolation of postjunctional a 2 -adrenoceptors.
In contrast to the a  j-adrenoceptor antagonists, rauw olscine (1|J.M) 
produced a marked rightward displacement of the NA CCRC after the protection 
protocol (Figure 12b. Table 3), with an estimated -logK^ value of 7.98. It was 
found necessary to use this lower concentration of o^-adrenoceptor antagonist, 
since the rightward displacement produced by 2.5|iM rauwolscine was sufficiently 
great that it prevented the calculation of a -logK^ value. Coincident with this 
protective effect of rauwolscine against phenoxybenzamine, was the removal of the 
component of the response to NA, which was "rauwolscine resistant" (compare 
Figure 9a with Figure 12b).
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F ig u re  No. 10
Effect of phenoxybenzamine (0.3p.M) ( # )  on responses to NA (O ) a) in 
the absence and b) in the presence o f the a 2-adrenoceptor antagonist 
rauwolscine (lfiM), in the rabbit isolated lateral saphenous vein.
Each point represents mean ± s.e.mean (n = 8 ). All responses to NA after 
trea tm en t w ith the com bination  o f rauw olscine  (lp.M ) and 
phenoxybenzamine (0.3pM) are significantly different from those in the 
presence of phenoxybenzamine alone (0.3|iM), p<0.05 Student's t- test.
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Reproducibilty of responses to NA in rabbit isolated lateral saphenous vein 
after attempted isolation of postjunctional a 2 -adrenoceptors. Results are 
expressed in two ways: a) as a % of the initial maximum response to NA 
(O) or b) as a % of the maximum response to NA after the combination 
of rauwolscine and phenoxybenzamine. ( # )  represents the first CCRC to 
NA after the protection protocol, while (□ )  represents the second.
Each point represents mean ± s.e.mean (n = 8 ).
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Effect of a-adrenoceptor antagonists on responses to NA ( # )  after attempted 
isolation of postjunctional a 2-adrenoceptors in rabbit isolated lateral 
saphenous vein, a) Effect of the apadrenocep to r antagonists prazosin 
(O.lfiM) ( □ )  and YM 12617 (O.lpM) (■ ) .  b) Effect of rauwolscine 
(l|iM ) (□ ). Results are expressed as a % of the maximum response to NA 
(O ) prior to the protection protocol.
Each point represents mean ± s.e.mean (n = 6  - 8 ).
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Representative trace recording of the effect of prazosin (0.1 p.M) on NA- 
induced contractions (cumulative addition; approximately 3 fold increments 
in concentration) of the rabbit isolated lateral saphenous vein, a) under 
normal experimental conditions and b) following attempted isolation of
C.
postjunctional a 2-adrenoceptors with the combination of rauwol^ine 
(ljiM ) and phenoxybenzamine (0.3jiM).
85
0.0
3p
M
 
NA
Attem pted isolation o f postjunctional a  j-adrenoceptors
The rationale behind this protocol was to protect the population o f ( X j -  
adrenoceptors from phenoxybenzamine with YM 12617 (see Figure 5). This otj- 
adrenoceptor antagonist prevented the complete abolition of responses caused by 
phenoxybenzamine (0.3jiM) alone (Figure 14a). In the presence of lpM  YM 12617 
a residual response to NA of 57.5 ± 5.8% remained, while 0.1|iM  prevented the 
abolition of 32.2 ± 5.6% o f the maximum response to NA. Subsequent 
experiments were carried out using the lower concentration of the antagonist. This 
concentration was chosen, since 0.1 pM YM 12617 has been reported to be inactive 
at both prejunctional ot2 -adrenoceptors, in the rat isolated vas deferens (Honda et 
al., 1985), and postjunctional o^-adrenoceptors in the rabbit isolated ear vein 
(Daly eta l., 1988b).
In approximately 25% of preparations, particularly those from young 
animals (< 2.3kg.), the responses were less than 15% of the original NA 
maximum, poorly maintained and subject to changes unrelated to the addition of 
NA to the bathing medium. These preparations were discarded from the subsequent 
quantitative analysis. The residual response in the remaining preparations treated 
with 0.1|iM  YM 12617 and 0.03|iM phenoxybenzamine, varied from 20 to 40% of 
the control maximum response. Unfortunately, successive CCRC's to NA 
following the protection protocol were not reproducible, there being an 
approximately 30% increase in the maximum response (Figure 15).
Effects o f a-adrenoceptor antagonists after attempted isolation of  
postjunctional a j -adrenoceptors
YM 12617 produced a concentration-dependent rightward shift in the
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CCRC to NA after attempted isolation of postjunctional a  ^ -adrenoceptors (Figure 
16a). The antagonism produced by YM 12617 appeared not to be competitive. The 
log agonist-concentration ratio for NA in the presence of O.OljiM YM 12617 was 
0.16 ±0.06 (n = 6 ), while a 10-fold higher concentration of YM 12617 produced 
only a 5-fold greater rightward displacement, 0.67 ± 0.10 (n = 11) (Table 3).
Surprisingly, following receptor protection with O .ljlM  YM 12617, 
rauwolscine (2.5jiM) produced a significant leftw ard shift of the NA CCRC 
(Figure 16b). This potentiating action of rauwolscine on the residual response to 
NA was abolished by YM 12617 (0.1 fiM), and the combination of the two 
antagonists produced a greater inhibition of responses to NA, than either antagonist 
alone (Figure 17a). The log agonist-concentration ratio value, in the presence of 
both rauwolscine (lp.M) and YM 12617 (0.1 (J.M), was increased to 0.93 ± 0.10 (n 
= 5). In contrast to rauwolscine, the selective ot2 -adrenoceptor antagonist CH 
38083 (ljiM ) (Vizi et al., 1986), produced a significant rightward displacement of 
the NA CCRC following attempted isolation of postjunctional a  j-adrenoceptors. 
This was associated with the uncovering of a small 'resistant' component of the 
response to NA (Figure 17b).
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F ig u re  No. 14
Effect of prior treatment with phenoxybenzamine (0.3pM) on responses to 
NA (O) a) in the absence ( # )  and b) in the presence o f the a x- 
adrenoceptor antagonist YM 12617 (lpM ) (□ )  and (0.1 pM) (H ), in the 
rabbit isolated lateral saphenous vein.
Each point represents mean ± s.e.mean (n = 4 - 11). All responses to NA 
after treatm ent with the com bination o f YM 12617 (0 .1 -lpM ) and 
phenoxybenzamine (0.3pM) are significantly different from those in the 
presence of phenoxybenzamine alone (0.3pM), p<0.05 Student's t- test.
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Reproducibility of responses to NA in rabbit isolated lateral saphenous vein 
after attempted isolation of postjunctional apadrenoceptors. Results are 
expressed in two ways a) as a % of the initial maximum response to NA (O ) 
or b) as a % of the maximum response to NA after the combination of YM 
12617 and phenoxybenzamine. ( # )  represents the first CCRC to NA after the 
protection protocol, while (□ ) represents the second.
Each point represents mean ± s.e.mean (n = 11). Statistically significant 
differences between the 1st and 2nd CCRC's after the protection protocol are 
represented by; *p<0.05, **0.01<p<0.001, Student's t- test.
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F ig u re  No. 16
Effect of a-adrenoceptor antagonists on responses to NA ( # )  after attempted 
isolation of a^adrenoceptors in rabbit isolated lateral saphenous vein, a) the 
effect of the aradrenoceptor antagonist YM 12617 (0.01/iM) (□ )  and (O.ljiM) 
(■ ) .  b) the effect of the a 2-adrenoceptor antagonist rauwolscine (l|iM ) (□ ). 
Results are expressed as a percentage of the maximum response to NA (O ) prior 
to the protection protocol.
Each point represents mean ± s.e.mean (n = 6  - 11). Statistically significant 
differences between responses in the absence and presence of rauwolscine (lfiM) 
(Figure b) are represented by; *p<0.05, **0.01<p<0.001, Student's t- test.
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a) Effect of the combination of YM 12617 (0.1 JIM) and rauwolscine 
(l[iM ) (□ )  and b) of the a 2-adrenoceptor antagonist CH 38083 (l|iM ) 
(□ )  on responses to NA ( # )  after attempted isolation of postjunctional a r  
adrenoceptors in rabbit isolated lateral saphenous vein. Results are 
expressed as a % of the maximum response to NA (O) prior to the 
protection protocol.
Each point represents mean ± s.e.mean (n = 5).
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Antagonist control ajjiso la tio n oc^ -isolation
prazosin 0.69 ±  0.07 n. a. 0.27 ±  0.07*
(0.1 jiM) (n = 1 2 ) (n = 6 )
YM 12617 0.69 ± 0 .1 2 0.67 ± 0 .1 0 0.26 ±0.06*
(0.1 pM) (n = 5) ( n = l l ) (n = 5)
rauwolscine 2.16 ± 0 .0 8 n. p.
a
1.98 ±0.11
(2.5jiM) IIa 
'_«■ (n = 6 )
T a b le  3
Log agonist concentration-ratio values for NA in the presence o f various 
antagonists, under control conditions and after attempted isolation of postjunctional 
a } -  and <X2~adrenoceptors respectively, ^denotes a significant difference from 
control values (p < 0 .0 1 ). 
n. a. - this experiment was not attempted.
n. p. - this value could not be calculated since rauwolscine enhanced responses to 
NA under these conditions.
- this log agonist concentration ratio was obtained with ljuM rauwolscine.
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Comparison of the effects of A 11 and Bav K 8644 on responses to NA 
mediated via postjunctional cxj - and a2~adrenoceptors in vascular 
smooth muscle
It has been suggested from whole animal studies that pressor responses 
mediated via ot2 -adrenoceptor stimulation, but not via a  j-adrenoceptor activation, 
can be selectively attenuated by calcium entry blockers (van Meel et at., 1981) and 
by angiotensin-converting enzyme inhibitors (De Jonge et al., 1981, 1982). There 
is evidence however, that this differential attenuation may be depend, not on 
receptor subtype, but on the nature of the response produced by a given agonist 
(O'Brien et al., 1985, Grant & McGrath, 1988b, MacLean & Hiley, 1988). 
Because of these conflicting observations, the present study examined the effects of 
angiotensin II (A II) and the calcium channel facilitator Bay K 8644 on responses to 
NA, mediated via postjunctional o tp  and (X2 -adrenoceptors, in vitro. Three 
isolated venous preparations, with differing a-adrenoceptor populations were used: 
the lateral saphenous vein, which contains a mixture of both a-adrenoceptors; the 
lateral saphenous vein after attempted isolation of homogeneous populations of both 
a i -  and a 2 -adrenoceptors; the ear vein, which contains almost exclusively 
postjunctional a 2 -adrenoceptors (Daly et al., 1988b) and the left renal vein, which 
contains a homogeneous population of a^-adrenoceptors (Daly et al., 1988c).
Lateral Saphenous Vein 
Effects o f A II  and Bay K  8644 on responses to NA
A II produced a concentration-dependent contraction in the lateral saphenous 
vein (Figure 18a). Responses to higher concentrations of A II, consisted of an 
initial rapid response which transiently returned to baseline after 6 - 8  mins. Lower
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concentrations produced contractions which were slower in onset and longer 
lasting, returning to baseline after 12-15 mins. Baseline tension remained stable 
after the transient contraction produced by A II, for at least the duration of the 
experiment.
A II (0.05-0.5|iM) had no effect on responses to NA when the full receptor 
complement was present in the lateral saphenous vein (Figure 19a). In contrast Bay 
K 8644 (0.03|iM), a concentration which had no effect on resting baseline tension, 
increased both the sensitivity and maximum response of the preparation to NA 
(Figure 19b, Table 5). Higher concentrations of Bay K 8644 (>0.3|iM) induced 
spontaneous contractions in the lateral saphenous vein.
Effects o f A II and Bay K  8644 on a-adrenoceptor antagonist potency
In a previous study in the rabbit lateral saphenous vein, it was reported that 
A II made responses to the reportedly selective a 2 -adrenoceptor agonist, BHT-920, 
more resistant to prazosin (Schumman & Lues, 1983), suggesting a selective 
facilitation of a 2 -adrenoceptor-mediated responses. The effects of A II (and of Bay 
K 8644) on the antagonism produced by a-adrenoceptor antagonists against 
responses to NA were therefore examined.
As mentioned previously both prazosin and rauwolscine non-competitively 
antagonised responses to NA in this preparation under normal experimental 
conditions (Figures 8,9 Table 1). A II (0.05p.M) reduced the potency of the 
selective a  j-adrenoceptor antagonist prazosin, particularly on the lower portion of 
the CCRC to NA (Figure 20). The log agonist-concentration ratio for NA, in the 
presence of O.ljiM prazosin, measured at the 25% level of the maximum response 
was significantly reduced, although this was less marked at the 50 and 75% levels
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(Table 4). Although the pA 2  value for prazosin, in the presence of A II, was 
reduced from 8.19 (8.67-7.72) to 7.55 (7.84-7.26), the slope of the Schild plot 
was still significantly different from unity, 0.81 (0.68-0.93). In contrast to the 
marked effects on prazosin antagonism in the lateral saphenous vein, A II (0.05jaM) 
was without effect on the antagonism produced by the selective o^-adrenoceptor 
antagonist, rauwolscine (Figure 21, Table 4). Bay K 8644 (0.03jiM) had a 
pronounced effect on the ability of prazosin to antagonise responses to NA (Figure 
22). The log agonist-concentration ratio value for NA in the presence of prazosin 
(0.1 jaM), measured at all levels of the maximum response to NA was significantly 
reduced (Table 4).
Lateral saphenous vein after a2~adrenoceptor isolation
After isolation of postjunctional o^-adrenoceptors, both A II and Bay K 
8644 markedly enhanced responses to NA (Figures 23, 24, Table 5). This was 
associated with an increase in both the sensitivity and maximum response of the 
preparation to NA. It is interesting to note that this facilitatory action of A II was 
observed with either 0.05|iM  or 5nM A II, the latter concentration producing a 
small contraction in only 2 of 6  preparations. The potentiation of 0-2-adrenoceptor- 
mediated responses produced by A II, was reversed by the angiotensin receptor 
antagonist, saralasin (0.01 - 0.1 |iM) (Figure 25). Neither concentration of saralasin 
alone, had an effect on the residual response to NA (Figure 25a). Interestingly, 
despite the fact that both concentrations of saralasin abolished the contractile 
response to A II (0.05[iM) (Fig, 18b), only the higher concentration of the 
antagonist was associated with a complete reversal of the facilitatory action of A II 
(Figure 25b,c). After attempted isolation of postjunctional a \ -adrenoceptors in the 
lateral saphenous vein, A II (0.05|iM) produced only a small leftward shift in the 
CCRC to NA (Figure 26).
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Figure No. 18
The peak contractile responses to angiotensin II and angiotensin I, and the effects of 
antagonists thereon, in several isolated venous preparations from the rabbit. Results are 
expressed as a % of the maximum response to NA obtained in each experiment.
Each column represents mean + s.e.mean of 6  - 28 experimental observations. 
***denotes a significant difference in the contractile response in the presence of 
antagonist, Student's f-test p<0.001.
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F ig u re  No. 19
Effects of a) angiotensin II 0.05jiM ( # )  and 0.5|iM  (□ )  and of b) Bay K 
8644 0.03|iM  ( # )  on responses to NA (O )  in isolated lateral saphenous 
vein after correction for time-related changes.
Each point represents mean ± s.e.mean (n = 6  - 10). Statistically significant 
differences between responses to NA in the absence and presence of Bay K 
8644 are represented by; *p<0.05, **0.01<p<0.001, Student's t- test.
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Effects of prazosin in the absence ( # )  and in the presence (□ )  of angiotensin II 
(0.05|iM ) a) O.OljiM b) O.lfiM and c) lfiM  on responses to NA (O )  in the 
rabbit isolated lateral saphenous vein.
Each point represents mean ± s.e.mean (n = 5 - 6 ). Statistically significant differences 
between responses to NA in the presence of prazosin alone and in combination with 
A II, are represented by; *p<0.05, **0.01<p<0.001, Student's t- test.
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Effects of rauwolscine in the absence ( # )  and in the presence ( □ )  of 
angiotensin II (0.05fiM) a) 0.05(iM b) 0.5]iM and c) 2.5[iM on 
responses to NA (O ) in the rabbit isolated lateral saphenous vein.
Each point represents mean ± s.e.mean (n = 4 - 5).
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Effect of prazosin in the absence ( # )  and in the presence ( □ )  of Bay K 8644 
(0.03pM) a)0 .01 |iM  b) 0 .1 |iM and  c) l|iM  on responses to NA (O ) in the rabbit 
isolated lateral saphenous vein.
Each point represents mean ± s.e.mean (n = 5). Statistically significant differences 
between responses to NA in the presence of prazosin alone and in combination with Bay 
K 8644 are represented by; *p<0.05, **0.01<p<0.001, ***0.001>p Student's t- test.
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A n ta g o n is t 25%
prazosin (O.l^M) 0.81 ± 0.07 0.69 ± 0.07 0.64 ±  0.10
(n = 1 2 )
prazosin (O.ljiM) 0 .6 0 ± 0 .0 9 a 0.57 ± 0.08 0.59 ±  0.09
with A II (0.05jiM)
(n = 7)
prazosin (O.ljiM) 0.49 ± 0.08b 0.35 ±  0.09b 0 .3 3 ± 0 .0 8 b
with Bay K 8644 (0.03jiM)
(n = 5)
rauwolscine (0.5jiM) 1.47 ± 0.14 1.70 ± 0.12 1.85 ± 0.09
(n = 5)
rauwolscine (0.5|iM) 1.38 ± 0 .18  1 .7 3 1 0 .0 8  1 .8 6 1 0 .0 7
with A II (0.05jiM)
(n = 5)
T a b le  4
log agonist concentration-ratio values for NA measured at the 25%, 50% and 75% 
level of the maximum response for NA in the presence o f prazosin (O.ljiM) or 
rauwolscine (0.05}iM) and the effects of A II (0.05}iM) and Bay K 8644 (0.03jiM) 
thereon.
denotes a significant difference in the value for prazosin (O.ljiM) calculated at the 
25% level of the maximum response to NA, in the presence o f A II, compared to 
control. p<0.05
denotes a significant difference in the value for prazosin (O.ljiM) calculated at the 
25%, 50% and 75% levels of the maximum response to NA in the presence of Bay 
K 8644 compared to control. p<0.05 Student's t- test.
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F ig u re  No. 23
Effects o f angiotensin II a) (5 nM) (□ ) and b) (0.05p.M) (■ )  on responses to NA ( # )  after 
isolation of postjunctional c^-adrenoceptors. Responses are expressed as a % of the original 
maximum response to NA before (O ) (a and b) or after ( # )  (c) the protection protocol.
Each point represents mean ± s.e.mean (n = 6  - 13). All points on the NA CCRC in the 
presence of A II, after a 2-adrenoceptor isolation (b and c), are statistically significantly 
different from those in the absence of A II, p<0.05, Student's t- test.
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Effects of Bay K 8644 (0.03jiM) ( □ )  on responses to NA ( # )  after 
isolation of postjunctional a 2-adrenoceptors in rabbit isolated lateral 
saphenous vein. Results are expressed as a % of a) the original maximum 
to NA (O )  or b) as a % of the maximum response after the protection 
protocol.
Each point represents mean ± s.e.mean (n = 6 ). Statistically significant 
differences between responses to NA in the absence and presence of Bay K 
8644 are represented by; *p<0.05, **0.01<p<0.001, Student's t- test.
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Effects of a) saralasin, 0.1}iM (□ )  alone and of b) saralasin, O.OljiM ( ■ )  and c) 
0.1 (J.M (□ ) , on A II (0.05|iM) induced potentiation ( # )  of responses to NA after isolation 
of postjunctional oc2-adrenoceptors in rabbit isolated lateral saphenous vein. Results are 
expressed as a % of the maximum response to NA following the protection protocol (O)- 
Each point represents mean ± s.e.mean (n = 6 ). Statistically significant differences between 
responses to NA in the absence and presence of A II and saralasin (O.OljiM) alone (b) are 
represented by; *p<0.05, **0.01<p<0.001, Student's t- test.
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Figure No. 26
Effects of angiotensin II 0.05|iM (□ ) on responses to NA ( # )  after attempted isolation of 
postjunctional -adrenoceptors in rabbit isolated lateral saphenous vein. Responses are 
expressed as % of a) the original NA maximum response (O) b) the maximum response 
after the protection protocol or c) the individual maximum response for each CCRC.
Each point represents mean ± s.e.mean (n = 6 ). Statistically significant differences between 
responses to NA in the absence and presence of A II, after receptor protection are 
represented by; *p<0.05, **0.01<p<0.001,*** p<0.001, Students’ t- test.
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The physiological precursor of A II, angiotensin I (A I) (0.05 - 0.5|iM ), 
produced a concentration-dependent contraction in the lateral saphenous vein (Fig 
18c). This contraction was again transient, but was characterised by a slower onset 
and longer duration, than equivalent sized responses to A II, returning to baseline 
after approximately 12-15 mins. A I mimicked the effects of A II, by producing a 
leftward shift in the NA CCRC and an increase in the maximum response to NA 
after (X2 -adrenoceptor isolation (Figure 27). Again, however, there was difficulty in 
reversing the facilitatory action of an angiotensin peptide with an appropriate 
antagonist. The angiotensin-converting enzyme inhibitor cilazoprilat (l|iM ) 
abolished contractile responses to A I (Fig 18c), but this was not associated with 
complete reversal of its facilitatory action (Figure 28b). Cilazoprilat (O.ljiM) had no 
effect alone, on responses to NA mediated via postjunctional a 2 -adrenoceptors in 
the rabbit isolated lateral saphenous vein (Figure 28a).
Other contractile agents
The effects of A II were also examined against a non a-ad renocep to r 
agonist. Bradykinin produced reproducible concentration-dependent contractions in 
the lateral saphenous vein (Figure 29a). These responses were unaffected by A II 
(0.05|iM) (Figure 29b). a,(3-methylene ATP (3|iM), in a similar manner to A II, 
produced a transient contraction, equivalent to 52.0 ± 5.5% (n = 5) of the original 
NA maximum response, in the isolated lateral saphenous vein. The presence of this 
agent was associated with a small, but significant, leftward shift in the CCRC to 
NA after isolation of postjunctional ot2 -adrenoceptors (Figure 30b,c). a ,  (3- 
methylene ATP (3jiM) was without effect on responses to NA when the full a -  
adrenoceptor complement was present (Figure 30a).
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F ig u re  No. 27
Effect o f Angiotensin I, 0.5jiM (■ )  and 0.05jiM (□ )  on responses to NA 
( # )  after isolation of postjunctional a 2-adrenoceptors in rabbit isolated 
lateral saphenous vein. Results are expressed as a % o f the maximum 
response to NA a) before (O ) or b) after ( # )  the protection protocol. 
Each point represents mean ± s.e.mean (n = 5). All responses to NA in the 
presence of A II, after isolation of postjunctional a 2 -adrenoceptors, were 
significantly different from those in the absence of A I, p<0.05, Student's t- 
test.
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Figure No. 28
a) Effects of lpM  cilazaprilat (□ )  on responses to NA alone and b) on 
the potentiation of NA responses, after isolation o f postjunctional a 2- 
adrenoceptors, produced by 0.05|iM  A I ( # )  in rabbit isolated lateral 
saphenous vein. Results are expressed as a % of the maximum response to 
NA (O ) a f^ r the protection protocol.
Each point represents mean ± s.e.mean (n = 6 ). Statistically significant 
differences between responses to NA in the absence and presence of A I and 
cilazaprilat are represented by; *p<0.05, **0.01<p<0.001, Student's t- test.
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a) Reproducibility of consecutive CCRC's to bradykinin in rabbit isolated 
lateral saphenous vein. (O) represents the 1 st, while ( # )  respresents the 
2nd CCRC. b) The effects of A II (0.05jiM) ( # )  on responses to 
bradykinin (O) in this preparation.
Each point represents the mean ± s.e.mean (n = 6 ).
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Figure No. 30
Effect of a,-(3-methylene ATP (0.03pM) (□ )  on responses to NA a) under normal 
experim ental conditions (O )  or b) and c) after isolation of postjunctional a 2- 
adrenoceptors ( # ) .  Results are expressed either as a % of the maximum response to 
NA (O ) prior to (a and b) or after the protection protocol ( # )  (c).
Each point represents the mean ± s.e.mean (n = 5 - 8 ). Statistically significant 
differences in responses to NA after receptor protection, in the presence and absence of 
a,(3-methylene ATP are represented b y ^ < 0 .0 5 ,  **0.01<p<0.001, Student's t- test.
Influence of A II and Bay K  8644 on voltage-operated and receptor- 
operated calcium channels in rabbit isolated lateral saphenous vein.
The superficial similarity of the facilitatory action of both A II and Bay K 
8644, on oc2 _adrenoceptor mediated responses to NA in the isolated lateral 
saphenous vein, prompted the study of their actions on responses to extracellular 
Ca2+ mediated by voltage-operated or receptor-operated calcium channels in this 
preparation.
The exchange of normal Krebs' for nominally Ca2+-free high K+ (65mM) 
Krebs', induced a small contraction in most preparations (equivalent in size to 
between 5-10% of the maximum response observed upon the readdition of 2.5mM 
Ca2+). Subsequently, consecutive Ca2+ CCRC's were superimposable (pD2  for 
Ca2+ - 3.49 ± 0.07 and 3.48 ± 0.08, n = 10; for 1st and 2nd CCRC's respectively, 
Figure 31a). A II (0.05pM) caused a significant rightward displacement of the 
Ca2+ CCRC (pD2  for Ca2+ - 3.49 ± 0.07 and 3.29 ± 0.07, n = 9; p<0.05. Figure 
32a) without altering the maximum response. In marked contrast, Bay K 8644 
(0.03jiM) failed to alter the sensitivity of the depolarised preparation to Ca2+ (pD2  
- 3 . 4 7  ± 0.06 and 3.46 ± 0.06, n = 8 ) but significantly increased the contractile 
response to all concentrations of Ca2+ (Figure 32a).
After isolation of postjunctional c^-adrenoceptors, NA (30|iM) produced a 
small transient contraction (7.7 ± 1.9 %, n = 9), which returned to baseline within 
10 mins., in nominally Ca2+-free Krebs'. Subsequently consecutive CCRC's to 
the re-addition of Ca2+ were reproducible (Figure 31b). A II (0.05JJ.M) produced a 
small increase in the maximum response to the re-addition of Ca2+, although this 
was not associated with a change in sensitivity of the preparation to Ca . In 
contrast Bay K 8644 increased both the sensitivity and the maximum response to
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the re-addition of Ca , upon stimulation of postjunctional (^-adrenoceptors with 
NA.
Effects o f A II and Bay K  8644 on responses to NA in the rabbit 
isolated left renal vein
The rabbit isolated left renal vein contains a homogeneous population of 
postjunctional otp-adrenoceptors (Daly e ta l ,  1988c). Consecutive CCRC’s to NA 
in this preparation were reproducible with time (Figure 33). A II (0.05jiM) 
produced a transient contraction in the left renal vein, which was equivalent in size 
to that seen in the lateral saphenous vein (Figure 18d). This concentration of A II 
was without effect on responses to NA (Figure 33, Table 5). In contrast, Bay K 
8644 (0.03fiM), which had no effect alone on resting baseline tension, increased 
the sensitivity and the maximum response of the preparation to NA (Figure 33, 
Table 5).
It has previously been shown that reducing the receptor reserve in the rabbit 
femoral artery increased the facilitatory effect of A II on responses to NA mediated 
via ai-adrenoceptors (Purdy & Weber, 1988). Therefore, the left renal vein was 
exposed to phenoxybenzamine (InM) for 30 mins to reduce the receptor reserve in 
this preparation. This produced an average 42.0 ± 9.3 % (range 17-75%, n = 5) 
reduction in the maximum response to NA, although there was no change in the 
sensitivity of the preparation to NA (pD2  for NA, 5.91 + 0.04 and 5.92 ± 0.11, 
before and after treatment with phenoxybenzamine respectively, n = 6 ). In two 
further preparations, phenoxybenzamine abolished all responses and in another 
failed to reduce the maximum response. These results have been excluded from the 
analysis. Even under these conditions, A II (0.05|iM) had no effect on the residual 
response remaining after phenoxybenzamine (Figure 34c, Table 5).
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Reproducibility of Ca2+ CCRC's in rabbit isolated lateral saphenous vein,
a) in the presence of KC1 (65mM) and b) in the presence of NA (30jiM) 
after isolation of postjunctional a 2 -adrenoceptors. (O) represents the 1 st 
CCRC, while ( # )  represents the 2nd CCRC.
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Effect of A II (0.05}iM) ( # )  and Bay K 8644 (0.03p.M) (□ )  on responses 
to the readdition of Ca2+ in the presence of a) 65mM KC1 and b) 30|iM 
NA after isolation of postjunctional a 2-adrenoceptors in the rabbit isolated 
lateral saphenous vein. Results are expressed as a % of the original maximum 
response to Ca .
Each point represents the mean ± s.e.mean (n = 6 -8 ). Statistically significant 
differences between responses in the absence and presence of A II or Bay K 
8644 are represented by *p<0.05, ** 0.01<p<0.001 Student's t- test.
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Effects o f A II and Bay K 8644 on responses to NA in rabbit isolated 
ear vein
NA produced concentration-dependent contractions in the isolated ear vein, 
a preparation containing predominantly postjunctional o^-adrenoceptors (Daly et 
al., 1988b). Unfortunately consecutive CCRC's to NA were not reproducible with 
time, there being an approximately 30% increase in the maximum response (Figure 
35a) although there was no change in sensitivity (pD2  for NA, 7.82 ± 0.08 and 
7.83 ± 0.08 for curves 1 and 2 respectively, n = 11). After correcting for time- 
related changes A II (0.05|iM), which again produced a transient contraction 
(Figure 18d), was observed to produce a small, but significant, leftward shift in the 
CCRC to NA (Figure 35b, Table 5). In contrast, Bay K 8644 (0.03p.M) did not 
affect resting tone and had no effect on responses to NA in this preparation (Figure 
35c, Table 5).
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a) Reproducibility of responses to NA in the rabbit isolated left renal vein. (O) 
represents the 1st CCRC to NA while ( # )  represents the 2nd. b) the effect of A 
II (0.05jiM) ( # )  and c) of Bay K 8644 (0.03jiM) ( # )  on responses to NA (O) 
in the same preparation.
Each point represents the mean ± s.e.mean (n = 5-7). Statistically significant 
differences between responses in the absence and presence of Bay K 8644 are 
represented by *p<0.05, **0.01<p<Pj^)l, ***p<0.001, Student's t- test.
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a) Effect of phenoxybenzamine (InM) ( # )  on responses to NA in the rabbit isolated 
left renal vein and the subsequent influence of b) time (□ )  and c) A II (0.05p.M) 
(□ ) , on the residual response remaining after the irreversible antagonist. Results are 
expressed as a % of the maximum response to NA (O ) prior to phenoxybenzamine. 
Each point represents the mean ± s.e.mean (n = 5-6). Statistically significant 
differences between responses in the absence and presence of phenoxybenzamine are 
represented by *p<0.05, Student's t-
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Reproducibility of consecutive CCRC's to NA in rabbit isolated ear vein. 
Results are expressed as a % of a) the initial control maximum response to 
NA or b) the maximum response to NA in each individual CCRC. (O ) 
represents the 1st CCRC while ( # )  represents the 2nd.
Each point represents the mean ± s.e.mean (n = 11). Statistically significant 
differences between responses to NA in the 1st and 2nd CCRC's are 
represented by * p<0.05, ** 0.01<p<0.001, ***p<0.001 Student's t- test.
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Effect of a) A II (0.05JJ.M) ( # )  and of b) Bay K 8644 (0.03|xM) ( # )  on 
responses to NA (O ) in rabbit isolated ear vein after correction for time 
related changes.
Each point represents the mean ± s.e.mean (n = 5-11). Statistically 
significant differences between responses in the absence and presence of A II 
are represented by *p<0.05, Student's t- test.
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preparation pD-> value r
control AJl control A II
LSV 7.31 ± 0 .0 8  7.40 ± 0 .1 0  1  1.05 ± 0 .0 5
(n = 1 0 )
LSVRP 6.83 ± 0.06 7.18 ± 0.08*** 1  1.18 ±  0.03***
(n = 13)
LRV 6.12 ± 0 .1 9  6.12 ± 0 .11  1  1.02 ±  0.04
(n = 5)
LRVP 5.76 ± 0 .1 6  5.85 ± 0 .17  1  0.93 ±  0.05
(n = 5)
EV 7.62 ± 0 .07  7.80 ±0 .31*  1 1.03 ± 0.07
control Bay K 8644 control Bay K 8644
LSV 7.28 ±0 .13  7.53 ±0 .10*  1  1.22 ±0.05**
(n = 5)
LSVRP 6.81 ± 0.16 7.23 ± 0.20*** 1 1.25 ± 0.05***
(n = 6 )
LRV 6.06 ±0 .08  6.24 ±0.10* 1 1.30 ± 0.03***
(n = 7)
EV 7.82 ± 0 .09  7.79 ±0 .05  1 1.09 ±0 .11
T a b le  5
pD 2  values (with 95% confidence limits) and Emax values as compared to the 
control maximum responses to NA, in the rabbit isolated lateral saphenous vein 
(LSV), lateral saphenous vein after receptor protection using rauwolscine (l|iM ) 
and phenoxybenzamine (0.3p.M) (LSVRP), left renal vein (LRV), left renal vein 
post treatment with phenoxybenzamine (InM) (LRVP) and the ear vein (EV). 
Differences between control and treated preparations were considered statistically 
significant if p<0.05 for either paired or unpaired observations - Student's r-test 
and are denoted by: * 0.01<p<0.05, **0.01<p<0.001, ***0.001<p.
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Alpha-adrenoceptors in the rabbit isolated distal saphenous artery -
influence of angiotensin II
The difficulty in demonstrating postjunctional o^-adrenoceptors, while acute 
in isolated venous preparations, has been even more difficult for arterial vessels in 
vitro (McGrath et al., 1989). Having successfully demonstrated postjunctional 
ct2 -adrenoceptors in the lateral saphenous vein, the a-adrenoceptor population, and 
the effects of contractile agents thereon, was studied in the corresponding arterial 
preparation, the distal saphenous arteiy.
Agonist Potencies
The a-adrenoceptor agonists NA, phenylephrine, Sgd 101/75 and UK-14304 
produced concentration-dependent contractions in the rabbit isolated distal 
saphenous artery. The rank order of potencies for these agonists was as follows: 
NA > phenylephrine = UK-14304 > Sgd 101/75. Based upon the maximum 
contractions, NA and phenylephrine can be classed as full agonists, while UK- 
14304 and Sgd 101/75 are partial agonists compared to NA (Figure 37). The pD2  
and Emax values for each agonist are given in Table 6 a.
Reproducibility o f responses to a-adrenoceptor agonists
Consecutive CCRC's to NA were reproducible in the rabbit isolated distal 
saphenous artery (pD 2  for NA: 7.19 ± 0.09 and 7.17 ± 0.1, n = 6 , for curves 1 
and 2 respectively) (Figure 38a). Likewise, two CCRC's to phenylephrine were 
superim posable (pD 2  for phenylephrine, 6.54 ± 0.05 and 6.50 ± 0.08, n = 5) 
(Figure 38b). Unfortunately, consecutive CCRC’s to the partial 0 4 -adrenoceptor 
agonist Sgd 101/75 were characterised by a small increase in the maximum
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response and sensitivity of the preparation to the agonist (Figure 39a). These time 
related changes in responses to Sgd 101/75 were therefore taken into consideration 
when examining the effects of antagonists or A II, against responses to the agonist. 
In addition, there was a small, time-dependent increase in the maximum response to 
U K -14304 in this preparation, although this was not associated with a change in 
sensitivity to the agonist (pD2  for UK-14304: 6.61 ± 0.10 and 6.47 ± 0.12, n = 7, 
for the 1st and 2nd CCRC's respectively) (Figure 39b).
Effects o f antagonists on responses to a-adrenoceptor agonists
As shown in Figure 40, the aj-adrenoceptor antagonist prazosin produced a 
concentration-dependent, rightward, parallel displacement of the NA CCRC. The 
p A 2  value for prazosin was 8.57 and the slope of the Schild plot was not 
significantly different from unity, indicating competitive antagonism (Table 6 b). In 
addition, O.ljiM prazosin produced an approximately 25-fold rightward shift in the 
CCRC to the agonists phenylephrine (Figure 41a), Sgd 101/75 (Figure 41b) and 
U K -14304 (Figure 41c).
A relatively high concentration of the selective a 2-adrenoceptor antagonist 
rauwolscine (l|iM ) produced only a 2-fold rightward shift in the CCRC to NA 
(Figure 40b). This concentration of rauwolscine was without effect on responses to 
either phenylephrine (Figure 41a) or the partial agonist Sgd 101/75 (Figure 41b). In 
contrast however, rauwolscine (l|iM ) produced a non-parallel rightward 
displacement of the CCRC to UK-14304 (Figure 41c). This rightward shift was 
more apparent against the lower portion of the CCRC to the reportedly selective 
oc2-adrenoceptor agonist. The log agonist concentration-ratio value at the level of 
25 % of the maximum response for UK-14304 in the presence of l^M  rauwolscine 
was significantly greater than that calculated at the 75 % level (0.54 i  0.08
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Concentration-dependent responses to the a-adrenoceptor agonists NA (O ), 
U K -14304 ( # ) ,  phenylephrine (□ )  and Sgd 101/75 ( ■ )  in rabbit isolated 
distal saphenous artery. Results are expressed as a % of a) the maximum 
response to NA in each preparation or b) the maximum response to each 
individual agonist.
Each point represents the mean ± s.e.mean (n = 5 - 7).
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Reproducibility of consecutive CCRC's to the a-adrenoceptor agonists a) 
NA and b) phenylephrine (PE) in rabbit isolated distal saphenous artery. 
Results are expressed as a % of the maximum response to each agonist in the 
1 st CCRC(O)- ( • )  represents the 2 nd CCRC 
Each point represents the mean ± s.e.mean (n = 5 - 6 ).
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Reproducibility of consecutive CCRC's to the a-adrenoceptor agonists a) 
Sgd 101/75 and b) UK-14304 in rabbit isolated distal saphenous artery. 
Results are expressed as a % of the maximum response to each agonist in the 
1 st CCRC(O)- ( # )  represents the 2 nd CCRC.
Each point represents the mean ± s.e.mean (n = 5 - 7). Statistically significant 
differences between the 1 st and 2nd CCRC's are represented by *p<0.05 
Student's t- test.
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compared to 0.32 ± 0.10 for the 25 and 75% levels respectively, n = 7, p< 0.05, 
Student s t- test). It should be noted however, that for all agonists, prazosin 
(0.1 (iM) was a more potent antagonist of responses than rauwolscine (lp.M).
Effects o f A II on responses to a-adrenoceptor agonists
A II (0.05}iM) produced a transient contraction, which returned to baseline 
after 12-15 mins, in the rabbit isolated distal saphenous artery. This response was 
equivalent to 37.8 ± 4.8 (n = 13) of the maximum response to NA in each 
preparation. A II had no effect on subsequent responses to either NA (Figure 42a) 
or phenylephrine (Figure 42b, Table 7). There was however, a small but significant 
leftward shift in the CCRC to the a^-adrenoceptor partial agonist Sgd 101/75 in the 
presence of A II (0.05|iM) (Figure 42c, Table 7).
In contrast to the relatively small effects on responses to the aforementioned 
agonists, A II (0.05pM) produced a marked increase in the sensitivity of the 
preparation to UK-14304. Since there was no change in the maximum response, 
this resulted in a change in the slope of the CCRC. The magnitude of the 
displacement produced by A II for the threshold concentration of U K-14304, was 
approximately 300-fold; 0.0 lpM  in the absence of A II compared to 0.0 InM in the 
presence of A II (Figure 43a, Table 7). A representative trace recording of the effect 
of A II (0.05jiM) on responses to UK-14304 is shown in Figure 44. A 10-fold 
lower concentration of A II (5nM) produced a contraction equivalent to 6.0 ± 2.1 (n 
= 6 ) of the maximum response to NA. This contraction was characterised by a 
slower onset of response than that to 0.05|iM A II, and in addition the response in 
two of the six preparations did not return completely to baseline. 5nM A II also 
uncovered a previously unseen component of the response to UK-14304, although 
the size of the "uncovered response" was smaller than that seen with 0.05pM A II 
(Figure 43b). The potentiation of responses to UK-14304 produced by A II, was
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compared to 0.32 ± 0.10 for the 25 and 75% levels respectively, n = 7, p< 0.05, 
Student's t- test). It should be noted however, that for all agonists, prazosin 
(0.1|iM) was a more potent antagonist of responses than rauwolscine (ljiM ).
Effects o f  A II  on responses to a-adrenoceptor agonists
A II (0.05p.M) produced a transient contraction, which returned to baseline 
after 12-15 mins, in the rabbit isolated distal saphenous artery. This response was 
equivalent to 37.8 ± 4.8 (n = 13) of the maximum response to NA in each 
preparation. A II had no effect on subsequent responses to either NA (Figure 42a) 
or phenylephrine (Figure 42b, Table 7). There was however, a small but significant 
leftward shift in the CCRC to the a  j-adrenoceptor partial agonist Sgd 101/75 in the 
presence of A II (0.05|iM) (Figure 42c, Table 7).
In contrast to the relatively small effects on responses to the aforementioned 
agonists, A II (0.05|iM ) produced a marked increase in the sensitivity o f the 
preparation to U K -14304. Since there was no change in the maximum response, 
this resulted in a change in the slope of the CCRC. The m agnitude o f the 
displacement produced by A II for the threshold concentration of U K -14304, was 
approximately 300-fold; O.OlpM in the absence of A II compared to 0.0 InM  in the 
presence of A II (Figure 43a, Table 7). A representative trace recording of the effect 
o f A II (0.05jiM) on responses to UK-14304 is shown in Figure 44. A 10-fold 
lower concentration of A II  (5nM) produced a contraction equivalent to 6.0 ±2.1  (n 
= 6 ) o f the maximum response to NA. This contraction was characterised by a 
slower onset of response than that to 0.05jiM A II, and in addition the response in 
two o f the six preparations did not return completely to baseline. 5nM A II also 
uncovered a previously unseen component of the response to U K-14304, although 
the size of the "uncovered response" was smaller than that seen with 0.05JJ.M A II 
(Figure 43b). The potentiation of responses to U K -14304 produced by A II, was
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Effect of the a-adrenoceptor antagonists a) prazosin O.OlpM ( # ) ,  0.1|iM  
( □ )  and lp.M ( ■ )  and of b) rauwolscine (ljiM ) ( # )  on responses to NA 
(O) in rabbit isolated distal saphenous artery. Results are expressed as a % of 
the initial maximum response to NA (O)-
Each point represents the mean ± s.e.mean (n = 5 - 6 ). Statistically significant 
differences between responses in the absence and presence of rauwolscine 
(lp.M) are represented by *p<0.05 Student's t- test.
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Effect o f the a-adrenoceptor antagonists, prazosin (O.ljiM) ( # )  and rauwolscine (ljiM ) 
( □ )  on responses to a) phenylephrine b) Sgd 101/75 and c) U K -14304 in rabbit 
isolated distal saphenous artery. Results are expressed as a % o f the initial maximum 
response to each agonist (O)-
Each point represents the mean ± s.e.mean (n = 5 - 7). Statistically significant differences 
between responses in the absence and presence of rauwolscine are represented by *p<0.05, 
**0.01<p<0.001, Student's t- test.
a)  A gonist
NA 
(n = 6 ) 
phenylephrine 
(n = 4)
Sgd 101/75 
(n = 5)
UK 14304 
(n = 7)
b)  Antagonist
prazosin 
(0.01 - 0.1 |iM )
T ab le  6
a) List o f pD 2  values (with 95% confidence limits) and Em ax values for a -  
adrenoceptor agonists; and of b) pA 2  value with the slope of the Schild plot (with 
95% confidence limits) for prazosin against responses to NA in rabbit isolated 
lateral saphenous vein. All experiments were carried out in the presence o f 
propranolol (l|iM ) and cocaine (10pM). The pA 2  value was determined from a 
regression analysis o f the log agonist concentration ratio from 1 2  individual 
observations.
P&2  
7.19 ± 0 .0 9  
6.54 ±  0.05 
4.69 ±  0.05 
6.42 ± 0 .1 1
M 2
8.57 
(8.81 - 8.34)
E m a x
1
0.99 ±  0.06 
0.42 ±  0.04 
0.72 ±  0.03
Slope
0.98 
(0 .87- 1.12)
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reversed by the angiotensin receptor antagonist, saralasin (ljiM ) (Figure 45). This 
concentration of saralasin had no effect on responses to U K -14304 alone (Figure 
45a)
Effects o f A II  on a-adrenoceptor antagonist potencies
Under normal experimental conditions, prazosin (0.1|iM ) was a more potent 
antagonist than rauwolscine (ljiM ) against all a-adrenoceptor agonists tested. In 
the presence o f A II however, the potency of these two antagonists against 
responses to U K -14304 was reversed in the lower portion o f the CCRC to UK- 
14304 (Figure 46). Prazosin (O.lpM) was ineffective against the "uncovered 
response" to low concentrations of U K -14304 in the presence o f A II, although it 
continued to displace the upper portion of the CCRC. In m arked contrast, 
rauwolscine (l|iM ) prevented the facilitatory action of A II on responses to UK- 
14304.
A II (0.05fiM) also had a profound effect on the ability o f prazosin to 
antagonise responses to the endogenous ligand NA (Figure 47). This was 
particularly true for the lower portion of the CCRC to NA, such that the log agonist 
concentration-ratio at the levels of 25 and 50% of the NA maximum response, in 
the presence of prazosin (O.ljiM), were significantly reduced from control values 
obtained in the absence of A II (Table 8 ).
A II (0.05JJ.M) was without effect on the rightward shift o f responses to 
phenylephrine produced by 0.1 |iM  prazosin (Figure 48a). A II appeared to make 
responses to the partial agonist Sgd 101/75 slightly more resistant to the 
antagonistic action of prazosin (0.1 (iM) (Figure 48b). Flowever A II (0.05p.M) 
alone produced a small leftward shift in the CCRC to Sgd 101/75 (Figure 42c).
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F ig u re  No. 42
Effect of A II (0.05}iM) ( # )  on responses to the a-adrenoceptor agonists a) NA b) 
phenylephrine and c) Sgd 101/75 in rabbit isolated distal saphenous artery. Results are 
expressed as a % of the maximum response to each agonist after correction for time-
related changes (O)-
Each point represents the mean ± s.e.mean (n = 5 - 6 ). Statistically significant differences 
between responses in the absence and presence of A II (0.05|iM ) are represented by 
*p<0.05, **0.01<p<0.001, Student's t- test.
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Figure No. 43
Effects of A II ( # )  a) 0.05p.M and b) 5nM on responses to U K -14304 
( O )  in rabbit isolated distal saphenous artery. Results are expressed as a % 
o f the initail maximum response to UK-14304.
Each point respresents the mean ± s.e.mean (n = 6  - 8 ). Statistically 
significant differences between responses in the absence and presence of A II 
(0.05jiM) are represented by *p<0.05, **0.01<p<0.001, Student's t- test.
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Figure No. 44
Representative trace recording of the effect of A II (0.05|iM ) on U K -14304 
induced contractions (cumulative addition; approximately 3 fold increments in 
concentration) of the rabbit isolated distal saphenous artery, a) control and b) in 
the presence of A II. For clarity responses to higher concentrations of UK-14304 
are not shown, although a maximum response was achieved in both situations.
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F ig u re  No. 45
Effects of saralasin (ljiM ) ( # )  a) alone and b) on A II (0.05|iM) induced 
potentiation ( □ )  of responses to U K -14304 in rabbit isolated distal 
saphenous artery. Results are expressed as a % of the control maximum 
response to U K -14304 (O)- 
Each point represents the mean ± s.e.mean (n = 5).
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azonist control A I I  present
e & 2  m
NA 
(n = 6 )
phenylephrine 
(n = 5)
UK-14304 
(n = 7)
Sgd 101/75 
(n = 5)
.Table 7.
List of pD 2  values (with 95% confidence limits) for a-adrenoceptor agonists in the 
absence and presence of A II  (0.05fiM) in rabbit isolated distal saphenous artery. 
**denotes a significant difference between responses in the absence and presence of 
A II (0.05pM ), p<0.01, Student's t- test.
7.25 ±  0.09 
6.56 ± 0.08 
6.59 ± 0 .1 2  
4.84 ±  0.06
7.17 ± 0 .1 0  
6.54 ± 0 .1 0  
7.78 ±  0.36** 
5.16 ± 0 .03**
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When this effect was taken into consideration, prazosin (0.1 jiM) produced similar 
rightward displacements in the absence and presence of A II (0.05|iM ). The log 
agonist concentration ratios values were approximately 1.44 and 1.46 respectively, 
(unpaired observations, n = 5).
Attempted isolation o f postjunctional (X2 -adrenoceptors
The previous results suggested that postjunctional a 2 -adrenoceptors could be 
dem onstrated in the rabbit isolated distal saphenous artery under appropriate 
experimental conditions. An attempt was therefore made to isolate a homogeneous 
population of postjunctional o^-adrenoceptors in this preparation using the receptor 
protection protocol outlined in Figure 4. Phenoxybenzamine (0.3jiM) virtually 
abolished all responses to NA in this preparation (Figure 49a). The rationale 
em ployed therefore, was to prevent phenoxybenzam ine binding to 0 C2 - 
adrenoceptors by m asking these receptors w ith IjiM  rauw olscine. This 
concentration of rauw olscine was considered to be w ithout effect at a p  
adrenoceptors, since it was ineffective against responses to phenylephrine in this 
preparation.
Agonist responses
The inclusion of rauwolscine (IjiM ) prior to, and during, the incubation 
period with phenoxybenzamine (0.3|iM ), did not result in part o f the response to 
NA being "spared" (Figure 49b). The maximum response to NA was reduced to a 
similar degree by phenoxybenzamine alone and by the combination of rauwolscine 
and phenoxybenzamine (% reduction of NA maximum response: 97.4 ± 1 .2  and 
95.8 ± 2.3, respectively). If however, the preparations were exposed to A II (5nm - 
0.05|iM ) after the combination of rauwolscine (l}iM) and phenoxybenzamine
136
a)
% 1 2 0 "] B
& 100* 
0 ) 
lm
B 80"
i « -n
f  4 0 “
c  20-  o u
^  0  -
-12 -10 8 6 -4
log [UK-14304] (M)
b)
S 120 n
log [UK-14304] (M)
F ig u re  No. 46
Effect of the a-adrenoceptor antagonists prazosin (0.1 pM) ( # )  and rauwolscine 
(lp.M ) ( □ )  on responses to U K -14304 (O) in a) the absence and b) the 
presence of A II (0.05JJ.M) in the rabbit isolated distal saphenous artery. Results 
are expressed as a % of the maximum response to U K -14304 obtained under 
normal experimental conditions (a) or in the presence o f A II (b).
Each point represents the mean ± s.e.mean (n = 7).
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Figure No. 47
Effects of prazosin in the absence ( # )  and in the presence ( □ )  o f A II 0.05|iM  a) 
O.OljiM b) 0.1p.M and c) ljiM  on responses to NA (O )  in the rabbit isolated distal 
saphenous artery. Results are expressed as a % of the initial maximum response to NA. 
Each point represents the mean ± s.e.mean (n = 5 - 6). Statistically significant differences 
between responses in the presence of prazosin alone and in combination with A II are 
represented by *p<0.05, **0.01<p<0.001, ***p<0.001, Student's t- test.
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Figure No. 48
Effect of prazosin (O.ljiM), in the absence ( # )  and in the presence (□ )  of A 
II 0.05p.M on responses to a) phenylephrine (O) and b) Sgd 101/75 (O) 
in rabbit isolated distal saphenous artery. Results are expressed as a % of the 
initial maximum response obtained for each agonist.
Each point represents the mean ± s.e.mean (n = 5). Statistically significant 
differences between responses in the presence of prazosin alone and in 
com bination with A II are represented by *p<0.05, **0.01<p<0.001, 
Student's t- test.
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A ntagonist 25%  50%  75%
prazosin (0.1 pM ) 1.55 ±  0.06 1.57 ± 0 .0 8  1.63 ±  0.06
(n -  6)
prazosin (0.1 pM ) 1 .0 8 ± 0 .0 9 a 1.32 ± 0 .0 6  1.67 ± 0 .0 7
with A II  (0.05pM)
(n = 6)
Table 8
Log agonist concentration-ratio values for NA in the presence o f prazosin (0.1 pM)
alone or in combination with A II (0.05pM) calculated at the levels o f 25%, 50%
and 75% of the maximum response to NA. 
a
represents a significant difference for the log agonist concentration ratio value for 
NA calculated at the 25% level of the maximum response in the presence o f A n .
(0.3|iM), concentration-dependent responses to NA were observed. The maximum 
response after attempted isolation of postjunctional o^-adrenoceptors was increased 
from 4.2 ±  2.3 to 35.1 ± 2.9 % (n = 11) of the initial maximum response to NA 
(Figure 50a) in the absence and presence of A II  (0.05|iM) respectively. Similarly, 
A II (5nM) allowed the expression of responses to NA equivalent to 23.3 ±  3.3 % 
(n = 9) o f the initial maximum response after treatment with the combination of 
rauwolscine and phenoxybenzamine (Figure 50b).
A II was also found to be a necessary prerequisite for the expression of 
responses to the a-adrenoceptor agonists phenylephrine and UK-14304 after the 
protection protocol (Figure 51a). In the presence o f A II all agonists, NA, 
phenylephrine and UK-14304, produced concentration-dependent contractions with 
pD 2  values of 6.66 ± 0.29 (NA), 5.15 ± 0.07 (phenylephrine, estimated value) and 
8.36 ± 0.31 (UK-14304) respectively (Figure 51b). Under these circumstances the 
relative potency of the agonists was: U K -14304 > NA > phenylephrine in 
contrast to the potency ratio of NA > phenylephrine = UK-14304 seen under 
normal experimental conditions (see Figure 37).
Effects o f a-adrenoceptor antagonists
As shown in Figure 52, responses to NA in the presence o f A II, after 
attempted isolation of postjunctional a 2 -adrenoceptors, were resistant to prazosin 
(0.1 pM ) (pD 2  values for NA; 6.66 ± 0.29 and 6.42 ± 0.18 in the absence and 
presence o f prazosin (0.1 pM) respectively, n = 5), but susceptible to rauwolscine 
(lpM ), which produced an approximately 100-fold rightward displacement of the 
CCRC to NA (Figure 52a). Furthermore, the combination of prazosin (0.1 (iM) and 
rauwolscine (IpM ) was no more effective at antagonising responses to NA than 
rauwolscine (lpM ) alone (Figure 52b).
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Figure No. 49
Effect o f prior incubation with phenoxybenzam ine (0.3|iM ) ( # )  on 
responses to NA (O) in a) the absence and b) the presence o f rauwolscine 
(IjiM ) in rabbit isolated distal saphenous artery. Results are expressed as a 
% of the initial maximum response to NA.
Each point represents the mean ± s.e.mean (n = 6). All points on the CCRC
to NA in the presence of either phenoxybenzamine alone or in combination 
with rauwolscine are significantly different from control, p<0.05, Student's 
t- test
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Figure No. 50
Effects of a) A II (0.05}iM) (□ )  and b) A II (5nM) (□ )  on responses to NA 
after attempted isolation of postjunctional a 2-adrenoceptors ( # )  in rabbit 
isolated distal saphenous artery. Responses are expressed as a % o f the 
maximum response to NA (O ) prior to the protection protocol.
Each point represents the mean ±  s.e.mean (n = 9 - 11). All responses to NA in 
the presence of A II after the protection protocol are significantly different from 
those after the protection protocol alone, p<0.05, Student's t- test.
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F ig u re  No. 51
Responses to the a-adrenoceptor agonists NA ( # ) ,  phenylephrine ( □ )  and 
U K -14304 ( ■ )  in a) the absence and b) the presence of A II (0.05jiM) after 
attempted isolation of postjunctional o^-adrenoceptors in rabbit isolated distal 
saphenous artery. Results are expressed as a % o f the maximum response to 
NA (O )  prior to the protection protocol.
Each point represents the mean ±  s.e.mean (n = 6 - 11).
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F ig u re  No. 52
Effect of a) prazosin (0.1 |iM) (□ )  and rauwolscine (l|iM ) ( ■ )  alone and of 
b) rauwolscine (lp.M) (■ )  alone and in combination with 0.1|iM  prazosin (□ ) 
on responses to NA, in the presence of A II (0.05jiM), after attempted isolation 
o f postjunctional a 2-adrenoceptors ( # )  in rabbit isolated distal saphenous 
artery. Results are expressed as a % of the maximum response to NA (O) prior 
to the protection protocol.
Each point represents the mean ± s.e.mean (n = 5 - 11).
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Effects o f other contractile agents on responses to UK-14304 in 
rabbit isolated distal saphenous artery
Bay K  8644
As demonstrated in the present study, A II and Bay K 8644 enhance 0 1 2 - 
adrenoceptor mediated responses in the rabbit isolated lateral saphenous vein. In 
addition, Bay K  8644 has been reported to be a necessary stimulus for the 
expression of 0 C2 -adrenoceptors in the canine saphenous artery (Sulpizio & Hieble, 
1987). The influence of Bay K 8644 on responses to U K -14304 in the rabbit 
isolated distal saphenous artery was therefore examined
Bay K 8644 (3nM - 0.3|iM ), without influencing resting baseline tension, 
significantly  increased responses to U K -14304 in this preparation. This 
enhancement was associated with an approximately 25% increase in the maximum 
response and a two-fold leftward displacement of the CCRC to U K -14304 and was 
maximal with the lowest concentration of Bay K 8644 employed (3nM) (Figure 
53). Despite the potentiation produced by Bay K 8644, there was no increase in the 
threshold concentration of U K-14304 for contraction, which was approximately 
0.01 |iM  in the absence and presence of Bay K 8644.
Angiotensin I
The physiological precursor of A II, angiotensin I (A I) (0.5|iM ) produced a 
transient contraction in the distal saphenous artery, equivalent to 55.7 ±  6.7% 
(n = 7) of the maximum response to NA. This contraction was characterised by a 
slower onset and longer duration than equivalent sized responses to A II, and in 
two of seven preparations the contraction did not completely return to baseline. The
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remaining residual contraction to A I was not greater than 5% of the maximum 
response to NA in either experiment. A I  mimicked the effects of A II  by producing 
a marked increase in the sensitivity of the distal saphenous artery to U K -14304, 
with a small increase in the maximum response (Figure 54a). The threshold 
concentration for contraction to U K -14304 was increased from approximately 
0.01|iM  to 0.01 nM in the presence of A I. A high concentration of the angiotensin- 
converting enzyme inhibitor captopril (lp.M) had no effect on responses to UK- 
14304 alone (Figure 54b). This concentration of captopril reduced, but did not 
completely abolish, the contractile response to A I (0.5|iM ). A peak response 
equivalent to 19.7 ± 8.8% (n = 5) of the maximum response to NA was obtained in 
the presence of the ACE inhibitor. In addition, captopril did not reverse the 
facilitatory action of A I on responses to U K -14304 (Figure 54c).
Phenylephrine
A concentration of phenylephrine selective for aj-adrenocep tors (lOnM), 
produced a sustained contraction equivalent to 13.8 ± 2.0% (n = 5) o f the 
maximum response to U K -14304 in the rabbit isolated distal saphenous artery. 
Subsequently, exposure of the preparation to U K -14304, resulted in concentration- 
dependent contractions to this agonist superimposed upon the phenylephrine- 
induced tone. The sensitivity of the preparation to U K -14304 was markedly 
increased in a m anner analogous to that seen with A II, with the threshold 
sensitivity o f the preparation to U K -14304 being increased from approximately 
O.OljiM to 0.03nM in the presence of the ctj-adrenoceptor agonist (Figure 55).
U46619
The thromboxane A2  mimetic agent, U46619 (InM ) produced a sustained
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contraction, equivalent to 24.2 ± 8.1% (n = 5) of the maximum response to UK- 
14304 in the rabbit isolated distal saphenous artery. Again, in the presence of a 
contractile agent, the preparation was exquisitely sensitive to U K -14304. 
Responses to the c^-adrenoceptor agonist were observed at concentrations as low 
as 0.01 nM, with no change in the maximum response, resulting in a flattening of 
the CCRC to U K -14304 (Figure 56a).
Potassium Chloride (KCl)
KC1 (17-20mM) produced a sustained contraction equivalent to 12.8 ±  3.8% 
(n = 4) of the maximum response to U K -14304 in this preparation. Responses to 
U K -14304 were significantly  enhanced when superim posed on top o f 
depolarisation-induced tone (pD2  values for UK-14304 were 6.39 ±0.11 and 6.89 
±  0.04 in the absence and presence of tone respectively, p<0.05, Student’s t- test, 
n = 4) (Figure 56b). This enhancement of responses however, was not associated 
with a marked increase in the threshold sensitivity of the preparation to U K -14304, 
as seen with A II, phenylephrine or U46619. In only one of four preparations, was 
the threshold concentration for contraction for UK-14304 less than InM.
5 -Hydroxytryptamine (5-HT)
5-HT (0.01(iM-0.3jiM) produced a sustained contraction equivalent to 17.9 ± 
6.1% (n = 5) of the maximum response to U K -14304 in the rabbit isolated distal 
saphenous artery. Inducing tone with this agent was not associated with a 
significant enhancement or "uncovering" of responses to U K-14304 (Figure 56c).
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F ig u re  No. 53
Effect of Bay K 8644 3nM ( # ) ,  0.03|iM  (□ )  and 3}iM ( ■ )  on responses 
to U K -14304 (O ) in rabbit isolated distal saphenous artery. Results are 
expressed as a % of the original maximum response to UK-14304 (O)- 
Each point represents the mean ± s.e.mean (n = 5). Statistically significant 
differences between responses in the absence and presence of Bay K 8644 
are represented by *p<0.05, **0.01<p<0.001, Student's t- test.
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Figure No. 54
Effect o f a) angiotensin I (0.5|iM) ( # )  b) captopril (l|iM ) ( # )  and c) the combination of 
A I (0.5|iM ) and captopril (l|iM ) ( # )  on responses to U K -14304 (O )  in rabbit isolated 
distal saphenous artery.
Each point represents the mean ± s.e.mean (n = 4 - 7). Statistically significant differences 
between responses to U K -14304 in the absence and presence of A I or the combination of 
captopril and A I, are represented by *p<0.05, **0.01<p<0.001, Student's t- test.
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Effects o f inducing tone with the selective a j-a d re n o c e p to r  agonist 
phenylephrine on responses to the selective a 2-adrenoceptor agonist UK- 
14304 ( # )  in rabbit isolated distal saphenous artery. Results are expressed 
as a % of the maximum response to UK-14304 (O)*
Each point represents the mean ± s.e.mean (n = 5). Statistically significant 
differences between responses to U K-14304 in the absence and presence of 
phenylephrine are represented by *p<0.05, Student's r- test.
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Figure No. 56
Effects of inducing tone with a) U46619 b) KC1 or c) 5-HT on responses to UK-14304 
( # )  in rabbit isolated distal saphenous artery. Results are expressed as a % o f the original 
maximum response to U K -14304 (O)-
Each point represents the mean ± s.e.mean (n = 5). Statistically significant differences 
between control responses and those in the presence of a contractile agent are represented by 
*p<0.05, **0.01<p<0.001, ***p<0.001, Student's t- test.
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Effects o f A II on responses to UK-14304 in various other arterial 
preparations from  the rabbit
A series of preliminary experiments were earned out in various other arterial 
preparations from the rabbit to determine the effects of A II  (0.05|iM) on responses 
to U K -14304. In these experiments preparations were initially exposed twice to 
3|iM  NA at 30 minute intervals. The response to the second exposure of 3|iM  NA 
was assumed to be maximal.
Femoral artery
U K -14304 produced concentration-dependent contractions in the rabbit 
isolated femoral artery with a maximum response equivalent to 50.8 ± 5.5% of the 
maximum response to NA. A II (0.05pM) produced a transient response in this 
preparation, the peak o f which was equivalent to 77.1 ± 3.4% of the NA 
maximum. This contraction did not completely return to baseline. Therefore a 
residual response equivalent to 9.3 ± 3.3 % of the NA maximum persisted prior to 
the onset of a 2nd CCRC to U K -14304. This concentration of A II significantly 
potentiated responses to U K -14304 at all points of the CCRC, producing an 
increase in the maximum response and sensitivity of the preparation to the agonist. 
This increase in sensitivity was particularly marked in the lower portion of the 
CCRC to U K -14304 (the mean log agonist concentrations required to produce 25% 
of the maximum response to UK-14304 were 6.84 ± 0.21 and 7.52 ±  0.16, in the 
absence and presence of A II respectively, n = 5, p<0.05 Student’s f-test) (Figure 
57a). Perhaps more im portantly however, the threshold concentration for 
contraction for U K -14304 was reduced from approximately 0.01 pM  under control 
conditions to 0.03nM in the presence of A II. This resulted in the shape of the 
CCRC to U K-14304 becoming distinctly biphasic.
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Superior Mesenteric artery
No responses were observed upon exposure of the superior mesenteric artery 
to U K -14304. A II (0.05jiM) produced a transient response equivalent to 26.9 ± 
8.9% (n = 5) of the NA maximum response in this preparation, however even in 
the presence of A II  this tissue remained unresponsive to U K -14304 (Figure 57b).
Central ear artery
U K -14304 produced concentration-dependent contractions in the rabbit 
isolated central ear artery with a maximum response equivalent to 71.4 ± 9.4 % of 
the maximum response to NA (n = 5). A II (0.05|iM) was virtually inactive in this 
preparation producing a response equivalent to only 1.9 ±  0.5 % o f the NA 
maximum. This concentration of A II did not significantly influence responses to 
UK-14304 (pD 2  values for UK-14304 were 6.74 ± 0.16 and 6.72 ±  0.15 in the 
absence and presence of A II respectively, n = 5) (Figure 58a)
Renal artery
U K -14304 produced concentration-dependent contractions in the renal artery 
with a maximum response equivalent to 19.9 ± 5.1% of the NA maximum response 
(n = 5). A II (0.05|iM) produced a transient contraction in this preparation which 
was equivalent to 57.1 ± 12.9% of the maximum response to NA. In the presence 
of A II, responses to U K-14304 were significantly increased in size, however this 
was not associated with a change in sensitivity of the preparation to the agonist 
(estimated pD 2  values for UK-14304 were 5.44 ± 0.09 and 5.61 ±  0.19, in the 
absence and presence of A II respectively, n = 5 ) or in the threshold concentration 
for contraction which was approximately lOjiM on each occasion (Figure 58b).
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F ig u re  No. 57
Effects of A II (0.05jiM) ( # )  on responses to U K -14304 (O ) in rabbit 
isolated a) femoral artery and b) superior mesenteric artery. Results are 
expressed as a % of the maximum response to NA obtained in each 
preparation.
Each point represents the mean ± s.e.mean (n = 4 - 5). Statistically 
significant differences between responses in the absence and presence of A II 
(0.05p.M) are represented by *p<0.05, **0.01<p<0.001, ***0.001 <p, 
Student's t- test.
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F ig u re  No. 58
Effect o f A II (0.05jiM) ( # )  on responses to U K -14304 ( O )  in rabbit 
isolated a) central ear artery and b) renal artery. Results are expressed as a 
% of the maximum response to NA obtained in each preparation.
Each point represents the mean ± s.e.mean (n = 5).
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Effects o f nifedipine on responses to NA mediated via postjunctional 
( X j -  and a o-adrenoceptors in rabbit isolated hlood vessels
In parallel with the subdivision of postjunctional a-adrenoceptors was an 
examination o f the Ca^+ sources utilised for contraction upon stimulation o f each 
subtype. From whole animal studies it has been suggested that postjunctional 0 C2 - 
adrenoceptor-mediated responses are more susceptible to the action o f calcium 
channel blockers than are those to a  ^ -adrenoceptor stimulation (Van Meel et a i ,  
1981), although this contention has been debated by other groups (O'Brien et a i ,  
1985, Nichols & Ruffolo, 1988). This prolonged disagreement reflects a limitation 
o f studies carried out in whole animals, where bolus injections o f 'selective' 
agonists invariably do not reflect "equilibrium" responses. In addition, clarification 
from in vitro experiments has not been forthcoming due to the lack o f suitable 
isolated vascular preparations which have populations o f postjunctional (X2 - 
adrenoceptors. T herefore, having dem onstrated  a m ethod for iso lating  
homogeneous populations of a^-adrenoceptors in an isolated arterial and venous 
preparation from the rabbit, the effect o f a calcium channel blocker, nifedipine, was 
examined on responses to NA. For comparison, the effect o f nifedipine against 
responses to NA mediated by postjunctional a  ^ -adrenoceptors in the rabbit isolated 
left renal vein was also attempted.
Lateral saphenous vein
Responses to NA were not reproducible with time when the full receptor 
complement was present in the rabbit isolated lateral saphenous vein (Figure 59a). 
There was a 17 ±  3 % increase in the maximum response to the agonist in the 2nd 
CCRC, although this was not associated with a change in the sensitivity o f the 
preparation to NA (pD2  value for NA, 7.73 ± 0.27 and 7.65 ± 0.17 for the 1st and
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2nd CCRC's respectively, n = 5). N ifedipine (0.01-0. lpM ) was apparently 
without effect on responses to NA under these conditions (Figure 59b). This agent 
did however prevent the time-related increase in response to NA seen in the 2nd 
CCRC. Therefore after correction for time-related changes, each concentration of 
nifedipine significantly reduced responses to NA (Figure 59c, Table 9). This 
reduction in the magnitude of the response to NA produced by nifedipine was not 
associated with a change in the sensitivity of the preparation (Table 9).
After isolation of postjunctional c^-adrenoceptors, responses to NA were 
reproducible with time. N ifedipine concentration-dependently reduced the 
magnitude of the responses to NA mediated via postjunctional (X2 -adrenoceptors 
(Figure 60a). This effect was maximal with 0.1 pM nifedipine. Again this reduction 
in the maximum response was not associated with a change in sensitivity of the 
preparation to NA (Figure 60b, Table 9).
KC1 produced concentration-dependent contractions in the rabbit isolated 
lateral saphenous vein. Nifedipine (0.1 pM ) markedly reduced responses to the 
depolarising agent, although contractions were still apparent with higher 
concentrations of KC1 (>40mM) (Figure 63a). These contractions were abolished 
by the subsequent addition of prazosin (0.1 pM).
Distal saphenous artery
Nifedipine (0.01-lpM ), at all concentrations employed, significantly reduced 
the sensitivity of the rabbit isolated distal saphenous artery to NA when the full a -  
adrenoceptor complement was present (Figure 61a, Table 9), although a reduction 
in the maximum response was observed only in the presence of the highest 
concentration (lpM ) of the calcium channel blocker.
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After isolation of postjunctional ot2 -adrenoceptors, responses to NA were 
observed only in the presence of A II (0.05pM). Nifedipine (0 .01-lpM ) had no 
effect on the size of the contraction produced by A II (responses to A II  (0.05pM) 
were equivalent to 22.7 ±  4.9 and 18.8 ± 4.3 % of the maximum response to NA in 
the absence and presence of nifedipine (0.1 pM ) respectively, n = 4), but produced 
a concentration-dependent depression of the maximum response to NA under these 
conditions (Figure 61b, Table 9). This reduction in the maximum response was not 
associated with a change in the sensitivity of the preparation to the agonist (Table 9)
KC1 produced concentration-dependent contractions in this preparation with a 
maximum response equivalent to 77.9 ± 4.9 (n = 5) of the maximum response to 
NA. These responses were virtually abolished by nifedipine (0.1 pM ) (Figure 63b). 
Again any residual response remaining after treatment with nifedipine could be 
abolished by adding prazosin (0.1 pM) to the bathing medium.
Left renal vein
In a preparation containing a homogeneous population of postjunctional a y  
adrenoceptors, the rabbit isolated left renal vein, nifedipine (O.lpM) produced a 
small but significant reduction in the maximum response to NA with no change in 
the sensitivity o f the preparation to the agonist (Figure 62, Table 9). Interestingly, 
exposure o f this preparation to KC1 resulted in only very small contractile 
responses, equivalent to only 18.0 ±  6.5 o f the maximum response to NA. Again 
these responses were virtually abolished upon exposure to nifedipine (0.1 pM ) 
(Figure 63c).
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Effect of nifedipine 0.01p.M ( # ) ,  O.ljiM (□ )  and IjiM  ( ■ )  on responses to 
NA (O )  after isolation of postjunctional a 2-adrenoceptors in rabbit isolated 
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preparation pP 2 value E-max
control Nifedipine control Nifedipine
LSV 7.47 ± 0.07 7.46 ±  0.09 1 0.86 ±  0.04**
(n = 5)
LSVRP 6.66 ± 0 .1 7  6.53 1 0 .2 4  1 0 .6 3 1 0 .0 5 * *
(n = 4)
DSA 7 .4 5 1  0.15 6 .8 8 1 0 .0 5 *  1 0 .9 1 1 0 .0 7
(n = 5)
DSARP 6 .6 6 1 0 .2 9  6 .9 5 1 0 .1 6  1 0 .3 0 1 0 .1 1 *
(n = 4)
LRV 6.07 1  0.20 5.90 1  0.16 1 0.80 1  0.07*
(n = 4)
Table 9
pD 2  values (with 95% confidence limits) and Emax values for NA in the presence 
of 0.1 jiM nifedipine as compared to the control values corrected for time-related 
changes in responses, in the rabbit isolated lateral saphenous vein (LSV), lateral 
saphenous vein after receptor protection using rauw olscine ( ljiM ) and 
phenoxybenzamine (0.3p.M) (LSVRP), distal saphenous artery (DSA), DSA after 
receptor protection with rauwolscine (lpM ) and phenoxybenzamine (0.3|iM) in the 
presence of A II (0.05|iM) (DSARP) and the left renal vein (LRV).
Differences between control and treated preparations were considered statistically 
significant if  p<0.05 for either paired or unpaired observations - Student's r-test 
and are denoted by: * 0.01<p<0.05, **0.01<p<0.001.
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Sympathetic neurovascular transmission in the rabbit isolated distal
saphenous artery
The fact that prazosin was found to be more effective at blocking responses 
to sympathetic nerve stimulation than it was at blocking equivalent sized responses 
to exogenous NA in whole animals, led to the suggestion that postjunctional a j -  
adrenoceptors were preferentially innervated, while (X2 -adrenoceptors were located 
extrajunctionally responding to circulating catecholamines (M cGrath, 1982). 
However, some relatively clear cut examples of innervated postjunctional <*2 - 
adrenoceptors have been demonstrated in a number of isolated venous preparations 
(eg. Flavahan et a i ,  1984, Docherty & Hyland, 1985). H aving dem onstrated 
prazosin-resistant responses to NA in the rabbit isolated distal saphenous artery 
under appropriate conditions, the a-adrenoceptors involved in m ediating the 
contractile response to sympathetic nerve stimulation in this preparation were 
examined. In the course of these experiments it was also found necessary to take 
into account the role of a purinergic component of the response to sympathetic 
nerve stimulation.
Responses to sympathetic nerve stimulation
Electrical field stimulation o f ring segments o f rabbit isolated distal 
saphenous artery resulted in frequency-dependent contractile responses which were 
reproducible for three frequency-response curves (FRC's) (Figure 64). With a 
stimulation duration of 1 second, 4Hz was found to be the threshold frequency for 
contraction of this preparation. Subsequent two-fold increments in the frequency of 
stimulation resulted in a graded increase in the size of contractile response observed 
up to the highest frequency applied, 64Hz, which did not produce a maximum 
response. These contractions were characterised by a rapid rise to a peak response
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approximately 5 seconds after the onset of electrical stimulation, which then 
returned to baseline over the period of 15-60 seconds. Contractile responses to a 
longer duration of electrical stimulation, 1 0  seconds, produced a larger peak 
response for a given frequency, which subsequently returned to baseline after 2 0 - 
60 seconds. All responses to sympathetic nerve stimulation at any frequency or 
duration were sensitive to tetrodotoxin (0.1 pM) (n = 3).
Effects o f  antagonists on responses to sympathetic nerve stimulation
The possible involvement of three receptor systems, postjunctional a y  and 
(X2 -adrenoceptors and purinoceptors, in m ediating the end-organ contractile 
response to sympathetic nerve stimulation in the rabbit isolated distal saphenous 
artery, was examined using three appropriate antagonists, prazosin (0.1 pM ) 
selective for aj-adrenoceptors, rauwolscine (lpM ) selective for (^-adrenoceptors 
and a,P-m ethylene ATP (3pM), a desensitising agent selective for purinoceptors. 
All experiments were carried out in the absence of either cocaine or propranolol.
Prazosin (0.1 pM) markedly reduced contractile responses to sympathetic 
nerve stimulation at all frequencies in the FRC (Figure 65a), leaving only a small 
residual contractile response to nerve stimulation (for 64Hz this was equivalent to 
17.2 ±  2.3 % of the initial control response). In contrast, rauwolscine (lpM ) 
produced an enhancement o f responses to electrical field stimulation in this 
preparation. This was particularly marked for lower frequencies or if a longer 
stimulation period was used (Figure 65b). A potentiation o f nerve-mediated 
responses was also observed in the presence of a,p-m ethylene ATP (3pM) at all 
frequencies o f the FRC (Figure 65c). This agent produced a transient contraction of 
the preparation equivalent to 113.9 ± 9.5 (n = 15) of the response to nerve 
stimulation at 64Hz, which returned to baseline after approximately 12-18 mins. No
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contractions were subsequently observed upon re-exposure of the preparation to 
a,p-m ethylene ATP (3|iM).
Since no antagonist on its own abolished responses to sympathetic nerve 
stimulation, the antagonists were tested in combination. As shown in figure 6 6 a the 
combination o f prazosin (0.1 pM) and a,p-m ethylene ATP (3pM ) was no more 
effective at inhibiting responses than prazosin alone. It should be noted however, 
that the potentiation of responses produced by a,p-m ethylene ATP (3pM) was no 
longer apparent in the presence of prazosin. In contrast, rauwolscine (lpM ) 
continued to enhance responses to sympathetic nerve stimulation at all frequencies 
even after blockade of postjunctional a  j-adrenoceptors with prazosin (0.1 |iM ) 
(Figure 6 6 b). With the combination of rauwolscine (lpM ) and a,P-methylene ATP 
(3pM ) contractile responses were significantly increased from control values, 
although these two agents together did not produce a greater potentiation than that 
seen either antagonist alone (Figure 6 6 c).
Prazosin (0.1 }iM) virtually abolished responses rem aining after the 
combination of rauwolscine (lpM ) and oc,p-methylene ATP (3pM) (Figure 67c). 
Similarly, a,P-methylene ATP (3pM) had a marked inhibitory effect on responses 
rem aining after the combination of prazosin (0.1 pM ) and rauwolscine (lpM ) 
(Figure 67b). These results therefore confirm an involvem ent for both ocj- 
adrenoceptors and purinoceptors in the end-organ contractile response to 
sympathetic nerve stimulation in this preparation. Such a role for postjunctional o^- 
adrenoceptors was more equivocal since rauwolscine (lpM ) reduced but did not 
abolish the small residual responses persisting after the combination o f prazosin 
(0.1 pM ) and ot,p-methylene ATP (3pM) (Figure 67a).
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Effect of the sequential administration of a) prazosin (0.1 pM) and a,p-m ethylene ATP (3pM) b) 
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Effect o f the sequential administration of a) rauwolscine (ljiM ) after the combination of 
prazosin (0.1 |iM ) and a ,p-m ethylene ATP (3|iM ) b) a ,p-m ethylene ATP (3|iM ) after 
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obtained in the 1st FRC (control).
Each point represents the mean ± s.e.mean (n = 3).
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Effects o f A II on responses to sympathetic nerve stimulation in 
rabbit isolated distal saphenous artery
A II has been demonstrated to produce an enhancement of responses to 
sympathetic nerve stimulation in a wide variety of vascular preparations (for review 
see Westfall, 1977). This effect has largely been ascribed to a prejunctional effect at 
enhancing transm itter release rather than a postjunctional action. However the 
present study has demonstrated an interaction betwen A II and responses to NA 
m ediated via postjunctional (^-ad renocep to rs in the rabbit isolated lateral 
saphenous vein and distal saphenous artery. Therefore the effects of A II on 
responses to sympathetic nerve stimulation in the rabbit isolated distal saphenous 
artery were examined.
A II (0.05pM ) produced a transient contraction in this preparation as 
described previously. This concentration of A II markedly increased reponses to 
electrical field stimulation of the distal saphenous artery at all points on the FRC 
(Figure 6 8 ). After isolation of purinoceptors in this preparation, with the use of the 
combination of prazosin (0.1 pM) and rauwolscine (lpM ), A II (0.05pM) produced 
a small but significant potentiation of nerve-mediated responses, particularly on the 
lower portion of the FRC (Figure 69b). After isolation o f postjunctional otj- 
adrenoceptors, with the use of the combination of rauwolscine (lp M ) and a ,p - 
methylene ATP (3pM), A II (0.05pM) was without effect on the already potentiated 
response (Figure 69c). In contrast, A II (0.05|iM) produced a marked enhancement 
of responses after attempted isolation of postjunctional ct2 -adrenoceptors using the 
combination of prazosin (0.1 pM ) and a,p-m ethylene ATP (3pM ) (Figure 69a). 
Interestingly this potentiated response in the presence o f A II was subsequently 
susceptible to an inhibitory action of lpM  rauwolscine, a concentration which in 
most other circumstances had potentiated nerve-mediated responses (Figure 70).
173
N
X
VO
a
t/3
G0
aV;ou
#
100
80
4Hz 8Hz 16Hz 32Hz 64Hz 4Hz 8Hz 
1 second 10 seconds
F ig u re  No. 6 8
Effect o f A II (0.05jiM) on responses to sympathetic nerve stimulation in 
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Effect of A II (0.05|iM) (hatched bars) on the residual response to sympathetic nerve stimulation
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Effect of rauwolscine (ljiM ) (hatched bars) on the response to sympathetic 
nerve stimulation remaining in the presence o f prazosin (0.1p.M), a ,p -  
methylene ATP (3|iM ) and A II (0.05jiM) (solid bars). The 1st FRC is 
represented by open bars, the 2nd in the presence of A n, by closed bars. 
Each point represents the mean ± s.e.mean (n = 7). Statistically significant 
differences between responses in the absence and presence rauwolscine 
(lp.M ) are represented by *p<0.05, **0.01<p<0.001, ***p<0.001, 
Student's f- test.
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Alpha-adrenoceptors in the rabbit isolated lateral saphenous vein
The rank order o f potencies for agonists in this preparation, U K -14304 > 
NA > phenylephrine strongly indicates a predominance of postjunctional 0*2' 
adrenoceptors over a  j-adrenoceptors in mediating contractile responses, and is 
similar to those found in previous studies in the rabbit isolated lateral saphenous 
vein (Schumann & Lues, 1983, Alabaster et al., 1985). This potency order for 
agonists is also similar to that observed in the rabbit isolated ear vein, a preparation 
which contains a homogeneous population of postjunctional ot2 -adrenoceptors 
(Daly et al., 1988b). Antagonist potency however, does not give clear support for 
this hypothesis.
High pA 2  values were obtained against NA for two agents, prazosin and 
YM 12617, which in other preparations are highly selective for a  j-adrenoceptors 
(Cam bridge et al., 1977, Honda et al., 1985), as well as for the selective a.2 ' 
adrenoceptor antagonist rauwolscine (Weitzell et al., 1979). The pA 2  value for 
rauwolscine, 8.41, is consistent with previously reported values for this antagonist 
at prejunctional ot2 -adrenoceptors in rat anococcygeus (McGrath, 1984) and rabbit 
vas deferens (Lattimer & Rhodes, 1985) and at postjunctional ot2 -adrenoceptors in 
the rabbit ear vein (Daly et al., 1988b). However, the pA 2  value obtained for 
prazosin, 8.19, is intermediate between its reported value at postjunctional a j -  
adrenoceptors in other rabbit blood vessels; aorta 8.85 (Honda et al., 1985), 
pulm onary artery 8.76 (Vizi et al., 1986) and its reported pA 2  value at 
prejunctional ot2 -adrenoceptors in the pulmonary artery, 6.3 (Kaposci et al., 
1987). Similarly, the pA 2  value for YM 12617, 8.36, is less than its reported value 
at postjunctional aj-adrenoceptors in rabbit aorta ( 1 0 .0 ) but greater than its value at
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prejunctional (^-adrenoceptors in rat vas deferens (6.4) (Honda et al. 1985).
Another interesting feature of the antagonism produced by a-adrenoceptor 
antagonists in this preparation, is that the slope o f the Schild plot for each 
antagonist is consistently less than unity, indicating non-competitive antagonism. In 
a concurrent study, this deviation from unity could not be attributed to incomplete 
blockade of neuronal uptake; 30(iM cocaine had no greater effect than IOjiM (used 
in the present study) on the CCRC to NA, nor could it be attributed to an intact 
extraneuronal uptake system, a feature which is o f limited importance in this 
preparation (Daly et al., 1988a). These results could be interpreted as evidence for 
a novel a-adrenoceptor mediating contraction in this preparation, with some 
properties of both postjunctional a ^ -  and a 2 -adrenoceptors, sim ilar to the 
prazosin-sensitive a 2 -adrenoceptor described by Neylon & Summers (1985). 
Alternatively, since the antagonists employed are known to possess varying degrees 
of selectivity for a j -  and a 2 -adrenoceptors, responses to NA may be the resultant 
o f an action on a mixed population of both postjunctional a j -  and a 2 - 
adrenoceptors. Evidence in favour of the latter possibility is provided by examining 
the slope of the CCRC to NA in the presence of rauwolscine in greater detail.
Increasing concentrations of the selective a 2 -adrenoceptor antagonist, 
rauwolscine, produce a consistent rightward displacement only in the upper portion 
o f the CCRC: a response equivalent in size to approximately 20-30% of the NA 
maximum was unaffected. In the presence of a concentration of prazosin which 
produced a 5 -10-fold rightward displacement alone, the component o f the response 
to NA which was resistant to rauwolscine was no longer apparent.
It is conceivable that the 'rauwolscine-resistant' component could be a 
consequence of the small transient contraction observed upon exposure to the
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antagonist, reducing the threshold for contraction. Prazosin (0.1 }iM) not only 
removed the 'rauwolscine-resistant' component of the response to NA, but also the 
contraction to rauwolscine. This explanation seems unlikely however, since a 
component of the response to NA in this preparation remains resistant to another 
(X2 -adrenoceptor antagonist CH 38083, an agent which did not produce a 
contraction (Daly et al., 1988a). In addition transient contractions produced by 
prazosin in the rabbit isolated aorta (Cavero et al., 1978) and by yohimbine in the 
rabbit isolated ear artery (Tayo et al., 1982) are not associated with the appearance 
o f a resistant component of responses to NA.
A much more likely explanation is that prazosin removes the 'rauwolscine- 
resistant' component by antagonising a component of the response to NA mediated 
by a population o f a  j-adrenoceptors. The presence o f both a -ad renocep to rs  
subtypes, with the a 2 -adrenoceptor subtype predominating, would explain why the 
pA 2  value for rauwolscine approximated its known value at (^-adrenoceptors, 
while pA 2  values for prazosin and YM 12617 are intermediate between their 
potency at ocj- and a 2 -adrenoceptors. The explanation for the lack of a 'resistant 
component' of responses to NA in the presence of a  j-adrenoceptor antagonists can 
be explained by a functional interaction between the a-adrenoceptor subtypes. This 
concept will be expanded later in the discussion.
Attempted isolation of postjunctional a-adrenoceptors subtypes in 
rabbit isolated lateral saphenous vein
Phenoxybenzamine (0.3jiM), an irreversible a-adrenoceptor antagonist 
(Furchgott, 1972), virtually abolished responses to NA in the rabbit isolated lateral 
saphenous vein. The basis for receptor isolation therefore, was to provide 
conditions whereby any postjunctional a 2 -adrenoceptors or postjunctional a j -  
adrenoceptors could be selectively protected by the inclusion of a selective
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concentration o f a suitable antagonist.
Attempted isolation o f postjunctional 0*2-adrenoceptors
The inclusion o f rauw olscine (ljiM ) prior to and during exposure to 
phenoxybenzamine, resulted in part of the response to NA being spared from the 
action o f phenoxybenzamine. Subsequently, the residual response to NA was 
antagonised by rauwolscine (l|iM ) which produced an approximately 100-fold 
rightward displacement o f the CCRC to NA after the protection protocol, with an 
estimated -logKg value of 7.98. This is a similar dissociation constant value to that 
obtained for rauwolscine against CX2 -adrenoceptor-mediated responses in other 
vascular preparations (Daly et al., 1988b, Lattimer & Rhodes, 1985). In addition, 
after the protection protocol there was no longer a component of the CCRC to NA 
which was resistant to rauwolscine. This contrasts with the 'rauwolscine-resistant' 
component of responses to NA observed when the full receptor complement was 
present in this preparation. Therefore treatment with phenoxybenzamine removes a 
component of the response to NA which was rauwolscine-resistant, prazosin- 
sensitive and therefore likely to have been mediated by postjunctional a j -  
adrenoceptors.
The functional rem oval of postjunctional a  j-a d re n o c e p to rs  by 
phenoxybenzamine is further supported by the observations that both prazosin and 
YM 12617 at the concentration of 0.1 fiM, which is a concentration 75-1000 times 
greater than their reported pA 2  value at a  j-adrenoceptors in other preparations (see 
Daly et al., 1988a), produced less than 3-fold rightward displacements of the 
residual response to NA after the protection protocol, and therefore were much less 
effective than against responses to NA than under control conditions.
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These results are consistent with a discrete population of postjunctional d2~ 
adrenoceptors which are preferentially protected by rauwolscine. The low potency 
for prazosin at this isolated subtype (pA 2  < 7) agrees well with that found by 
Schumann & Lues (1983) in this preparation against BHT-920 induced contractions 
in the presence o f A II (pA2  = 6 .8 ). Furthermore, the low potency of YM 12617 
(pA 2  < 7) is also consistent with an action at ct2 -adrenoceptors (Honda et al.,
1985).
Attempted isolation o f postjunctional aj-adrenoceptors
In contrast to the relatively clear-cut observations obtained after receptor 
protection with rauwolscine, attempted protection of part of the response to NA 
with the selective aj-adrenoceptor antagonist YM 12617 (O.ljiM) did not yield 
straightforward results.
Firstly, YM 12617 antagonised the remaining residual response in an 
apparently non-competitive manner. A 10-fold increase in the concentration of YM 
12617 was not associated with a corresponding 10-fold increase in the rightward 
displacement of the NA CCRC. If only a  j-adrenoceptors had been spared from the 
action o f phenoxybenzamine, YM 12617 might have been expected to be a 
competitive antagonist. In addition, the estimated -logK^ value for YM 12617 
under these conditions (7.67) was not significantly different from the pA 2  value 
obtained for this antagonist when the full receptor complement was present; both 
values are considerably less than that observed at a  j-adrenoceptors in the rabbit 
isolated aorta (pA2  10.0) (Honda et al., 1985) or the rabbit isolated renal vein (V. 
G. Wilson, personal communication); pA 2  approximately 9.5.
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Secondly, rauwolscine (2.5jiM) produced an enhancement of responses 
after attempted isolation of postjunctional cx^-adrenoceptors at low concentrations 
o f the CCRC to NA, while inhibiting response to higher concentrations of NA. 
This potentiation o f responses to NA was inhibited by YM 12617 and the 
combination o f the two antagonists produced a greater displacement o f the NA 
CCRC to NA than either antagonist alone. The potentiation o f responses produced 
by rauwolscine is difficult to explain. However since YM 12617 blocked both 
contractile responses and the potentiation o f responses to NA produced by 
rauwolscine, an agonistic action or interaction with aj-adrenoceptors for the <X2~ 
adrenoceptor antagonist cannot be excluded. If this were true, it would suggest 
subtle differences for the population of postjunctional a  j-adrenoceptors in the 
lateral saphenous vein from that found in other rabbit vascular preparations such as 
the thoracic aorta, ear artery or renal vein (Daly et al., 1988c).
Finally, the selective o^-adrenoceptor antagonist CH 38083 (Vizi et al.,
1986) effected a marked inhibition of responses following protection with O.lpM 
YM 12617, suggesting the presence of postjunctional oc2 -adrenoceptors. This 
inhibition was associated with the appearance of a small resistant component of the 
response to NA, although this was considerably less than that seen with 
rauwolscine. Thus after attempted isolation of postjunctional otj-adrenoceptors, 
responses are resistant to one <X2 -adrenoceptor antagonist, rauw olscine, but 
susceptible to another CH 38083.
Taken together these observations cannot be reconciled by NA acting on a 
single population of a  \ -adrenoceptors. With the exception o f the potentiation 
produced by rauwolscine, the antagonists inhibited responses to NA, irrespective of 
subtype specificity. In many ways these results parallel the observations with 
antagonists against responses to NA under normal conditions. YM 12617 produced 
non-competitive antagonism under both conditions, a resistant component of
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responses to NA persisted in the presence of an o^-adrenoceptor antagonist and the 
combination o f a ^ -  and (X2 -adrenoceptor antagonists produce a greater shift than 
either alone. This leads to the conclusion that YM 12617 (0.1 |iM ) failed to isolate a 
hom ogeneous population of a  j-adrenoceptors, but rather protected a mixed 
population of a-adrenoceptors.
Since the concentration of phenoxybenzam ine em ployed abolished 
responses to NA in the absence of YM 12617, the responses blocked by CH 38083 
might arise if limited protection of the (^-adrenoceptor subtype was afforded by the 
inclusion of 0.1|iM  YM 12617 during the incubation period. While there is always 
the problem of assumed selectivity of an antagonist at any given concentration, 
CH 38083 (ljiM ) can be considered selective for (^-adrenoceptors, since under 
control conditions, this concentration of CH 38083 w-as associated with a resistant 
component of responses to NA (see Daly et al., 1988a). This then questions the 
selectivity of O.ljiM YM 12617 for aj-adrenoceptors. This concentration of YM 
12617 however is ineffective at postjunctional a 2 ~adrenoceptors in the canine 
isolated saphenous vein (Honda et al., 1985) and rabbit isolated ear vein (Daly et 
al., 1988b) and in addition is virtually inactive against responses to NA after 
isolation o f postjunctional ot2 -adrenoceptors in the lateral saphenous vein (present 
study).
This apparent paradox could be explained if a residual a 2 -adrenoceptor 
component, which survives phenoxybenzamine, but cannot reach threshold for 
contraction alone, was facilitated by the response mediated by the aj-adrenoceptors 
protected by YM 12617. Evidence for such a functional synergistic interaction 
between a-adrenoceptor subtypes, both in this preparation and in the rabbit distal 
saphenous artery, will be discussed in greater detail later in the discussion.
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Alternatively, it has been suggested that the diversity of chemical structures 
capable o f inhibiting a-adrenoceptors can be taken as evidence that some 
antagonists produce their effects by attachm ent to ’extrareceptor' sites not 
necessarily corresponding to the area of agonist attatchment (see: McGrath, 1982, 
Ariens & Simonis, 1983). If this were correct for postjunctional ot2 -adrenoceptors 
in the rabbit lateral saphenous vein, it seems possible that YM 12617 may compete 
with phenoxybenzam ine at a critical 'extra-receptor' site, thereby preventing 
irreversible inactivation, but without hindering the access o f the agonist to the 
receptor. Thus after incubation with 0.1 JiM YM 12617, contractile responses to NA 
would result from the co-stim ulation of a population o f both a ^ -  and 0 C2 - 
adrenoceptors.
In conclusion, based upon the receptor protection experiments in the rabbit 
isolated lateral saphenous vein, w-ith 'selective' concentrations of either ot|- or 0 1 2 - 
adrenoceptor antagonists in com bination with the irreversib le antagonist 
phenoxybenzamine, two populations of postjunctional a-adrenoceptors can be 
identified. One population has the characteristics of an a 2 -adrenoceptor (prazosin 
or YM 12617-resistant, rauw-olscine-sensitive), while the other possesses some of 
the characteristics of an a j-ad renocep to r (YM 12617-sensitive, rauwolscine- 
resistant). Although complete isolation of postjunctional a 2 * adrenoceptors could be 
demonstrated, only limited success was achieved in isolating the aj-adrenoceptor 
subtype. The aforementioned protocol therefore, allows us to ’manufacture’ a 
preparation containing a hom ogeneous population o f postjunctional a 2 ~ 
adrenoceptors, which can be studied using the definitive a-adrenoceptor agonist 
NA (Furchgott, 1972). This overcomes the necessity of using ’selective’ agonists 
alone or in combination with a selective a  j-adrenoceptor antagonist, normally used 
to study a 2 -adrenoceptor-mediated responses in other preparations containing a 
mixed population of a-adrenoceptors (eg. the canine saphenous vein, see: Flavahan
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et al., 1984, Ruffolo & Zeid, 1985).
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Comparison o f the effects o f A II and Bay K  8644 on responses to NA 
mediated via postjunctional (Xj- and a-adrenoceptors in vascular 
smooth muscle
Contractile responses to angiotensin II
A II, at all concentrations which were suprathreshold, produced transient 
contractions in the rabbit isolated lateral saphenous vein, ear vein and left renal 
vein. Subsequent exposure of these preparations to A II was not associated with a 
contractile response. The transient, tachyphylactic nature of responses to A II 
appears to be a feature in most isolated venous and arterial preparations (see: Peach 
1977) and has been reported previously for both the rabbit lateral saphenous vein 
(Schuman & Lues, 1983) and renal vein (Webb, 1982).
Since responses to even low concentrations o f A II (threshold for 
contraction) are not maintained, it is unlikely that this feature is solely a reflection of 
exposure to an excessively high concentration of A n . Rather, this inability of A II 
to m aintain a contractile response is more probably associated with some 
consequence of the formation of the drug receptor interaction, such that once 
formed, there is a subsequent inability to maintain the production of diacylglycerol 
and therefore continued protein kinase C activation (Danthuluri & Deth, 1986). This 
process would ultim ately lim it the ability of A II to produce an influx of 
extracellular Ca^+ into the smooth muscle cell. Interestingly a number of situations 
exist where tachyphylaxis to A II can be reversed, most notably by inducing tone in 
isolated vascular preparations with an appropriate agent such as KC1 (Nicholas, 
1970, Goodfriend & Simpson, 1981, Juul et al., 1987). The presence o f tone 
would therefore explain why responses to infusions of lower concentrations of A II 
are maintained and reproducible under in vivo conditions (Bohr, 1974).
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Another puzzling feature of the action of A II in vitro, is the difficulty in 
correlating the concentrations of A II found in plasm a with those required to 
produce a direct vasoconstrictor action in isolated vascular preparations. The plasma 
concentrations of A II have been estimated to be in the order of 0.1 nM in man 
(Boyd & Peart, 1974) while even in the pithed rat, where the renin-angiotensin 
system is highly activated, the plasma levels of A II are only in the order of 0.5nM 
(Grant & McGrath, 1988a). In the vast majority of isolated blood vessels, large or 
small, venous or arterial, concentrations of A II exceeding InM  are generally 
required before contractile responses are observed (Hof et al., 1982, Juul et al., 
1987, Schumann & Lues 1983). This apparent paradox between the plasma levels 
of A II and those required to contract vascular smooth muscle could be reconciled 
if, as has recently been proposed, the most important source of A II production is 
within the vascular smooth muscle cell. This would result in the levels of A II  at the 
vascular smooth muscle being largely independent of the levels of A II found in the 
general circulation (Campbell, 1987, Dzau, 1988, Unger et al., 1989). Validation 
of this proposal, and determination of 'physiological' levels o f A II, would require 
overcoming the difficulty in measuring the concentration of A II  at the level of the 
vascular smooth muscle cell.
Comparison o f the actions o f A II and Bay K  8644
ACE inhibitors and Ca^+ channel blockers (CCB's) have qualitatively 
similar effects on a-adrenoceptor-mediated pressor responses in the pithed rat (van 
M eel et al., 1981, De Jonge et al., 1981, 1982, O 'Brien et al., 1985). For 
example, in the latter study, the authors demonstrated that the second component of 
the pressor response to the bolus injection of an agonist in the pithed rat, was 
antagonised in a similar manner by both ACE inhibitors and CCB's, while the first 
component of the response was relatively unaffected. These observations prompted
187
the consideration that A II may have been an endogenous facilitator of voltage- 
operated Ca^+ channels. If this were true then we may have expected A II  and Bay 
K 8644 to produce qualitatively similar effects on responses to NA mediated via 
either postjunctional otj- or oc2 -adrenoceptors in vitro.
Upon examination of a number of isolated venous preparations however, a 
similarity of action for these agents was not apparent. A II produced a potentiation 
of responses in the rabbit isolated ear vein and in lateral saphenous vein (although 
only after isolation of postjunctional ot2 -adrenoceptors), while Bay K 8644 
produced a small but significant enhancement of responses to NA in all the venous 
preparations attempted with the exception of the ear vein. Therefore, a similar action 
for these agents was observed only in the lateral saphenous vein.
Even in this preparation, a closer examination of the influence of A II and 
Bay K 8644 on Ca^+-evoked contractions, revealed marked differences in their 
effects on voltage-operated Ca^+ channels. Bay K 8644 enhanced Ca^+-induced 
contractions in the presence of a depolarising concentration of KC1, without altering 
the sensitivity of the voltage-operated Ca^+ channel. This observation is consistent 
with the voltage-operated C a^+ channel facilitatory effect of this agent, first 
described by Schramm et al. (1983) and of the observations of Su et al. (1984) in 
the rat tail artery. In contrast however, A II inhibited the Ca^+-induced contractions 
mediated via voltage-operated channels, an effect associated with a reduction in 
channel sensitivity to Ca^+ . It is difficult to understand the mechanism o f this 
inhibition, since A II has no reported calcium channel blocking actions.
In contrast, both A II and Bay K 8644 produced an enhancement of 
responses to the re-addition of C a^+ , after isolation o f postjunctional a.2~ 
adrenoceptors, in the presence of NA as a stimulatory agent. Therefore, both these 
agents can enhance responses to extracellular Ca^+ mediated via receptor-operated
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Ca^+ channels. Since this effect is seen with Bay K 8644, this suggests that at least 
part o f the response subsequent to postjunctional a 2-adrenoceptor stimulation is 
mediated via voltage-operated Ca^+ channels. Some caution is perhaps warranted 
in assum ing that the action of Bay K 8644 and other 1,4-dihydropyridine 
derivatives is solely on voltage-operated channels, since Bay K 8644 clearly had a 
greater effect on those Ca^+ channels activated by NA than those activated by KC1. 
In addition, Bay K 8644 has been reported to enhance postjunctional ot2 - 
adrenoceptor-mediated responses in the canine saphenous vein (Eskinder & Gross,
1987), a preparation in which (^-adrenoceptor stimulation is not associated with 
changes in membrane potential (Matthews et al., 1984).
To conclude however, since A II and Bay K 8644 have qualitatively 
different effects on responses to NA in different blood vessels, this clearly denotes 
that these agents do not act in the same manner, as has been suggested from 
observations in vivo.
Effect o f A II on postjunctional otj - and a2 -adrenoceptors
A number of observations in the present study suggest a selective interaction 
between A II and responses mediated via postjunctional (^-adrenoceptors. Firstly, 
A II produced a modest reduction in the potency of prazosin against responses to 
NA in the lateral saphenous vein. These results are essentially similar to those 
obtained by Schumann & Lues (1983) in the same preparation, who demonstrated 
that responses to BHT-920, which under normal circumstances were markedly 
inhibited by prazosin, became much more resistant to the a j-a d re n o c e p to r  
antagonist in the presence of A II. A lack of effect of A II on aj-ad renocep to r- 
mediated responses in this preparation is suggested by the absence of an influence 
o f A II on responses to NA in the presence of rauwolscine i.e. the size of the
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'rauwolscine-resistant' component is similar in the absence and presence of A II.
Secondly after isolation o f postjunctional ot2 -adrenoceptors in the rabbit 
lateral saphenous vein, A II produced an increase in both the maximum response 
and sensitivity of the preparation to the NA. This effect o f A II was mediated 
through a specific receptor since it could be blocked by the A II receptor antagonist 
saralasin (Zimmerman & Kraft, 1979). Interestingly, despite the fact that saralasin 
(O.OljiM) virtually abolished contractile responses to A II, a 10-fold higher 
concentration of antagonist was required to completely reverse the facilitatory action 
of this peptide. These results represent a dissociation between the concentrations of 
A II required for a facilitatory action on responses to NA and a direct action on 
vascular smooth muscle, such that the form er can occur with subcontractile 
concentrations of A II. In accord with this idea, A II (5nM) also produced a 
consistent facilitation of postjunctional oc2 -adrenoceptor-mediated responses, while 
producing a very small contraction in only 2  of 6  preparations.
It should be noted that the sensitivity of responses to NA after attempted 
isolation of postjunctional a  j-adrenoceptors in the rabbit lateral saphenous vein 
was also increased by A II. As discussed previously however, it is likely that 
pretreatment with 0.1 pM  YM 12617 and 0.3pM phenoxybenzamine results in the 
protection of a mixed population of both a-adrenoceptor subtypes. It is therefore 
not possible to dissociate the potentiation produced by A II under these conditions, 
from a possible action on postjunctional a 2 -adrenoceptors.
Further evidence for a selective interaction between A II and postjunctional 
a 2 -adrenoceptors is provided in the rabbit isolated distal saphenous artery. A II 
produced a marked increase in the sensitivity in this preparation to the relatively
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'selective' oc2 -adrenoceptor agonist U K -14304, resulting in the introduction of a 
previously unseen component of responses to this agonist. These 'uncovered' 
responses were unaffected by a concentration of prazosin (0.1 p.M) which is 
approxim ately 50 times greater than that corresponding to its pA 2  value at 
postjunctional a  j-adrenoceptors in this preparation (8.57). In contrast, rauwolscine 
(ljiM ) prevented the potentiation of responses to U K -14304 produced by A II. 
This therefore represents a complete reversal of antagonist potencies in this 
preparation, such that in the presence of A II, rauwolscine (l|iM ) is more potent 
against response to U K -14304 than prazosin (0.1 JiM), while under normal 
experimental conditions the converse is true. In the same preparation, A II was 
w ithout effect on responses to the selective a j -a d re n o c e p to r  agon ist, 
phenylephrine.
Finally, A II produced a small but significant enhancement of responses to 
NA in the rabbit isolated ear vein, a preparation containing an almost homogeneous 
population of postjunctional a 2 -adrenoceptors (Daly et al., 1988b). In contrast, in 
the left renal vein, a preparation containing a hom ogeneous population of 
postjunctional aj-adrenoceptors (Daly et al., 1988c), A II was without effect on 
responses to NA.
Since the presence of a large receptor reserve can attenuate the inhibition of 
contractile responses produced by calcium channel blockers (Nichols & Ruffolo,
1988) or by modulation of temperature (Flavahan & Vanhoutte, 1986), it is 
possible that reciprocal facilitatory actions may be masked by the existence of such 
a feature in a given preparation. However, even after reducing the receptor reserve 
in the left renal vein with phenoxybenzamine, no potentiation of a^-adrenoceptor- 
m ediated responses to NA was observed in the presence of A II. These 
observations fail to corroborate those of Purdy & W eber (1988) who were able to 
demonstrate a facilitation of a  j-adrenoceptor-mediated responses in rabbit isolated
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femoral artery, this effect being particularly marked when the receptor reserve had 
previously been reduced with benextramine. A number of observations however 
suggest that postjunctional c^-adrenoceptors may be present in the rabbit isolated 
femoral artery. In the present study, A II introduced a component of responses to 
U K -14304 in this preparation which was previously absent, in an analogous 
manner to that seen in the distal saphenous artery. In addition, Purdy & W eber 
found that responses to NA were slightly more resistant to prazosin in the presence 
of A II after the receptor reserve had been reduced in the rabbit femoral artery. 
Again this situation is analogous with that seen in the distal saphenous artery, 
where postjunctional c^-adrenoceptors can be quite clearly demonstrated.
Taken in isolation, these observations strongly suggest a selective 
interaction between A II and postjunctional c^-adrenoceptors. Due to the lack of 
suitable isolated vascular preparations which have populations of postjunctional 
(^-ad renocep to rs, no com parative studies have previously been attempted. 
However A II has been shown to potentiate responses to NA in a number of 
isolated vascular preparations such as the rat caudal artery (Nicholas, 1970), 
perfused mesenteric arteries from a number of species (Malik & Najletti, 1976, 
Chiba & Tsukada, 1986, Panisset & Bourdois, 1968), human digital arteries 
(Moulds & Worland, 1980) and in canine hindpaw (Zimmerman & Kraft, 1979). It 
is interesting to note that more recent characterisations of the a -adrenocep tor 
populations in at least some of these cutaneous preparations, with the realisation of 
the existence of both postjunctional ot}- and o^-adrenoceptors on vascular smooth 
muscle, have revealed responses mediated via postjunctional oc2 -adrenoceptors. For 
example, ot2 -adrenoceptor-mediated responses have been observed in human digital 
arteries (Glusa & Markwardt, 1983, Stevens & Moulds, 1985), in the rat caudal 
artery or perfused rat tail (Rajanayagam & Medgett, 1987, Templeton eta l., 1989) 
and in the feline mesenteric vascular bed (Lippton et al., 1987). Thus the
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potentiation produced by A II may reflect an interaction with postjunctional 0 *2 -
adrenoceptors.
A number of other observations however, suggest that this interpretation 
m ay be too simplistic. For example, Day & M oore (1976) have demonstrated a 
non-specific facilitatory action for A II on responses to various contractile agents, 
including NA, in rabbit isolated aorta. Similarly, Chiba & Tsukada (1986) also 
observed an increase in responses to KC1, as well as NA, in the canine mesenteric 
artery in the presence of A H  Since ouabain produced similar effects, these authors 
concluded that A n  modulated responses to vasoactive agents by producing a small 
depolarization of the cell membrane, thereby reducing the threshold for contraction. 
Such a non-specific sensitisation of vascular smooth muscle is unlikely to account 
for the effects of A II in the present study since, when the full receptor complement 
was present in the saphenous vein, responses to bradykinin and NA were 
unaffected by A II, as were responses to NA and phenylephrine in the distal 
saphenous artery.
Two further studies suggest a more complex interaction between A II and 
postjunctional a-adrenoceptors. This interaction is apparently related to some 
process responsible for determining the expression of intrinsic activity for synthetic 
agents, and is irrespective of subtype specificity. For example, Lues & Schumann 
(1984) have reported that A II converted the action of BHT-920 from a weak 
antagonist to a partial agonist at postjunctional a  j-adrenoceptors in the rabbit 
isolated aorta (Lues & Schumann, 1984). These results were repeated in the rabbit 
m esenteric artery, in which it was also observed that A II conferred 0 C2 - 
adrenoceptor agonism (prazosin-resistant contractile responses) on two relatively 
selective (^-adrenoceptor antagonists, rauwolscine and BDF 6143 (Lues et a i,  
1984). The introduction of responses, produced by A II, to BHT-920 in these
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preparations is essentially similar to that seen with U K -14304 in the distal 
saphenous artery, although different a-adrenoceptor subtypes are mooted to be 
involved. Therefore, rather than the a-adrenoceptor subtype being the crucial factor 
involved, A II  may act on some other common feature of responses to these agents, 
such as their dependence on extracellular Ca^+, to produce its facilitatory effects. 
However, one of the main tenets of the present study was to examine the influence 
o f various agents on the definitive, endogenous a-adrenocep tor agonist, NA 
(Furchgott, 1972), and as such A II clearly produces a selective enhancement of 
responses to this agonist mediated via postjunctional a 2 -adrenoceptors.
Effect o f A I on postjunctional ct2-adrenoceptor-mediated responses
The physiological precursor of A II, angiotensin I (A I) mimicked the 
facilitatory action of A II on postjunctional a 2 -adrenoceptor-mediated responses. 
Responses to NA after isolation of postjunctional a 2 -adrenoceptors in the lateral 
saphenous vein were potentiated by A I, while this agent also 'uncovered' a 
previously unseen component of responses to U K -14304 in the distal saphenous 
artery. There was however, some difficulty in reversing the potentiating action of 
A I with angiotensin-converting enzyme (ACE) inhibitors. Cilazaprilat (ljiM ), a 
concentration 500-fold greater than its IC^q value at inhibiting enzyme-substrate 
interactions (Natoff & Redshaw, 1987), abolished contractions to A I in the lateral 
saphenous vein, but this was not associated with a com plete reversal o f the 
facilitatory action of this peptide. Similarly, another ACE inhibitor, captopril, at a 
concentration approximately 150 times greater than its IC 5 Q value (ljiM ) (Natoff & 
Redshaw, 1987), did not reverse the facilitatory action o f A I in the distal 
saphenous artery. Indeed captopril (lfiM ) did not even com pletely abolish 
contractile responses to A I (0.5|iM) in this preparation.
Three possible explanations could be forwarded to explain why the ACE
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inhibitors failed to completely reverse the effects of A I. For example, it is possible 
that A I produces a facilitation of t^-adrenoceptor-m ediated  responses alone, 
although this seems unlikely since A I has no reported biological activity on 
vascu lar sm ooth m uscle (See: Peach 1977). Secondly, despite the high 
concentrations of ACE inhibitors employed, these may have been insufficient to 
result in complete inhibition of ACE. Thirdly, it is possible that A I  was converted 
to A II  by enzymes other than ACE, such as tonins (Boucher et al., 1974).
The fact that ACE inhibitors reduced or abolished the contractile response to 
A I demonstrates that A II can be generated locally by the action of vascular or 
endothelial angiotensin converting enzyme in both these preparations. To this 
extent, therefore, there may be a dissociation between the concentrations of A II 
found at the level o f vascular smooth muscle and those found in the general 
circulation. The lack of inhibitory effect of either cilazaprilat, captopril or saralasin 
on responses mediated via postjunctional oc2 -adrenoceptors alone, demonstrates 
that a complete, functional, local renin-angiotensin system is not to be found in 
either preparation in vitro, and is therefore dependent on some other component of 
the renin-angiotensin system not present in vascular smooth muscle, under the 
conditions employed. Demonstration of the local conversion of A I to A II, with 
subsequent facilitatory actions on responses to NA or sym pathetic nerve 
stimulation, has previously been demonstrated in the perfused rat mesentery and 
kidney vasculatures (Malik & Najletti, 1976, Boke & Malik, 1983).
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Effects o f Bay K  8644 and nifedipine on responses to NA mediated 
via postjunctional a j - and a-adrenoceptors
There has been considerable debate in recent years concerning the relative 
importance of different Ca^+ pools that may be activated following stimulation of 
postjunctional a-adrenoceptors. In particular this has focussed on the susceptibility 
o f responses to selective a j -  and o^-adrenoceptor agonists to 1,4-dihydropyridine 
derivatives in studies from whole animals. A num ber o f observations have 
suggested that vasopressor responses evoked by 0*2' t»ut not a l-adrenocep tor 
agonists are susceptible to the action of these agents, leading to the belief that 0*2' 
adrenoceptor-m ediated responses are wholly dependent on the influx of 
extracellular C a^+ through 1,4-dihydropyridine-sensitive C a^+ channels. In 
contrast, responses to aj-adrenoceptor stimulation have been postulated to activate 
principally the release of Ca^+ from intracellular sources with a smaller dependence 
on the influx of extracellular Ca^+ (for review see: van Zwieten & Timmermans,
1987). This hypothesis seems simplistic, however, since responses to some a y  
adrenoceptor agonists are markedly attenuated by calcium channel blockers 
(CCB's) in the pithed rat (Timmermans et al., 1983a,b).
Several explanations have been forwarded to explain these observations 
(Timmerm ans et al., 1983a,b, Nichols & Ruffolo, 1988). However the use of 
whole animals to study these phenomena is less than ideal for a number o f reasons. 
For example, these studies have generally used bolus injections of agonists, which 
do not produce ’equilibrium responses'. Responses to a-adrenoceptor agonists are 
often biphasic, each phase of which can be differentially modulated by a number of 
factors (O ’Brien et al., 1985). In addition, the measurement o f mean arterial 
pressure does not reflect possible differential effects of agonists on cardiac output 
and total peripheral resistance (see: McGrath et al., 1989). Therefore it was
196
desirable to examine the effects of 1,4-dihydropyridine derivatives on responses to 
NA mediated via postjunctional a y  and CX2 -adrenoceptors in isolated vascular 
preparations.
Responses to NA in rabbit isolated lateral saphenous vein, left renal vein, 
ear vein and distal saphenous artery have been shown to be at least partly dependent 
on the influx of extracellular Ca^+ for contraction (Daly et al., 1989). No evidence 
was obtained in these preparations to suggest that 1,4-dihydropyridine derivatives 
differentially influence responses mediated via either postjunctional a y  or ql^ - 
adrenoceptors. For example, Bay K 8644, an activator of voltage-dependent Ca^+ 
channels (Schramm et al., 1983), produced an enhancement of responses mediated 
via cx2 -adrenoceptors in the lateral saphenous vein. This was suggested by the 
reduction in potency of prazosin against responses to NA in the presence of Bay K 
8644 and directly demonstrated after isolation of a homogeneous population of 
postjunctional (^-adrenoceptors. In addition, this agent also potentiated responses 
to NA mediated via postjunctional a  ^ -adrenoceptors in the left renal vein.
Conversely, but in agreement with these observations, nifedipine, an 
inhibitor of voltage operated Ca^+ channels (Fleckenstein, 1977), produced a 
concentration-dependent reduction in the maximum response to NA after isolation 
of postjunctional (^-adrenoceptors in the lateral saphenous vein. This agent did 
not, however, completely block responses to NA under these conditions. Similarly, 
nifedipine reduced, but did not abolish, responses to NA after isolation of a.2~ 
adrenoceptors in the rabbit distal saphenous artery. Since responses to NA under 
these conditions are dependent upon the presence of A II (see later), it was 
theoretically possible that the reduction in the maximum response could be related to 
reduction in the activity of this agent. Nifedipine (l|iM ) however, did not affect the 
magnitude of the peak contractile response to A II. Therefore, the reduction in 
responses to NA is likely to reflect an action of nifedipine on the post receptor
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events subsequent to (^ -ad renocep to r stim ulation. The m axim ally effective 
concentration of nifedipine (0.1 |iM ) in both these preparations also reduced the 
magnitude of a  j-adrenoceptor-m ediated responses in the left renal vein. These 
results therefore demonstrate that at least part of the response to NA in these 
preparations is mediated via the influx of C a^+ through 1,4-dihydropyridine- 
sensitive channels, irrespective of the subtype stimulated.
Since responses to NA after isolation of postjunctional 0 C2 -adrenoceptors in 
the lateral saphenous vein are completely dependent upon the influx of extracellular 
Ca^+ (Daly et al., 1989), the nifedipine-resistant component of responses to NA 
seen under these conditions must reflect the entry of Ca^+ via 1,4-dihydropyridine- 
resistant, receptor-operated channels. Such channels also appear to be responsible 
for the influx of extracellular C a^+ following postjunctional (^ -ad ren o cep to r 
stimulation in the isolated ear vein, since Bay K 8644 was without effect on 
responses to NA. In agreement with this hypothesis, nifedipine has been shown to 
be inactive in this preparation (V.G. Wilson, personal communication).
The few other comparative studies attempted in vitro further outline the 
dangers inherent in generalising the susceptibility of responses mediated via a 
particular receptor to the blocking action of agents which interfere with one aspect 
o f stim ulus-response coupling. For example, while 1,4-dihydropyridines can 
influence postjunctional a 2 -adrenoceptor-mediated responses in a number of 
vascular preparations such as the rat saphenous vein (Cheung, 1985), feline 
mesenteric bed (Lippton et al., 1987) or canine saphenous artery (Sulpizio & 
Hieble, 1987) responses to NA, in the presence of prazosin (o^-adrenoceptor- 
mediated), are unaffected by Bay K 8644 in the human hand vein (Arner et al., 
1988). In addition, postjunctional a j-ad renocep to r-m ed ia ted  responses are 
facilitated by Bay K 8644 and reduced by nimodipine in human hand veins (Arner
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et al., 1988), but in contrast are resistant to the action of Bay K 8644 in the canine 
saphenous vein (Eskinder & Gross, 1987).
Therefore a sufficient number of exceptions can be demonstrated in isolated 
vascular preparations, that prevent the direct association between a-adrenoceptor 
subtype and susceptibility to 1,4-dihydropyridine derivatives, which has been 
postulated in vivo. The differential effect of CCB’s in whole animals is more 
likely to reflect a limitation of measuring only the change in the peak response to the 
bolus injection o f an agonist. For example, CCB's have no differential effect on 
responses mediated via either postjunctional a ^ -  or a 2 -adrenoceptors, if  the area 
under the curve is used as a measure of the whole response to a given agonist 
(M cGrath & O ’Brien, 1987). Likewise, these agents reduce the size o f the 
responses to infusions, which give a more 'equilibrium' type response, o f agonists 
selective for either subtype (McGrath & O'Brien, 1987, Lefevre-Borg et al.,
1988).
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Postjunctional a-adrenoceptors in rabbit isolated distal saphenous
artery
The rank order o f potencies for agonists in this preparation, NA > 
phenylephrine > U K -14304 > Sgd 101/75 strongly indicates a predominance of 
postjunctional ap-adrenoceptors in mediating contractile responses, and is similar 
to that observed in various other vascular preparations from the rabbit which 
contain homogeneous populations of a  j-adrenoceptors (see: Daly et al., 1988c). 
In addition, prazosin produced a concentration-dependent rightward displacement 
of the CCRC to NA, with a pA 2  value of 8.57 and the slope of the Schild plot did 
not significantly differ from unity, indicating competitive antagonism. This pA 2  
value for prazosin is consistent with reported pA 2  values against a  ^ -adrenoceptor- 
mediated responses in other vascular preparations from the rabbit such as the 
thoracic aorta (8.7) (Docherty et al., 1981), ear artery (8.6) (Hieble et al., 1982) 
or rabbit pulmonary artery (8.8) (Kaposci et al., 1987).
Conversely, rauwolscine (l|iM ), a concentration approximately 100 times 
greater than that equivalent to its pA 2  value at postjunctional (X2 -adrenoceptors in 
the rabbit ear vein (Daly et al., 1988b) and its dissociation constant in the lateral 
saphenous vein after isolation of postjunctional ot2 -adrenoceptors (present study), 
produced only a small rightward displacem ent o f the CCRC to NA in this 
preparation. Therefore, the estimated -log K g value for rauwolscine (6.32) in the 
rabbit distal saphenous artery is slightly higher, but not dissimilar to its reported 
pA 2  value at postjunctional aj-adrenoceptors in other preparations, such as the 
thoracic aorta (6.1) and ear artery (5.5) (Daly et al., 1988c). Further evidence that 
under normal experimental conditions this preparation contains solely postjunctional 
ai-adrenoceptors is provided by the observation that prazosin (O.ljiM) was a more 
potent antagonist against responses to phenylephrine, Sgd 101/75 and UK-14304
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than was rauwolscine (1|J.M).
Influence o f  A I I  on a-adrenoceptor-m ediated responses
As mentioned previously, A II, without altering resting baseline tension, 
produced a marked increase in the sensitivity of responses to U K -14304 in the 
rabbit isolated distal saphenous artery. Thus, previously absent responses were 
'uncovered' at low concentrations of U K -14304. These responses were unaffected 
by prazosin at a concentration which is approximately 50 times greater than for its 
pA 2  value at aj-adrenoceptors in this preparation. The CCRC to U K -14304 in the 
presence of A II however, was shifted to the right at higher concentrations of UK- 
14304, indicating the continued expression of responses m ediated via 
postjunctional a  j-adrenoceptors. In contrast, in the presence of A II, rauwolscine 
(lfiM ) antagonised the responses to U K -14304 more effectively than prazosin 
(0.1 JiM), in effect preventing the increase in sensitivity to U K -14304 produced by 
A II. Therefore in the presence of A II responses to an a-adrenoceptor agonist, 
U K -14304, were more suceptible to rauwolscine than they were to prazosin, and 
are likely to have been mediated by postjunctional a 2 -adrenoceptors.
In contrast to the marked effects of A II on responses to U K -14304, this 
agent was without effect on responses to NA (non-selective) and the selective a j -  
adrenoceptor agonist phenylephrine. It did however produce a small increase in the 
sensitivity of the preparation to the partial agonist Sgd 101/75, providing the first 
evidence in the present study that A II can produce a facilitation of responses 
mediated via postjunctional a^-adrenoceptors.
Before classifying the uncovered responses to U K-14304 in the presence of 
A II as being mediated via postjunctional a 2 -adrenoceptors, it was desirable to
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demonstrate activity for NA at these receptors. In accord with this hypothesis, A II 
made responses to NA more resistant to the antagonistic action o f prazosin, 
particularly on the lower portion of the CCRC. This is similar to the effect of A II 
on prazosin antagonism seen in the lateral saphenous vein and the introduction of a 
prazosin-resistant component of responses strongly indicates the presence of both 
postjunctional 0C|- and a 2 ~adrenoceptors in the distal saphenous artery. These 
results also parallel observations in the rat tail artery, in which the lower third of the 
CCRC to NA is slightly ’resistant' to prazosin over a limited prazosin concentration 
range (Rajanayagam  & M edgett, 1987) and in which postjunctional (X2 - 
adrenoceptor-mediated responses have subsequently been demonstrated (Templeton 
et al., 1989). The lack of effect of A II  on the antagonism produced by prazosin on 
responses to Sgd 101/75 and phenylephrine demonstrates that responses produced 
by these agonists in the absence and presence of A II w ere m ediated via 
postjunctional a  ^ -adrenoceptors.
Attempted isolation o f postjunctional CX2-adrenoceptors in rabbit 
isolated distal saphenous artery
Phenoxybenzamine (0.3}iM), an irreversible a-adrenoceptor antagonist 
(Furchgott, 1972), virtually abolished responses to NA in the rabbit isolated distal 
saphenous artery. The basis for receptor isolation, therefore, was to provide 
conditions whereby any postjunctional a 2 -adrenoceptors could be selectively 
protected by the inclusion of ljiM  rauwolscine in an analogous manner to that used 
in the lateral saphenous vein. This concentration of a 2 -adrenoceptor antagonist was 
considered to be selective since it was without effect on responses to phenylephrine 
in the distal saphenous artery.
In contrast to the saphenous vein, the inclusion of rauwolscine (lpM ) prior 
to and during exposure to phenoxybenzamine, did not result in part of the response
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to NA being spared from phenoxybenzamine. This does not indicate the absence of 
postjunctional ct2 -adrenoceptors however, since in the presence o f A II 
concentration-dependent responses were observed to the a-adrenoceptor agonists 
U K -14304, NA and phenylephrine. The rank order of potencies for these agonists, 
UK-14304 > NA > phenylephrine differs from the potency order for these agents 
under normal circumstances, NA > phenylephrine >U K -14304, and is similar to 
the potency order for agonists found in the rabbit ear vein, which contains 
predominantly postjunctional a 2 -adrenoceptors (Daly eta l., 1988b).
Additionally, responses to NA after the receptor protection protocol in the 
presence of A II were resistant to 0.1 |iM  prazosin, a concentration approximately 
150-times greater than for its pA 2  value on postjunctional a^-adrenoceptors in this 
preparation. They were however, susceptible to rauw olscine (1|J.M) which 
produced an approximately 100-fold rightward displacement of the CCRC to NA, 
with an estimated -logK g value of 8.01. This value corresponds well with that 
obtained against responses to NA in the lateral saphenous vein after isolation of 
postjunctional a 2 -adrenoceptors and against responses to NA in the rabbit ear vein 
(Daly et al., 1988b). Further evidence favouring the existence of a homogeneous 
population of postjunctional a 2 -adrenoceptors under these conditions, is provided 
from the observation that the combination of prazosin (0.1 |iM ) and rauwolscine 
(ljiM ) was no more effective at inhibiting responses to NA than rauwolscine (l|iM ) 
alone. Essentially these results are similar to those obtained under normal 
experimental conditions, where A II was a prerequisite for the demonstration of 
prazosin-resistant responses to both U K -14304 and NA.
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Interaction between postjunctional d j - and a^-adrenoceptors
A number of observations in the rabbit isolated lateral saphenous vein and 
distal saphenous artery suggest that postjunctional a ^ -  and o^-adrenoceptors do 
not co-exist in a simple manner. For example, despite the fact that postjunctional 
o^-adrenoceptors can be clearly dem onstrated in both preparations, under 
appropriate conditions, no component of the response to NA is resistant to prazosin 
when both a-adrenoceptors are present. In addition, having clearly demonstrated a 
facilitatory ro le for A II on responses m ediated via postjunctional a.2~ 
adrenoceptors, we may then have expected this agent to enhance responses to NA, 
a non-selective agonist, when the full receptor complement was present in each 
preparation. Such an action was observed in neither.
These apparently paradoxical observations could be reconciled if the two 
postjunctional a-adrenoceptors reside on the same cells and interact at the level of a 
common post-receptor site in the events leading to contraction. Thus, responses 
mediated by postjunctional a 2 -adrenoceptors in the distal saphenous artery may be 
dependent upon simultaneous stimulation of the a  j-adrenoceptor population. With 
the latter predominating, this would explain the relatively high potency of prazosin, 
with no component of responses to NA (or other agonists) being resistant to the 
-adrenoceptor antagonist, and the relatively low potency of rauwolscine. Since 
both a-adrenoceptors are present under normal experimental conditions, the 
positive influence required for the expression of a 2 -adrenoceptor-m ediated  
responses would be provided by stimulation of postjunctional aj-adrenoceptors. 
Assuming a similar mechanism to be involved, the requirement for A II would 
therefore be superfluous, explaining the lack of a facilitatory action for this agent 
against responses to NA when the full receptor complement was active.
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If  however, a  j-adrenoceptors are inhibited, by either prazosin or 
phenoxybenzamine, this positive influence for A II would subsequently be a 
prerequisite for the expression of o^-adrenoceptor-m ediated responses. This 
therefore explains the induction o f prazosin-resistance produced by A II, and the 
requirement for the presence of this agent to produce responses to NA mediated via 
postjunctional ot2 -adrenoceptors, after irreversible inactivation of postjunctional 
a  j-adrenoceptors with phenoxybenzam ine. An interaction between the a -  
adrenoceptors in this preparation was directly demonstrated by inducing a small 
degree o f tone in the distal saphenous artery with a selective concentration of 
phenylephrine (O.OljiM). Stim ulation o f a j-ad ren o cep to rs  resulted in the 
introduction of a previously 'unseen' component of responses to U K -14304, at 
very low concentrations, analogous to that introduced by A II. Attempting to 
examine the effects of a-adrenoceptor antagonists on these responses would have 
negated the experiment. However it is reasonable to assume that the uncovered 
responses to U K -14304 w'ere mediated via postjunctional a 2 -adrenoceptors. The 
concept of interacting postjunctional a-adrenoceptors in the distal saphenous artery 
is represented diagramatically in Figure 71.
A similar interaction between postjunctional a-adrenoceptors is also 
im plicated in the lateral saphenous vein, although the dependency o f a 2 * 
adrenoceptor-mediated responses on a  j-adrenoceptor stimulation is somewhat less. 
This is apparent since NA can clearly sustain a response alone after isolation of 
postjunctional a 2 -adrenoceptors, contrasting with the distal saphenous artery, 
where responses are wholly dependent on the presence of a stimulatory agent. The 
relatively high pA 2  value obtained for rauwolscine in this preparation indicates that 
a 2 -adrenoceptors are the predominant subtype, but their susceptibility to prazosin 
indicates some dependence upon a small degree of stimulation o f the a j -  
adrenoceptor population. Despite a competitive action of prazosin at postjunctional 
ai-adrenoceptors, this would not necessarily result in a parallel shift in the agonist
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NA
NA
a d A l l
contraction
(prazosin-sensitive)
contraction
(prazosin-sensitive)
alpha-l> alpha-2
Rauwolscine • small effect 
Prazosin - large effect 
(no resistant component)
Positive influence of A II for alpha-2-adrenoceptor expression not required
NA
A l lAD
no contraction
no contraction
contraction
(prazosin-resistant)
Positive influence of A II required for alpha-2-adrenoceptor expression after 
blockade of positive influence from alpha-1 adrenoceptors
Figure No. 71
D iagram m atic representation o f the postulated in teraction betw een 
postjunctional a-adrenoceptor subtypes in the rabbit isolated distal saphenous 
artery. Note that under normal circumstances, a 2-adrenoceptors provide the 
positive input required for the expression of a 2-adrenoceptors, therefore all 
responses are sensitive to prazosin. A II, is only required if a  j -adrenoceptors
are blocked with either prazosin or phenoxybenzamine.
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CCRC, because of the unequal influence o f prazosin on the two sets o f receptor- 
m ediated events i.e. blockade of a  j-adrenoceptor m ediated contractions and 
facilitation and lack of blockade of o^-adrenoceptor-mediated contractions. Again 
under these circumstances, the facilitatory action o f A II on postjunctional 
adrenoceptor-mediated responses is apparent only if  a  ^ -adrenoceptors are blocked 
by prazosin or phenoxybenzamine.
In contrast to both the distal saphenous artery and lateral saphenous vein 
responses to NA in the rabbit isolated ear vein are resistant to prazosin, but 
susceptible to rauwolscine (Daly et al., 1988b). Therefore, the positive co­
operation of postjunctional a  ^ -adrenoceptors is not required for the expression of 
0 C2 -adrenoceptor-mediated responses in this preparation. These three preparations 
therefore, provide a spectrum for the ability of (^-adrenoceptors to sustain a 
response alone. It is interesting to note that the facilitatory action of A II is greatest 
where (X2 -adrenoceptor-mediated responses are least manifest (distal saphenous 
artery), and least where they are easily demonstrated (ear vein), and that this 
parallels the degree of interaction between postjunctional a-adrenoceptor subtypes.
An analogous situation, to the interaction between a-adrenoceptor subtypes 
in the lateral saphenous vein, appears to exist for P^- and P2 -adrenoceptors ^ a t  
m ediate relaxation to NA in guinea-pig isolated tracheal strips (Carswell & 
Nahorski, 1983). Here, the existence of the pj-subtype was clearly evident from 
the presence o f a resistant component of responses to NA in the presence of the 
selective p 2 -adrenoceptor antagonist ICI 118,551. However, no component of the 
NA CCRC was resistant to the selective pj-adrenoceptor antagonist atenolol and 
the slope of the Schild plot was less than unity. The authors suggested that this wras 
indicative of a functional interaction between two subtypes of adrenoceptors that 
mediate the same functional response. Similarly, an even more subtle interaction
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between a functionally active population of a  j-adrenoceptors and a 'quiescent' 
population o f ot2 -adrenoceptors on the cat nictitating m em brane has been 
dem onstrated (Shepperson, 1984). C ontractile responses to selective ocj- 
adrenoceptor agonists were potentiated by prior exposure to a selective a 2~ 
adrenoceptor agonist, even though these agonists failed to produce a functional 
response. This effect could be blocked by selective a 2 -adrenoceptor antagonists.
As mentioned in the introduction, since the original demonstration of 
postjunctional (^-adrenoceptors in the pithed rat (Drew & Whiting, 1979, Docherty 
ex a l., 1979, Docherty & McGrath, 1980), identification of this subtype on isolated 
vascular preparations, both responding to NA and resistant to prazosin or a suitable 
a |-a d re n o c e p to r antagonist, has proved very difficult. W hile a num ber of 
explanations have been forwarded to explain the elusive nature of this receptor 
subtype (see: McGrath et al., 1989), it is clear from the present study that one such 
factor that may conspire to render contractions mediated by postjunctional 0 C2 - 
adrenoceptors 'prazosin-sensitive', is the dependency of o^-adrenoceptor-mediated 
contractions on stimulation of aj-adrenoceptors. Since other contractile agents can 
substitute for the positive influence of a j  -adrenoceptors, prazosin-resistant 
responses could be easily demonstrated in whole animals due to the presence of 
circulating vasoactive substances. In this respect, A II would assume great 
im portance, particularly in models such as the pithed rat where the renin- 
angiotensin system is highly activated (Grant & McGrath, 1988b).
Such an interaction between postjunctional a-adrenoceptors has widespread 
implications for the characterisation of the a-adrenoceptor populations in blood 
vessels currently available for study in vitro. This is perhaps best illustrated by two 
further examples, which suggest that the clear demonstration of a 2 -adrenoceptor- 
mediated responses has been obscured by their indirect sensitivity to prazosin.
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Firstly, responses to NA in the isolated vascular bed o f the rat tail are 
prazosin-sensitive, rauwolscine-resistant (aj-m ediated) under normal experimental 
conditions, but in contrast, a sizeable component of the response to NA becomes 
prazosin-resistant, rauw olscine-sensitive (ot2 -mediated) in the presence of 
vasopressin induced tone (Templeton et al., 1989). Similarly, inducing tone with 
phenylephrine also introduced rauwolscine-sensitive responses to UK-14304 in this 
preparation (Templeton, 1988). Secondly, responses to NA in the rabbit femoral 
artery were shown to be prazosin-sensitive, rauwolscine-resistant, and therefore by 
definition a  j-adrenoceptor-mediated (Purdy & Weber, 1988). In the present study 
however, A II introduced a component of responses to U K -14304 in the femoral 
artery in an analogous manner to that seen in the distal saphenous artery. It would 
seem reasonable therefore, to predict that further analysis would demonstrate 
unequivocably the presence of postjunctional a 2 -adrenoceptors in the femoral 
artery.
Such an interaction between postjunctional a^ - and ct2 -adrenoceptors may 
also partially explain the wide disparity in the relative potencies of a ^ -  and 0-2' 
adrenoceptor antagonists found between vascular preparations (see: Drew, 1985, 
M cGrath et al., 1989). If, for example, the expression o f postjunctional CX2 - 
adrenoceptors is completely dependent upon a  j-adrenoceptor stimulation, then we 
may expect that prazosin, in all situations, should potently antagonise responses in 
a competitive manner (as is the case in the distal saphenous artery). The relative 
potency of ot2 -adrenoceptor antagonists will however, depend upon the relative 
predominance of this subtype. Therefore, with an increasing contribution of 
postjunctional o^-adrenoceptors to the total response, the pA 2  values for <X2 ~ 
adrenoceptor antagonists will increase accordingly. It is interesting to note 
therefore, that in the human femoral artery and canine portal vein, in both of which 
there is some evidence suggesting the presence of postjunctional oc2 -adrenoceptors 
(Glusa & Markwardt, 1983, Furuta, 1988), that prazosin is only 11-35-fold more
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potent than yohimbine (De Mey & Vanhoutte, 1981, Shoji et a l,  1983), in contrast 
to the rabbit pulmonary artery (Starke, 1981), rat aorta or portal vein (Digges & 
Summers, 1983) where the differential is greater than 200-fold.
This situation becom es even m ore com plex if  postjunctional a.2~ 
adrenoceptors in a particular preparation, have some ability to sustain responses 
alone, but are facilitated by stimulation of the a  j-adrenoceptor subtype. Under 
these circumstances, the nature of the antagonism produced by a-adrenoceptor 
antagonists would tend to be associated with non-parallel shifts of the agonist 
CCRC, due to their unequal influence on the two sets of receptor-mediated events, 
and may also be associated with the appearance of a resistant component o f the 
response. The rat tail artery (Rajanayagam & M edgett, 1987) and the lateral 
saphenous vein (present study, Daly et al., 1988a) represent two functional 
examples of such an interaction.
The facilitatory influence of vasoactive agents on postjunctional 0*2- 
adrenoceptors is not limited to A II and aj-adrenoceptors, since the thromboxane 
mimetic U46619 also produced a similar potentiation of responses to U K -14304 in 
the rabbit distal saphenous artery. Similarly, Furuta (1988) has shown that the 
selective a 2 -adrenoceptor agonist, B-HT 920, produced yohimbine-sensitive, 
prazosin-resistant contractile responses of the canine portal vein in the presence of a 
wide range of vascular stimulants. A number of striking differences exist between 
this preparation and the distal saphenous artery however. For example, Bay K 8644 
and KC1 also uncovered responses to B-HT 920 in the canine portal vein, leading 
the author to conclude that the uncovering of a 2 -adrenoceptor-mediated responses 
was associated with an increase in intracellular Ca^+ levels. These agents although 
potentiating responses to U K -14304 in the rabbit distal saphenous artery, did not 
produce a marked increase in the threshold concentration o f U K -14304 for
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contraction, which was characteristic of the introduction of postjunctional 
adrenoceptor-mediated responses. This suggests that the potentiation produced by 
Bay K 8644 and KC1 in this preparation, represents an enhancement o f UK-14304 
responses mediated via postjunctional a  j-adrenoceptors. Therefore it is unlikely 
that an increase in the intracellular Ca^+ levels alone is an adequate explanation for 
the effects of various vasoactive agents on a 2 -adrenoceptor-mediated responses in 
the distal saphenous artery.
Since postjunctional (^-adrenoceptors can be uncovered in the distal 
saphenous artery by a number of agents which stimulate specific receptors, it would 
seem reasonable to assume that o^-adrenoceptor expression is dependent upon (or 
facilitated by) some common process activated by these agents. It is therefore 
interesting to note that a  j-adrenoceptors, A II receptors and thromboxane receptors 
are linked to activation of the phosphatidylinositol pathway in vascular smooth 
muscle (Abdel-Latif, 1986). Due to the inability to clearly demonstrate functionally 
active postjunctional (^-adrenoceptors in isolated vascular preparations, little is 
known about the biochemical consequencies of their activation. However in a 
variety of non-vascular tissues, stimulation of a 2 -adrenoceptors is closely linked 
with the production of cyclic AMP (Isom & Limbird, 1988). It is therefore 
possible, that the interaction between vasoactive agents and postjunctional 0-2' 
adrenoceptors in vascular smooth muscle, may be the result of an interaction 
between two differing second messenger systems, mediating the same functional 
response.
In relation to the nature of the potentiation produced by vasoactive agents on 
responses to UK-14304, it is interesting to observe that the combination of agonists 
which mediate the same functional response, via different second messenger 
systems, interact in a synergistic manner, while those which utilise the same second
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messenger pathway are merely additive in non-vascular tissues (Sugden et al., 
1984, Cocks et al., 1984). While such a synergistic interaction between different 
second messenger systems would be a suitable explanation for the effects of A II, 
phenylephrine and U46619 on responses to U K -14304, it should be noted that 
5-HT receptor stimulation is also associated with increasing the turnover of the 
phosphatidylinositol pathway in vascular smooth muscle (Abdel-Latif, 1986). This 
agent did not uncover a component of responses to U K -14304. This observation is 
difficult to explain in terms of the above simplistic hypothesis. However it is 
possible that the vascular receptors activated by 5-HT do not reside on the same 
smooth muscle cells as postjunctional <X2 -adrenoceptors. This would therefore 
preclude any intracellular, biochemical interaction subsequent to stimulation of these 
receptors.
Sympathetic neurovascular transmission in the rabbit isolated distal
saphenous artery
Sym pathetic neurovascular transm ission in the rabbit isolated distal 
saphenous artery is the resultant o f a com plex interaction between three 
postjunctional receptor systems, a j-ad ren o cep to rs , purinoceptors and 0 C2 - 
adrenoceptors. In order to demonstrate contractile responses to each o f these three 
receptor systems, responding to a nerve released transmitter, some manipulation of 
the experimental conditions was required.
a  1 -adrenoceptors
Postjunctional a  j-adrenoceptors clearly have a predom inant role in 
mediating the end-organ contractile responses to sympathetic nerve stimulation in 
the rabbit isolated distal saphenous artery. Prazosin (0.1 |iM ), a concentration 
selective for a  j-adrenoceptors in this preparation (see previous section), markedly 
attenuated or abolished nerve-mediated responses when applied alone, or after the 
combination of rauwolscine (lfiM ) and a,p-methylene ATP (3pM).
Purinoceptors
The demonstration of a purinergic component of responses to sympathetic 
nerve stimulation was apparent only after complete adrenergic blockade. The P2 - 
purinoceptor desensitising agent a ,p -m ethy lene  ATP (3}iM) (Kasakov & 
Bumstock, 1983) abolished the residual response remaining after the combination 
o f prazosin (O.ljiM) and rauwolscine (ljiM ). This inhibitory effect o f a ,p -  
methylene ATP is consistent with the blockade of purinergic transmission which 
has been described in a number of other vascular preparations (eg. Muramatsu,
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1986, Ramme et al., 1987). In the absence of any other antagonist however, a ,p - 
methylene ATP (3jiM) produced an enhancement of responses to sympathetic nerve 
stimulation. Similar results have been obtained in both the rabbit isolated lateral 
saphenous vein and ileocoelic artery (unpublished observations). It appears likely 
therefore, that determination of an inhibitory effect o f a,p-m ethylene ATP under 
these circumstances is offset by a more dominant facilitatory influence of this agent 
on adrenergic transmission. The mechanism for the facilitatory action of a ,P - 
m ethylene ATP is unknown, although two possible explanations could be 
forwarded. Firstly, it could be the result o f a postjunctional enhancement of 
adrenergic responses or alternatively it may be due to the inhibition o f a 
prejunctional purinoceptor-mediated negative feedback mechanism. The former 
suggestion seems more likely however, since responses to exogenous NA in the 
ileocoelic artery are potentiated by a,P-m ethylene ATP (J. Bulloch, personal 
communication).
It should be noted that in a previous study, Bumstock & W arland (1987) 
demonstrated a marked inhibitory effect for a,P-methylene ATP on nerve-mediated 
responses in the rabbit saphenous artery. It is now apparent that these authors used 
the proximal saphenous artery rather than the distal saphenous artery used in the 
present study (G. Burnstock, personal com m unication). These results are 
particularly interesting because they clearly indicate that marked differences can 
occur in the sympathetic transmission process between sequential segments o f a 
vascular preparation.
£*2-adrenoceptors
Rauwolscine (ljiM ) can be considered selective for (X2 -adrenoceptors since 
it was without effect on responses to phenylephrine or Sgd 101/75 in this
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preparation. Under normal conditions rauwolscine (l}iM) produced a potentiation 
of responses to sympathetic nerve stimulation in the distal saphenous artery. This 
effect is in accord with its inhibitory influence on a 2 -adrenoceptor-m ediated 
autoinhibition (for reviews see: W estfall, 1977, Starke, 1987, Stjame, 1989). 
Furthermore, rauwolscine produced an enhancement of responses in the presence 
o f prazosin (0.1 |iM ). Since this response was subsequently abolished by a ,p -  
methylene ATP (3jj.M) it seems reasonable to conclude that this effect represents an 
increase in the output o f the purinergic transm itter by a sim ilar blockade of 
prejunctional feedback.
This prejunctional o^-adrenoceptor mediated negative feedback system can 
obviously com plicate the dem onstration o f 'innervated' postjunctional o.2~ 
adrenoceptors, due to the mutually opposing actions of antagonists, particularly if 
0 C2 -adrenoceptors are not the predominant subtype. This is further complicated in 
the distal saphenous artery ( and maybe in other preparations) by the dependency of 
postjunctional oc2 -adrenoceptors upon a degree of stimulation of the ocj-subtype. 
The combination of these two factors may explain the difficulty associated in 
demonstrating postjunctional o^-adrenoceptors responding to NA released from 
nerves in isolated vascular preparations. Indeed, 'innervated' postjunctional a.2~ 
adrenoceptors have been demonstrated most convincingly in the saphenous veins 
from various species (Flavahan et al., 1984, Cheung, 1985, Docherty & Hyland, 
1985), in each of which oc2 -adrenoceptors are the predom inant postjunctional 
subtype and their expression is not completely dependent upon a positive influence 
from a 2 -adrenoceptor stimulation (Flavahan & Vanhoutte, 1987).
Contractile responses to sympathetic nerve stim ulation, mediated by 
postjunctional ot2 -adrenoceptors, could be demonstrated under the appropriate 
conditions in the distal saphenous artery. When this preparation was exposed to
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A II (0.05|J.M), the small residual response remaining after the combination of 
prazosin (0.1 pJM) and a,(3-methylene ATP (3pM) was markedly potentiated. This 
response was subsequently inhibited by rauwolscine (ljiM ) providing the direct 
demonstration that postjunctional (X2 -adrenoceptors are located postjunctionally, 
sufficiently close to the neurovascular junction that they can respond to NA released 
from nerves. This situation is essentially analogous to that seen with exogenous 
NA, w here postjunctional 0 C2 -adrenoceptor-m ediated responses are only 
demonstrable after inhibition of a^-adrenoceptors in the presence of A n .
A number o f other studies also suggest the existence of postjunctional 
interactions betw een a-adrenocep tors involved in m ediating responses to 
sympathetic nerve stim ulation. For exam ple in the canine saphenous vein, 
responses to low frequencies of nerve stimulation are abolished by both a -p  and 
a 2 -adrenoceptor antagonists (Flavahan et al., 1984). Since the selectivity of the 
concentrations of antagonist employed remained unquestioned, these observations 
strongly suggested that responses to nerve stimulation reflected a supra-additive 
interaction between the a-adrenoceptor subtypes. Similar observations have been 
made in the hind limb of the dog and in human digital arteries (Gardiner & Peters, 
1982, Stevens & Moulds, 1985). Therefore, in analogous manner to the interaction 
between a-adrenoceptors responding to exogenous NA, a 2 -adrenoceptor-mediated 
responses to nerve stimulation may be rendered sensitive to prazosin and may, in 
part, account for their elusive nature in isolated vascular preparations.
Effect o f A II  on responses to sympathetic nerve stimulation
As mentioned in the introduction, A II  has been demonstrated to potentiate 
responses to sympathetic nerve stimulation in a wide variety of smooth muscle 
preparations. This effect has largely been ascribed to a prejunctional facilitatory 
mechanism, since equivalent-sized responses to NA in most preparations were
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prazosin (0.1 p.M) and a,p-m ethylene ATP (3pM) was markedly potentiated. This 
response was subsequently inhibited by rauwolscine (ljiM ) providing the direct 
demonstration that postjunctional cx2 -adrenoceptors are located postjunctionally, 
sufficiently close to the neurovascular junction that they can respond to NA released 
from nerves. This situation is essentially analogous to that seen with exogenous 
NA, where postjunctional a 2 -adrenoceptor-m ediated  responses are only 
demonstrable after inhibition of ap-adrenoceptors in the presence of A II.
A number of other studies also suggest the existence of postjunctional 
interactions between a-adrenocep tors involved in m ediating responses to 
sympathetic nerve stim ulation. For exam ple in the canine saphenous vein, 
responses to low frequencies of nerve stimulation are abolished by both a ^ -  and 
(X2 -adrenoceptor antagonists (Flavahan et al., 1984). Since the selectivity o f the 
concentrations o f antagonist employed remained unquestioned, these observations 
strongly suggested that responses to nerve stimulation reflected a supra-additive 
interaction between the a-adrenoceptor subtypes. Similar observations have been 
made in the hind limb of the dog and in human digital arteries (Gardiner & Peters, 
1982, Stevens & Moulds, 1985). Therefore, in analogous manner to the interaction 
between a-adrenoceptors responding to exogenous NA, a 2 -adrenoceptor-mediated 
responses to nerve stimulation may be rendered sensitive to prazosin and may, in 
part, account for their elusive nature in isolated vascular preparations.
Effect o f A II on responses to sympathetic nerve stimulation
As mentioned in the introduction, A II has been demonstrated to potentiate 
responses to sympathetic nerve stimulation in a wide variety of smooth muscle 
preparations. This effect has largely been ascribed to a prejunctional facilitatory 
mechanism, since equivalent-sized responses to NA in most preparations were
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potentiated to a smaller degree than those to nerve stimulation (for reviews see: 
Z im m erm ann, 1979, W estfall, 1977). W ithout m easuring the output of 
radioactively labelled neurotransmitters it is difficult to determine the site of action, 
whether pre- or postjunctional, of an agent which produces facilitation of nerve- 
mediated responses. However, a number o f experimental observations suggest that 
A H can act at both levels to potentiate sympathetic nerve-mediated responses in the 
rabbit isolated distal saphenous artery.
The uncovering by A II of prazosin-resistant, rauwolscine-sensitive nerve- 
m ediated responses is analogous to the effects o f this agent on responses to 
exogenous NA. This, therefore, indicates a postjunctional interaction between A II 
and one of the components of sympathetic nerve mediated transmission in the distal 
saphenous artery. In addition, however, A II probably has a prejunctional 
facilitatory action. This seems likely since this peptide potentiated responses to 
sympathetic nerve stimulation under all circumstances, the exception being in the 
presence o f rauwolscine and a,P-m ethylene ATP, when nerve responses were 
already markedly increased. Further experiments would be required however, to 
determine the site of action of A II.
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Abstract
The results presented in this thesis provide evidence that postjunctional CX2 - 
adrenoceptors can be demonstrated in an isolated arterial and venous preparation 
from  the rabbit, under appropriate conditions. Under norm al circum stances, 
responses to NA in both the lateral saphenous vein and distal saphenous artery, are 
susceptible to low concentrations of selective a  j-adrenoceptor antagonists. This 
could be taken as an indication either for atypical a-adrenoceptors (saphenous vein) 
or for a homogeneous population of postjunctional a  j-adrenoceptors (saphenous 
artery). However, a closer examination of each preparation suggests that the 
effectiveness of agents such as prazosin or YM 12617 in these preparations, results 
from an interaction between postjunctional a^ - and a 2 -adrenoceptors. Therefore, 
the expression of postjunctional a 2 -adrenoceptor-mediated responses are partially or 
wholly dependent upon a degree of stimulation of postjunctional aj-adrenoceptors. 
Such an interaction may mask the presence of postjunctional a 2 -adrenoceptors in 
other isolated vascular preparations. These results have implications for classifying 
receptors by the susceptibility of agonists to prazosin (or equivalent). Such an 
interaction also complicates the demonstration of postjunctional a 2 -adrenoceptors 
responding to nerve-released NA in the saphenous artery. The ease in demonstrating 
prazosin-resistan t responses in vivo could be explained by the presence of 
vasoactive substances, with A II of particular importance, which can substitute for 
aj-adrenoceptors to provide the necessary positive influence for a 2 -adrenoceptor 
expression. H aving isolated homogeneous populations of both a ^ -  and a 2 ~ 
adrenoceptors, comparative studies on the effects of agents such as calcium channel 
blockers/facilitators on responses to the endogenous ligand NA could be attempted. 
This approach overcomes the limitations of studies in vivo. No differential effects 
for 1,4-dihydropyridines were observed on responses to NA mediated via either 
subtype.
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